Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024172	s-epo	u/l (u/l)	3593	4503	0.00%
3024172	s-epo	iu/l (u/l)	1564	1991	0.45%
3024172	s-epo	— (—)	903	1002	100.00%	Distribution not available
3024172	s-erytropoietiini	u/l (u/l)	41	42	0.00%
3024172	erytropoietiini	iu/l (u/l)	34	37	0.00%
3024172	erytropoietiini,seerumista	iu/l (u/l)	31	31	0.00%
3024172	s-erytropoietiini	iu/l (u/l)	29	29	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Anaemias

458

313

10.02

319.21

1.4

1.1

90.46

14.32

u/l

7.12

424

270

Myeloproliferative diseases

849

409

27.96

307.65

1.3

1.2

29.66

45.32

u/l

0.88

703

356

Other and unspecified anaemias

1072

2130

5.09

307.65

1.3

80.88

27.13

u/l

11.74

964

1801

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

316

131

34.53

307.65

1.4

1.1

136.90

20.68

u/l

12.83

281

117

Other diseases of blood and blood-forming organs, wide

1074

1068

11.22

307.65

1.4

1.2

43.66

33.95

u/l

0.89

947

931

Other anaemias

1076

2143

5.06

307.65

1.3

83.46

27.25

u/l

11.45

968

1812

Secondary polycythaemia

397

107

70.05

307.65

1.4

1.2

15.59

51.07

u/l

1.17

347

Myeloproliferative diseases (CML excluded)

814

381

29.46

307.65

1.3

1.2

26.09

46.77

u/l

1.29

672

331

Other diseases of blood and blood-forming organs

775

333

32.82

307.65

1.4

1.2

25.47

37.99

u/l

0.94

684

289

Polycythaemia vera

439

163

41.22

307.65

1.3

1.2

18.53

21.80

u/l

0.20

333

142

Aplastic and other anaemias

1145

2280

4.97

307.65

1.3

83.13

27.55

u/l

12.30

1031

1926

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2446

3206

5.66

307.65

1.3

53.29

21.45

u/l

13.66

2184

2744

Essential (haemorrhagic) thrombocythaemia

335

175

25.21

307.65

1.3

1.2

32.01

20.09

u/l

0.71

297

150

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

328

168

25.67

307.65

1.4

1.2

135.15

19.12

u/l

13.63

291

150

L01XX Other antineoplastic agents

512

274

24.82

307.65

1.2

31.95

50.13

u/l

0.70

418

234

Renal failure

957

2380

3.81

294.39

1.3

32.21

40.63

u/l

1.35

838

2040

Chronic kidney disease

704

1601

4.57

282.14

1.2

1.3

30.51

41.30

u/l

1.53

627

1372

Primary_lymphoid and hematopoietic malignant neoplasms

628

1359

4.86

270.39

1.3

98.54

34.78

u/l

7.77

573

1165

Primary_lymphoid and hematopoietic malignant neoplasms

628

1376

4.79

266.09

1.3

1.2

98.54

26.15

u/l

10.67

573

1174

Other and unspecified diseases of blood and blood-forming organs

202

112

23.04

260.24

1.5

1.2

47.01

32.97

u/l

0.40

178

102

Heart failure, not strict

1265

3081

2.89

234.94

1.2

1.3

41.00

33.70

u/l

0.95

1132

2640

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

328

450

8.05

229.56

1.4

1.2

73.10

22.99

u/l

6.89

311

390

Heart failure and antihypertensive medication

508

604

5.74

227.28

1.2

1.4

38.94

47.09

u/l

0.45

457

520

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1454

3460

2.61

216.26

1.2

1.3

30.21

35.63

u/l

0.70

1281

2993

Chronic myeloproliferative disease

142

34.88

208.59

1.5

1.1

76.73

27.31

u/l

1.86

127

Renal tubulo-interstitial diseases

1301

3890

2.61

205.68

1.3

34.99

36.07

u/l

0.11

1139

3377

Multiple myeloma, excluding all cancers (controls excluding all cancers)

234

244

11.00

205.45

1.4

1.1

87.80

21.02

u/l

6.70

222

212

Diabetes, insulin treatment (Kela reimbursement)

1514

3793

2.48

203.65

1.2

1.3

29.86

36.22

u/l

0.91

1337

3284

Multiple myeloma and malignant plasma cell neoplasms

230

240

10.98

201.79

1.4

1.1

87.74

21.24

u/l

6.52

219

208

Type 2 diabetes

1442

3436

2.53

200.52

1.2

1.3

31.76

36.16

u/l

0.47

1275

2976

Diabetes mellitus

1461

3541

2.50

198.42

1.2

1.3

33.25

35.94

u/l

0.24

1297

3068

Multiple myeloma and malignant plasma cell neoplasms

230

250

10.53

195.82

1.4

1.2

87.74

40.26

u/l

2.55

219

214

Diabetes, varying definitions

1451

3544

2.48

194.54

1.2

1.3

33.37

35.93

u/l

0.23

1289

3070

Diabetes medication

1463

3727

2.42

186.97

1.2

1.3

31.49

36.09

u/l

0.54

1289

3233

Type 2 diabetes, wide definition

1220

3137

2.58

180.75

1.2

1.3

31.35

37.00

u/l

0.69

1080

2716

Heart failure,strict

909

2257

2.98

179.72

1.2

1.4

40.80

37.98

u/l

0.24

810

1912

Type 2 diabetes, definitions combined

1360

3361

2.45

177.53

1.2

1.3

30.90

36.31

u/l

0.60

1199

2907

Type 2 diabetes, strict (exclude DM1)

1360

3381

2.43

175.50

1.2

1.3

30.92

36.44

u/l

0.62

1199

2927

Type 2 diabetes, definitions combined, including avohilmo

1331

3324

2.40

166.61

1.2

1.3

31.53

36.55

u/l

0.53

1179

2878

Other (not insulin) diabetes medications

1376

3570

2.36

165.80

1.2

1.3

29.83

36.38

u/l

0.93

1212

3091

Hypertensive diseases (excluding secondary)

717

1290

3.28

156.61

1.3

31.34

25.13

u/l

0.55

639

1115

Heart failure, strict

964

2686

2.64

153.03

1.2

1.4

41.08

38.82

u/l

0.20

854

2292

Hypertension, essential

1041

2327

2.59

150.24

1.2

1.3

31.87

34.80

u/l

0.26

927

2014

Biguanides

1329

3656

2.27

148.30

1.2

1.3

27.42

35.91

u/l

1.61

1173

3166

All-cause Heart Failure

939

2640

2.62

146.80

1.2

1.4

40.41

38.22

u/l

0.19

832

2252

Glucagon-like peptide-1 (GLP-1) analogues

887

2828

2.63

145.21

1.2

1.4

34.01

39.79

u/l

0.64

782

2437

Hypertensive diseases

1044

2361

2.53

144.46

1.3

30.45

35.32

u/l

0.51

931

2043

Hypertension

1044

2361

2.53

144.38

1.3

30.45

35.32

u/l

0.51

931

2043

Endocrine, nutritional and metabolic diseases

1007

2005

2.58

140.18

1.3

35.65

35.98

u/l

0.02

899

1739

Metabolic disorders

1301

3698

2.21

137.22

1.3

35.57

33.36

u/l

0.22

1139

3215

Acute myeloid leukaemia and myelodysplastic syndromes

111

16.99

125.86

1.3

1.1

169.61

43.44

u/l

3.15

Other abnormal findings of blood chemistry

169

216

8.63

125.83

1.4

1.3

19.70

44.79

u/l

1.39

155

191

Other heart diseases

596

1290

3.09

124.23

1.2

1.3

36.70

25.01

u/l

1.26

528

1110

Other bacterial diseases

1258

4166

2.11

121.57

1.3

54.94

28.59

u/l

5.95

1098

3623

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

127

118

12.46

121.08

1.4

1.1

79.05

35.63

u/l

2.47

119

Multiple myeloma

127

118

12.46

121.08

1.4

1.1

79.05

35.63

u/l

2.47

119

Antihypertensive medication - note that there are other indications

633

1174

2.98

116.96

1.2

1.3

34.53

38.87

u/l

0.23

548

1030

Insulin medication

846

3054

2.40

116.33

1.2

1.3

36.05

37.28

u/l

0.09

746

2635

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

423

1271

3.42

114.91

1.3

19.29

33.96

u/l

3.55

371

1090

Any reimbursement code in KELA

610

1005

3.07

114.75

1.3

1.2

44.66

16.05

u/l

3.32

526

879

Cardiovascular diseases (excluding rheumatic etc)

697

1482

2.74

113.56

1.3

37.26

27.19

u/l

0.84

610

1288

Other disorders of white blood cells

164

241

7.31

107.45

1.4

1.2

53.28

50.90

u/l

0.04

147

207

Atrial fibrillation and flutter with reimbursement

405

733

3.62

105.46

1.2

1.4

25.84

28.15

u/l

0.19

365

619

Atrial fibrillation and flutter

453

915

3.29

103.44

1.2

1.3

28.55

29.64

u/l

0.08

398

776

Iron deficiency anaemia

598

2309

2.61

100.88

1.3

47.18

35.82

u/l

0.79

522

1992

Nutritional anaemias

678

2744

2.44

99.17

1.3

52.27

35.21

u/l

1.49

594

2350

Other heart diseases, wide

1080

3242

2.09

99.00

1.2

1.3

34.12

30.16

u/l

0.44

955

2812

Cardiovascular diseases

626

1274

2.70

97.51

1.3

34.28

31.09

u/l

0.17

545

1109

Acute renal failure

361

1092

3.41

97.23

1.3

35.06

42.25

u/l

0.50

305

934

Dyspnoea

1119

4321

2.00

96.43

1.3

41.90

33.38

u/l

1.08

999

3733

Bacterial Sepsis

666

2469

2.44

95.45

1.3

56.20

35.46

u/l

2.61

569

2134

Bacterial infection, other or unspecified

741

2923

2.32

95.34

1.3

65.09

31.65

u/l

5.98

645

2514

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1112

3472

2.03

94.61

1.3

62.99

28.20

u/l

6.61

974

3034

1112

3472

2.03

94.61

1.3

62.99

28.20

u/l

6.61

974

3034

GASTRO-related operations

943

2165

2.20

93.69

1.3

1.2

46.32

22.75

u/l

3.44

820

1888

Any gastric operation

943

2165

2.20

93.69

1.3

1.2

46.32

22.75

u/l

3.44

820

1888

Influenza and pneumonia

1260

4353

1.92

93.14

1.3

59.46

27.22

u/l

7.04

1100

3813

Disorders of lipoprotein metabolism and other lipidaemias

1088

3405

2.03

93.06

1.2

1.3

33.06

33.93

u/l

0.08

956

2956

Fever of other and unknown origin

721

2926

2.31

92.86

1.4

1.3

61.58

30.34

u/l

5.41

641

2514

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

152

247

6.66

90.76

1.4

1.2

51.37

21.33

u/l

4.28

147

214

Cardiac arrhythmias

660

1799

2.45

89.62

1.3

24.19

32.41

u/l

1.51

587

1549

Insulin, intermediate and long-acting

787

3574

2.19

89.61

1.2

1.3

35.43

34.78

u/l

0.04

691

3092

ILD medications

1367

4045

1.87

89.60

1.3

50.40

26.64

u/l

5.93

1221

3492

Other and unspecified disorders of white blood cells

128

177

7.82

88.78

1.5

1.2

59.32

46.01

u/l

0.24

115

156

Pneumonias (Asthma/COPD co-morbidities)

1198

4395

1.91

87.58

1.3

61.48

27.34

u/l

7.25

1048

3845

Implicit Sepsis

948

3632

2.05

87.43

1.3

41.93

32.24

u/l

1.35

807

3164

All pneumoniae

1203

4405

1.90

87.36

1.3

61.16

27.48

u/l

7.12

1052

3855

Transplanted organ and tissue status

217

500

4.54

86.72

1.3

91.10

32.38

u/l

2.76

195

430

Gout

476

1626

2.73

85.85

1.3

1.4

49.14

36.61

u/l

0.91

433

1395

ILD medications: prednisolone, methylprednisolone, prednisone

1312

4012

1.86

85.63

1.3

49.06

26.01

u/l

5.49

1169

3461

Abnormal findings on examination of blood, without diagnosis

699

2943

2.26

84.90

1.4

1.3

37.77

36.10

u/l

0.11

632

2529

Implicit bacterial Sepsis

585

2231

2.45

84.85

1.3

56.16

36.38

u/l

2.04

492

1922

Abnormalities of breathing

1064

3210

1.99

84.84

1.2

1.3

37.56

34.54

u/l

0.25

950

2778

Neoplasms

854

2119

2.18

84.20

1.3

1.2

48.76

18.27

u/l

4.38

754

1857

Non-ischemic cardiomyopathy

462

1395

2.78

84.14

1.3

44.54

40.03

u/l

0.26

414

1180

Other and unspecified iron deficiency

468

1772

2.69

84.09

1.3

46.86

35.52

u/l

0.60

410

1520

Insulin, combination of fast acting with intermediate-acting or long-acting

847

3794

2.09

84.05

1.2

1.3

36.06

34.93

u/l

0.08

747

3280

Medical observation and evaluation for suspected diseases and conditions

869

2079

2.16

82.89

1.3

1.2

40.88

28.11

u/l

1.65

744

1798

Sleep apnoea

1147

4134

1.90

82.78

1.3

26.63

35.54

u/l

2.18

994

3613

Sleep apnoea, including avohilmo

1191

4146

1.88

82.66

1.3

29.23

35.02

u/l

0.86

1034

3627

Unspecified kidney failure

205

474

4.51

81.53

1.4

1.2

26.31

43.52

u/l

1.42

180

407

Sleep disorders (combined)

1192

4234

1.86

80.30

1.3

26.24

35.95

u/l

2.60

1039

3699

Heart failure and bmi 25plus

568

1607

2.49

79.61

1.2

1.4

44.40

36.25

u/l

0.68

501

1365

Statin medication

812

2128

2.16

79.39

1.3

36.95

36.52

u/l

0.02

725

1840

Dialysis, with operation codes

248

672

3.83

79.34

1.2

1.3

39.70

42.84

u/l

0.13

220

586

Other nutritional deficiencies

748

3478

2.13

79.21

1.2

1.3

36.10

34.01

u/l

0.12

641

3048

Diseases of arteries, arterioles and capillaries (FINNGEN)

332

712

3.32

78.72

1.2

1.4

25.96

31.94

u/l

0.46

290

601

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1160

4430

1.86

78.58

1.3

61.50

27.90

u/l

6.81

1017

3871

Hypothyroidism (congenital or acquired)

250

340

4.27

78.25

1.4

1.1

20.35

14.03

u/l

0.68

225

294

Pure hypercholesterolaemia

937

3186

2.00

77.61

1.2

1.3

37.08

34.74

u/l

0.20

827

2766

Obesity

715

3345

2.14

77.38

1.2

1.3

35.70

33.40

u/l

0.13

613

2929

Haemolytic anaemias

113

159

7.71

77.28

1.8

1.2

64.89

43.23

u/l

0.59

104

138

Hypothyroidism and >3 levothyroxin purchases

248

340

4.24

77.04

1.4

1.2

20.35

14.03

u/l

0.67

223

294

Hypothyroidism, levothyroxine purchases

248

340

4.24

77.04

1.4

1.1

20.35

14.03

u/l

0.67

223

294

First line medication for Crohn's disease

1302

3955

1.81

76.99

1.3

1.2

49.59

25.98

u/l

4.99

1166

3409

Obesity and other hyperalimentation

717

3365

2.13

76.81

1.2

1.3

35.65

33.39

u/l

0.13

614

2946

Purpura and other haemorrhagic conditions

250

707

3.66

75.02

1.4

1.3

93.60

37.07

u/l

3.41

229

614

Condition for Implicit Sepsis (Organ dysfunction codes)

1025

3959

1.90

74.96

1.3

39.46

31.95

u/l

1.02

878

3456

Gout, FINNGEN

476

1933

2.52

74.38

1.3

49.14

38.22

u/l

0.75

433

1648

Pneumonia, organism unspecified

1067

4180

1.86

73.57

1.3

57.11

27.32

u/l

6.58

929

3654

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1102

4097

1.84

72.67

1.2

1.3

43.71

29.33

u/l

2.35

969

3571

Septicaemia

557

2347

2.32

72.45

1.3

61.96

33.38

u/l

2.73

488

2013

Explicit Sepsis

570

2424

2.29

71.96

1.3

64.19

34.98

u/l

2.82

497

2089

Infections, IBD-co-morbidities

233

439

3.94

71.73

1.3

1.4

68.22

36.64

u/l

1.35

206

381

Coagulation defects, purpura and other haemorrhagic conditions

306

1009

3.11

71.45

1.5

1.2

80.80

36.76

u/l

3.11

280

880

Depression medications

279

376

3.77

70.87

1.2

1.1

36.98

13.66

u/l

1.47

241

329

Lymphoid leukaemia

146

288

5.38

70.76

1.3

1.2

110.75

21.49

u/l

2.33

133

249

Obesity due to excess calories

545

2397

2.30

70.70

1.2

1.3

38.37

31.88

u/l

0.34

465

2090

Thrombocytopenia, unspecified

164

362

4.76

69.42

1.5

1.2

113.24

37.88

u/l

3.70

151

314

Non-invasive ventilation

274

814

3.22

67.35

1.3

1.5

52.36

37.21

u/l

0.67

247

691

Other septicaemia

496

2103

2.35

67.01

1.3

64.82

33.80

u/l

2.59

431

1802

Lymphoid leukaemia

146

306

5.06

65.99

1.3

1.2

110.75

45.57

u/l

1.34

133

271

Oral corticosteroids

1228

4299

1.74

65.54

1.3

45.12

29.95

u/l

2.45

1100

3712

Valvular heart disease excluding rheumatic fever

588

1963

2.22

65.29

1.2

1.4

41.17

34.07

u/l

0.69

521

1668

Non-rheumatic valve diseases

585

1954

2.21

64.71

1.2

1.4

41.29

34.10

u/l

0.70

518

1660

Parasetamol

918

2464

1.92

63.81

1.3

1.2

36.30

32.46

u/l

0.34

811

2137

Myeloid leukaemia

130

7.75

62.87

1.3

1.2

151.88

19.98

u/l

3.52

116

General symptoms and signs

1240

3604

1.74

62.74

1.3

41.41

28.65

u/l

2.04

1097

3118

Continuous positive airway pressure

266

736

3.18

62.61

1.3

1.4

34.48

38.36

u/l

0.16

215

629

L04AD Calcineurin inhibitors

194

535

3.75

60.57

1.3

135.04

33.34

u/l

3.87

177

466

Nephropathy related operations

232

723

3.32

59.96

1.3

37.00

47.10

u/l

0.57

208

633

Bleeding

991

4079

1.78

59.56

1.2

1.3

46.48

32.22

u/l

1.68

875

3528

Examination and observation for other reasons

686

2063

2.04

59.40

1.3

1.2

47.44

28.07

u/l

2.46

627

1783

Glomerular diseases

298

1076

2.84

59.21

1.2

1.3

27.52

40.29

u/l

1.35

269

930

Inflammatory bowel disease treatment related agents

1280

4369

1.68

58.78

1.3

47.54

30.38

u/l

2.92

1147

3775

Codeine

1053

3286

1.77

58.68

1.3

34.80

30.03

u/l

0.46

940

2846

Cerebrovascular diseases (FINNGEN)

347

934

2.69

58.32

1.2

1.3

29.92

28.74

u/l

0.06

306

792

Tramadol

895

3152

1.84

58.24

1.2

47.26

30.34

u/l

1.63

797

2725

Dental caries

349

1362

2.58

57.91

1.6

1.3

81.94

27.74

u/l

4.10

311

1176

Anaemia in chronic diseases classified elsewhere

101

8.41

57.42

1.2

61.00

25.36

u/l

0.67

Myeloid leukaemia

144

6.99

57.23

1.3

1.2

151.88

32.19

u/l

2.89

128

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

442

1189

2.38

56.16

1.3

43.83

26.29

u/l

1.16

398

1021

Hypertensive heart and/or renal disease

345

1036

2.63

56.12

1.3

1.4

29.97

47.44

u/l

2.19

296

883

Dentinal caries

319

1218

2.65

56.00

1.6

1.3

87.76

27.20

u/l

4.29

285

1046

Codeine or tramadol medication

1291

4356

1.65

55.99

1.3

32.90

34.23

u/l

0.12

1150

3775

Glomerular disorders in diseases classified elsewhere

218

690

3.27

54.96

1.2

1.3

29.43

46.12

u/l

1.19

194

598

Polyarthropathies

800

2893

1.86

54.17

1.3

47.74

31.90

u/l

1.55

725

2509

Other special examinations and investigations of persons without complaint or reported diagnosis

779

2079

1.91

53.74

1.2

36.49

28.11

u/l

0.85

687

1798

Disorders of other endocrine glands

497

2336

2.12

52.45

1.3

1.2

29.49

35.50

u/l

0.40

444

2019

Episodal and paroxysmal disorders

1204

3737

1.66

52.43

1.3

30.92

36.44

u/l

0.70

1065

3245

Persons encountering health services for specific procedures and health care

1167

4395

1.66

52.29

1.4

1.2

47.29

29.16

u/l

2.67

1034

3806

Diseases of oesophagus, stomach and duodenum

1170

4328

1.65

51.93

1.3

40.23

31.29

u/l

1.37

1017

3777

ILD medications: immunosuppressive drugs

672

3433

1.89

51.67

1.3

67.20

25.32

u/l

6.48

608

2976

Other soft tissue disorders, not elsewhere classified

1009

3661

1.71

51.46

1.3

31.18

35.88

u/l

0.59

890

3171

Acquired haemolytic anaemia

111

7.43

50.36

1.5

1.2

66.90

38.42

u/l

1.02

Opioids

1065

3323

1.69

50.13

1.3

41.78

29.80

u/l

1.38

938

2880

Pain in throat and chest

897

3147

1.75

49.51

1.2

1.3

30.02

33.28

u/l

0.40

785

2722

Symptoms and signs involving the circulatory and respiratory systems

1076

3216

1.69

49.48

1.2

1.3

32.27

34.50

u/l

0.22

960

2783

Malaise and fatigue

567

2404

1.99

48.87

1.4

1.3

36.98

31.64

u/l

0.60

489

2052

Certain infectious and parasitic diseases

1084

3260

1.68

48.55

1.3

41.92

27.56

u/l

2.39

941

2832

Insulin, fast-acting

451

2166

2.11

47.15

1.2

1.3

31.10

33.73

u/l

0.16

408

1876

Chronic lymphocytic leukaemia, helper endpoint

146

6.20

47.00

1.4

1.1

120.39

18.42

u/l

1.45

129

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

146

6.20

47.00

1.4

1.1

120.39

18.42

u/l

1.45

129

Haemorrhage from respiratory passages

437

1933

2.13

46.07

1.3

43.66

37.39

u/l

0.30

390

1644

Complications of surgical and medical care, not elsewhere classified

1052

4657

1.63

45.84

1.3

43.01

32.62

u/l

1.22

930

4041

Chronic lymphocytic leukaemia

151

6.00

45.40

1.4

1.2

120.39

53.21

u/l

0.74

127

Diseases of arteries, arterioles and capillaries

799

3446

1.75

45.10

1.3

32.81

38.42

u/l

0.84

699

2968

Genitourinary diseases

716

1959

1.85

44.58

1.3

42.88

35.04

u/l

0.47

625

1735

Acute tubulo-interstitial nephritis

627

3030

1.85

44.41

1.3

37.39

39.85

u/l

0.17

544

2603

Combinations of oral blood glucose lowering drugs

373

1710

2.22

44.21

1.2

1.4

23.41

40.40

u/l

3.25

325

1474

Pain in limb

834

3546

1.71

43.90

1.3

33.38

35.57

u/l

0.19

739

3065

COPD/asthma related infections

1116

3472

1.62

43.90

1.3

47.13

28.20

u/l

3.49

975

3034

COPD/asthma/ILD related infections

1116

3472

1.62

43.90

1.3

47.13

28.20

u/l

3.49

975

3034

Oedema, not elsewhere classified

372

1698

2.21

43.82

1.3

43.17

32.50

u/l

0.75

325

1441

Hypothyroidism, drug reimbursement

126

211

4.32

43.81

1.2

1.1

18.70

9.96

u/l

2.00

114

180

Erysipelas

645

3267

1.82

43.31

1.2

1.3

41.84

29.54

u/l

1.76

560

2825

Asthma, excluding more controls

754

2262

1.79

43.16

1.2

1.3

33.95

26.14

u/l

0.98

680

1974

Asthma, unspecified (mode), excluding more controls

510

2053

1.97

42.51

1.3

42.50

26.29

u/l

1.34

454

1788

Any event in cancer register

967

3500

1.65

42.50

1.4

1.2

54.67

22.54

u/l

5.62

830

3069

Disorders of gallbladder, biliary tract and pancreas

1066

4325

1.60

42.04

1.2

1.3

36.53

33.41

u/l

0.26

940

3752

Used for control exclusion in common control thyroid runs

1144

3667

1.59

42.03

1.3

37.21

31.61

u/l

0.55

1021

3162

Neurological diseases, wide definition

296

582

2.57

41.44

1.2

1.3

29.82

33.33

u/l

0.15

260

513

Heart failure and coronary heart disease

458

1701

2.04

41.31

1.2

1.3

34.40

45.18

u/l

1.37

400

1451

Insulin, fast-acting or short human

452

2284

2.00

41.17

1.2

1.3

31.06

33.92

u/l

0.18

409

1974

Persons encountering health services for examination and investigation

735

2079

1.78

41.15

1.3

1.2

46.00

28.11

u/l

2.14

650

1798

Other diseases of intestines

1097

4042

1.59

41.13

1.3

31.29

33.13

u/l

0.21

975

3507

Conduction disorders

344

1291

2.24

40.77

1.3

1.4

27.90

37.63

u/l

1.34

292

1092

Diverticular disease of intestine

822

3252

1.69

40.70

1.4

1.3

44.68

32.70

u/l

1.02

734

2807

Implicit viral Sepsis

251

1005

2.54

40.63

1.3

63.51

39.67

u/l

1.22

212

875

Viral Sepsis

251

1006

2.54

40.55

1.3

63.51

39.63

u/l

1.22

212

876

Gout, idiopatic and unspecified

348

1612

2.20

40.35

1.4

1.3

38.96

37.87

u/l

0.05

317

1383

Hypertensive Heart Disease

285

976

2.42

40.08

1.3

1.4

32.66

45.54

u/l

1.21

243

828

Other disorders of fluid, electrolyte and acid-base balance

354

1594

2.17

39.77

1.3

38.35

36.54

u/l

0.13

296

1365

Cardiomyopathy

232

908

2.60

39.40

1.2

1.4

30.65

32.58

u/l

0.10

213

769

Presence of cardiac and vascular implants and grafts

575

2383

1.85

39.22

1.2

1.4

33.24

35.09

u/l

0.17

505

2047

Gout, unspecified

295

1300

2.32

38.71

1.4

1.3

39.73

37.22

u/l

0.11

271

1108

Secondary hypertension

112

285

3.99

38.63

1.3

1.2

42.42

39.29

u/l

0.06

102

240

Neurological diseases

911

2799

1.65

38.59

1.2

1.3

33.66

37.31

u/l

0.29

807

2439

Diseases of spleen

8.20

38.37

1.3

1.1

88.82

21.00

u/l

0.87

Chronic periapical parodontitis

268

1136

2.40

38.32

1.3

70.64

27.77

u/l

2.93

233

972

Other pulmonary diagnosis

855

2579

1.67

38.08

1.2

1.3

44.84

26.30

u/l

2.44

753

2250

Asthma (only as main-diagnosis), excluding more controls

668

2262

1.77

38.07

1.3

40.61

26.14

u/l

1.30

599

1974

Excluding asthma or asthma-COPD overlap

854

2579

1.67

37.87

1.2

1.3

44.32

26.30

u/l

2.32

749

2250

Care involving dialysis

146

460

3.28

37.30

1.2

1.3

30.69

50.45

u/l

0.97

131

399

Gastrointestinal diseases

605

1672

1.82

36.51

1.3

40.99

22.41

u/l

2.12

532

1441

Diseases of the skin and subcutaneous tissue

1099

3569

1.55

36.45

1.3

42.54

30.94

u/l

1.42

959

3095

Gout, strict definition

264

1142

2.36

36.25

1.3

41.12

38.97

u/l

0.08

237

972

ILD differential diagnosis

844

2578

1.65

35.87

1.2

1.3

44.69

26.29

u/l

2.36

740

2251

COPD differential diagnosis

844

2579

1.65

35.82

1.2

1.3

44.69

26.28

u/l

2.36

740

2252

Paroxysmal tachycardia

221

735

2.57

35.70

1.2

1.4

40.10

33.58

u/l

0.15

195

621

AV-block

217

777

2.58

35.57

1.3

1.4

29.31

37.00

u/l

0.70

189

651

Iron deficiency anaemia secondary to blood loss (chronic)

215

855

2.56

35.43

1.3

1.2

59.83

39.22

u/l

0.57

187

736

Hernia of abdominal wall, postoperative

203

784

2.63

35.42

1.3

1.2

33.28

22.02

u/l

0.84

175

672

Persons encountering health services in other circumstances, wide

1267

4448

1.49

34.57

1.3

45.09

31.59

u/l

1.74

1120

3862

Parodontitis or operation codes

961

4593

1.55

34.26

1.3

44.13

32.95

u/l

1.05

834

4005

Parodontitis

959

4594

1.55

33.97

1.3

43.30

33.13

u/l

0.93

832

4006

Ischaemic heart disease, wide definition

861

3397

1.60

33.82

1.2

1.3

30.93

36.14

u/l

0.73

758

2938

Finngen Rheumatological endpoints

988

3649

1.55

33.72

1.2

1.3

40.89

29.58

u/l

1.20

870

3165

Autoimmune diseases excluding thyroid diseases

1083

3975

1.52

33.47

1.3

47.84

32.15

u/l

1.92

971

3430

General examination and investigation of persons without complaint and reported diagnosis

666

2076

1.72

33.45

1.4

1.2

37.34

28.12

u/l

1.02

582

1796

Diseases of pulp and periapical tissues

390

2016

1.96

33.43

1.4

1.3

61.61

27.62

u/l

3.33

337

1759

Complications of procedures, not elsewhere classified

821

4497

1.59

33.30

1.3

35.03

33.33

u/l

0.15

731

3900

Chronic periodontitis, including avohilmo

952

4594

1.54

33.22

1.3

43.29

33.17

u/l

0.91

826

4007

Pacemaker

411

2106

1.92

33.17

1.3

27.13

39.50

u/l

2.77

356

1797

STROKE

603

2432

1.73

33.04

1.2

1.3

35.52

35.73

u/l

0.01

528

2092

Cholelithiasis, broad definition with cholecystitis

899

3962

1.56

32.94

1.2

1.3

39.59

34.91

u/l

0.33

791

3419

Asthma

777

2556

1.64

32.90

1.2

1.3

34.15

26.40

u/l

1.03

701

2233

Cholelithiasis

867

3890

1.57

32.64

1.2

1.3

36.04

35.22

u/l

0.06

764

3362

Ulcer of lower limb, not elsewhere classified

201

807

2.55

32.59

1.3

1.2

37.72

45.05

u/l

0.38

175

699

Asthma, unspecified (mode)

519

2321

1.79

32.33

1.3

42.38

26.68

u/l

1.33

462

2024

Complications of medical and surgical care

749

4465

1.60

32.13

1.3

50.95

32.84

u/l

1.78

649

3870

Ischemic heart diseases

861

3442

1.58

32.11

1.2

1.3

30.01

36.03

u/l

0.91

761

2977

Hyperlipidaemia, other/unspecified

446

2307

1.85

31.97

1.3

36.06

39.91

u/l

0.33

385

1983

Other disorders of skin and subcutaneous tissue

715

4068

1.62

31.96

1.3

45.75

34.87

u/l

0.95

617

3530

Autoimmune diseases excluding thyroid diseases, strict definition

1043

3852

1.52

31.95

1.3

48.68

32.52

u/l

1.89

933

3322

Gingivitis and periodontal diseases

970

3259

1.55

31.82

1.3

38.12

30.69

u/l

0.72

850

2834

Hypopituitarism

113

336

3.46

31.67

1.2

41.01

48.50

u/l

0.10

289

Disorders of mineral metabolism

124

391

3.26

31.62

1.3

1.2

26.70

39.54

u/l

0.92

111

338

Coronary atherosclerosis

771

3110

1.61

31.55

1.2

1.3

31.65

36.63

u/l

0.65

677

2692

Factors influencing health status and contact with health services

382

953

2.03

31.36

1.2

1.3

49.13

22.41

u/l

1.98

335

828

1163

4175

1.48

31.18

1.3

41.44

32.70

u/l

1.04

1006

3638

Other blood glucose lowering drugs, excl. Insulins

219

940

2.37

30.62

1.3

27.07

43.95

u/l

1.71

195

799

Autoimmune diseases

1147

3987

1.48

30.35

1.3

38.69

32.08

u/l

0.80

1022

3441

Exclusions for E4_PCOS_BROAD

200

828

2.45

30.22

1.2

33.53

42.20

u/l

0.22

176

719

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

379

956

2.00

30.14

1.2

1.3

41.99

28.71

u/l

0.72

332

817

Benign neoplasm of colon, rectum, anus and anal canal

590

2509

1.69

29.93

1.3

1.2

36.34

23.28

u/l

1.86

514

2172

Osteopathies and chondropathies

565

3197

1.69

29.80

1.3

36.12

34.29

u/l

0.14

504

2752

Cardiodefibrillation

455

2563

1.80

29.74

1.3

32.99

40.65

u/l

0.90

411

2194

COPD (mode)

371

1542

1.93

29.49

1.2

1.3

31.28

29.46

u/l

0.15

308

1320

Cardiomyopathy (excluding other)

169

656

2.63

29.39

1.2

1.3

17.46

32.38

u/l

2.67

154

558

Benign neoplasm: Colon

527

2352

1.73

29.37

1.4

1.2

38.25

24.28

u/l

1.78

462

2029

Type 1 diabetes

265

1248

2.14

29.33

1.2

1.3

35.76

35.02

u/l

0.03

241

1071

Chronic gastritis

331

1696

1.98

29.26

1.5

1.3

49.18

35.43

u/l

0.60

291

1463

Benign neoplasms

998

3730

1.50

29.24

1.3

36.95

32.95

u/l

0.35

874

3252

Infections of the skin and subcutaneous tissue

583

3521

1.66

29.06

1.2

1.3

33.15

32.79

u/l

0.02

508

3080

Cardiomyopathies, Primary/intrinsic

166

643

2.63

29.00

1.2

1.4

17.58

32.77

u/l

2.65

151

546

Oxycodone

401

2118

1.85

28.97

1.8

1.3

63.33

34.86

u/l

3.96

349

1814

Diseases of oral cavity, salivary glands and jaws

963

3277

1.52

28.96

1.3

39.82

30.75

u/l

0.94

844

2849

Parodontitis and operation codes

886

4568

1.52

28.93

1.3

43.60

33.42

u/l

0.85

769

3986

Asthma (only as main-diagnosis)

685

2556

1.63

28.89

1.3

40.24

26.40

u/l

1.26

611

2233

Other arrhythmias

589

2723

1.67

28.62

1.3

33.31

31.23

u/l

0.10

534

2350

Asthma (mode)

745

2578

1.60

28.55

1.3

33.25

26.29

u/l

0.85

675

2251

Intestinal infectious diseases

916

4782

1.50

28.29

1.3

47.35

32.65

u/l

1.57

797

4171

Benign neoplasms

738

2638

1.59

28.15

1.3

1.2

38.55

21.99

u/l

1.99

648

2309

Diarrhoea and gastroenteritis of presumed infectious origin

686

3951

1.59

28.14

1.3

42.90

31.33

u/l

1.09

593

3440

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

338

1778

1.92

27.63

1.2

36.44

34.68

u/l

0.05

304

1543

Other antidepressants

1086

3896

1.46

27.51

1.3

35.96

36.23

u/l

0.02

948

3410

Chronic periodontitis

192

822

2.38

27.08

1.5

1.2

69.61

30.80

u/l

1.57

172

706

Chronic lower respiratory diseases

1197

4563

1.43

26.78

1.2

1.3

39.40

33.93

u/l

0.49

1055

3975

Hard cardiovascular diseases

836

3557

1.52

26.54

1.2

1.3

30.66

37.43

u/l

0.97

732

3082

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

130

328

2.96

26.53

1.2

1.4

46.71

45.94

u/l

0.01

112

279

Diseases of the respiratory system

670

2089

1.62

26.51

1.3

48.65

26.83

u/l

2.27

589

1817

Other disorders of teeth and supporting structures

242

1152

2.13

26.28

1.2

1.3

52.17

29.15

u/l

1.63

212

987

Obesity, other/unspecified

306

1592

1.94

25.85

1.2

39.80

34.08

u/l

0.20

270

1394

Direct fill therapy

166

680

2.48

25.82

1.3

1.2

97.04

40.86

u/l

1.94

152

584

Type 1 diabetes, wide definition, subgroup 1

217

1001

2.19

25.45

1.2

1.3

39.36

36.76

u/l

0.08

195

864

Disorders of choroid and retina

840

4126

1.49

25.11

1.3

41.70

35.21

u/l

0.65

725

3583

Symptoms and signs involving the urinary system

789

4072

1.51

25.05

1.4

1.3

31.53

35.98

u/l

0.65

670

3551

Disorders of lens

719

2959

1.54

24.56

1.2

1.3

37.23

34.19

u/l

0.26

623

2578

Diseases of the digestive system

481

2900

1.67

24.50

1.2

1.3

38.11

34.45

u/l

0.29

426

2499

Infarction of spleen

11.88

24.10

1.3

1.0

73.02

13.07

u/l

1.28

Calcific aortic valvular stenosis, operated

347

1889

1.82

23.84

1.2

1.3

46.21

39.09

u/l

0.57

304

1615

Calcific aortic valvular stenosis

347

1889

1.82

23.84

1.2

1.3

46.21

39.09

u/l

0.57

304

1615

Peripheral artery disease

509

2512

1.65

23.76

1.2

1.3

34.28

40.01

u/l

0.63

446

2159

Calcific aortic valvular stenosis, including rheumatic fever

348

1897

1.82

23.74

1.2

1.3

46.08

39.49

u/l

0.51

305

1621

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

657

3984

1.54

23.64

1.3

44.41

35.91

u/l

0.81

572

3454

Operations 2 for CAVS

346

1889

1.81

23.55

1.2

1.3

46.32

39.09

u/l

0.58

303

1615

Calcific aortic valvular stenosis, diagnosis (helper)

346

1889

1.81

23.55

1.2

1.3

46.32

39.09

u/l

0.58

303

1615

Agranulocytosis

129

491

2.68

23.44

1.3

1.2

129.12

37.15

u/l

3.67

113

429

Other diseases of the digestive system

356

2012

1.79

23.23

1.2

1.3

42.05

37.51

u/l

0.27

312

1731

Type 1 diabetes, wide definition

222

1073

2.09

23.11

1.2

1.3

38.64

36.23

u/l

0.07

200

928

Disorders of thyroid, IBD co-morbidities

154

453

2.50

22.98

1.3

1.4

18.08

35.92

u/l

1.72

138

397

GI-bleeding

355

2013

1.78

22.90

1.2

1.3

42.07

37.30

u/l

0.29

315

1734

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

599

3870

1.55

22.71

1.3

53.24

34.07

u/l

1.43

517

3360

Myocardial infarction

564

2569

1.59

22.43

1.2

1.3

33.48

38.99

u/l

0.61

495

2206

Spondylopathies

820

3402

1.47

22.34

1.4

1.3

36.41

32.65

u/l

0.27

729

2939

Gastro-oesophageal reflux disease

663

3895

1.52

22.26

1.3

32.22

31.50

u/l

0.07

565

3391

Other acute lower respiratory infections

517

3104

1.60

22.25

1.3

48.32

31.65

u/l

1.64

447

2683

Major coronary heart disease event excluding revascularizations

712

3285

1.51

22.20

1.2

1.3

30.20

38.09

u/l

1.41

624

2832

Diseases of liver

359

2062

1.76

22.18

1.3

37.21

33.28

u/l

0.24

322

1777

Soft tissue disorders

1009

3706

1.42

22.11

1.3

31.87

35.57

u/l

0.39

889

3209

Benign neoplasm of colon, rectum, anus and anal canal

642

3827

1.52

22.11

1.3

36.88

37.76

u/l

0.06

559

3308

All influenza

261

1366

1.93

21.81

1.5

1.3

70.02

25.87

u/l

2.14

229

1186

Intracranial trauma

510

2379

1.61

21.76

1.3

38.30

37.45

u/l

0.04

453

2072

Failure and rejection of transplanted organs and tissues

6.28

21.70

1.4

1.2

181.72

34.19

u/l

1.13

Other CVD (FINNGEN)

115

329

2.79

21.59

1.3

1.4

35.71

35.12

u/l

0.02

104

276

Diseases of the musculoskeletal system and connective tissue

535

1665

1.62

21.58

1.3

41.38

30.30

u/l

0.81

468

1456

Other autoimmune haemolytic anaemias

6.60

21.48

1.5

1.2

65.35

24.23

u/l

1.17

Diseases of the eye and adnexa

798

2717

1.48

21.38

1.3

36.04

32.99

u/l

0.22

692

2384

Cholecystectomy

674

4001

1.50

21.35

1.3

42.40

35.21

u/l

0.45

600

3452

Low back pain

696

3608

1.49

21.30

1.3

34.67

34.56

u/l

0.01

604

3129

Other diseases of pleura

493

2743

1.61

21.26

1.3

44.01

38.73

u/l

0.42

408

2379

Testicular hypofunction

176

3.85

21.24

1.3

1.2

13.90

35.34

u/l

1.86

153

Extracorporeal dialysis

337

2.97

21.15

1.2

1.3

24.79

56.61

u/l

1.80

291

Dorsalgia

960

3680

1.42

21.14

1.3

33.29

34.74

u/l

0.14

849

3190

Diabetic nephropathy, excluding more controls

228

955

2.03

21.08

1.2

30.36

25.91

u/l

0.33

203

824

Other disorders of skin and subcutaneous tissue, not elsewhere classified

168

759

2.25

20.99

1.3

1.2

34.05

40.71

u/l

0.26

145

657

Obesity related asthma

342

1973

1.75

20.84

1.3

38.52

32.19

u/l

0.27

307

1709

Other retinal disorders

652

3503

1.51

20.82

1.3

39.98

36.91

u/l

0.23

565

3029

Hypertensive Renal Disease

142

4.14

20.81

1.2

16.38

69.15

u/l

2.28

119

Hyperkalaemia

283

3.13

20.62

1.3

57.75

53.31

u/l

0.09

247

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1070

4429

1.38

20.55

1.2

1.3

41.40

31.59

u/l

1.16

956

3848

Exclusions for E4_PCOS_CONSORTIUM

576

2334

1.55

20.53

1.2

1.3

41.05

35.59

u/l

0.26

497

2053

Amputation of toe

110

416

2.72

20.44

1.2

42.56

49.29

u/l

0.22

100

364

Senile cataract

655

2709

1.51

20.28

1.2

1.3

38.39

35.32

u/l

0.24

571

2348

Gonarthrosis [arthrosis of knee](FG)

783

3181

1.46

20.18

1.3

34.74

30.52

u/l

0.32

686

2746

Dental pulpitis 2

732

2539

1.48

20.14

1.3

45.39

35.10

u/l

0.77

642

2181

Dental pulpitis 4

1064

4011

1.38

20.11

1.3

39.39

33.17

u/l

0.59

925

3486

Bronchitis

1008

4790

1.39

20.11

1.3

39.64

33.85

u/l

0.69

871

4181

Diseases of pulp and periapical tissues, including avohilmo

1062

4006

1.38

20.01

1.3

39.77

33.04

u/l

0.65

923

3482

Nerve, nerve root and plexus disorders

1029

4702

1.38

19.93

1.3

31.25

35.34

u/l

0.46

916

4072

Dental pulpitis 1

1063

4014

1.38

19.92

1.3

39.41

33.16

u/l

0.59

924

3489

Parodontitis or/and operation codes

625

2459

1.52

19.90

1.3

39.57

33.26

u/l

0.42

544

2170

Angina pectoris

634

2858

1.51

19.89

1.2

1.3

31.97

38.36

u/l

0.90

565

2458

Idiopathic thrombocytopenic purpura

143

4.07

19.86

1.3

1.2

95.82

37.20

u/l

0.82

124

Use of hypnotics and sedatives

1047

4409

1.38

19.83

1.3

37.74

34.00

u/l

0.34

914

3842

Explicit bacterial Sepsis

128

529

2.46

19.68

1.5

1.2

67.19

42.61

u/l

0.75

119

463

Myocardial infarction, strict

521

2447

1.57

19.62

1.2

1.3

34.22

39.53

u/l

0.54

459

2099

Other dorsopathies, not elsewhere classified

974

3693

1.40

19.60

1.3

32.46

34.63

u/l

0.22

858

3203

Enterocolitis due to Clostridium difficile

138

592

2.37

19.56

1.2

66.42

38.52

u/l

1.14

118

506

Cutaneous abscess, furuncle and carbuncle

262

1426

1.86

19.47

1.2

36.83

34.01

u/l

0.10

227

1246

Other diseases of liver

197

975

2.05

19.47

1.4

1.3

27.71

41.03

u/l

0.76

174

843

Myocardial infarction, without ST-elevation

445

2577

1.61

19.42

1.3

33.13

39.35

u/l

0.66

379

2208

Testicular dysfunction

197

3.53

19.37

1.3

1.2

13.88

55.00

u/l

1.92

168

Major coronary heart disease event

747

3454

1.45

19.35

1.3

30.36

37.24

u/l

1.19

661

2983

Pain (limb, back, neck, head abdominally)

766

2643

1.46

19.30

1.3

38.76

35.84

u/l

0.19

688

2267

Fall on same level

1097

4518

1.36

19.12

1.3

38.90

33.19

u/l

0.53

970

3932

Abnormalities of heart beat

321

1847

1.73

19.10

1.2

1.3

40.25

36.27

u/l

0.12

278

1574

Hypo-osmolality and hyponatraemia

185

899

2.08

19.05

1.3

37.40

40.66

u/l

0.16

157

773

Benign neoplasm: Colon

538

3474

1.53

19.02

1.4

1.3

38.12

39.21

u/l

0.07

471

2995

Symptoms and signs involving cognition, perception, emotional state and behaviour

918

4644

1.39

19.01

1.3

34.62

34.10

u/l

0.04

800

4044

Venous thromboembolism

542

3475

1.52

18.96

1.4

1.3

51.56

35.82

u/l

1.16

479

2983

Asthma-related infections

538

3495

1.52

18.83

1.3

46.42

34.23

u/l

0.91

473

3014

Asthma, hospital admission 2, infections

538

3495

1.52

18.83

1.3

46.42

34.23

u/l

0.91

473

3014

Unspecified haematuria

452

2453

1.59

18.77

1.3

34.78

38.87

u/l

0.38

387

2137

Hernia

903

4421

1.39

18.63

1.3

37.08

33.43

u/l

0.32

791

3845

Dental operations

701

2458

1.47

18.55

1.2

1.3

47.11

32.94

u/l

1.29

601

2116

Other disorders of urethra and urinary system

623

3162

1.48

18.50

1.2

1.3

26.87

39.44

u/l

3.00

539

2729

Dental caries 3

830

2994

1.42

18.48

1.3

39.38

34.80

u/l

0.32

718

2588

Volume depletion

114

462

2.51

18.34

1.1

1.2

25.38

51.09

u/l

1.77

394

Adjustment and management of implanted device

216

1129

1.94

18.30

1.3

1.2

30.61

37.57

u/l

0.60

190

963

Acute bronchitis

400

2439

1.62

18.24

1.3

47.33

33.60

u/l

1.00

343

2097

Cerebrovascular diseases

752

3792

1.43

18.18

1.3

37.62

37.23

u/l

0.03

654

3285

Dental caries 1 and operation codes

875

3214

1.40

17.97

1.3

39.26

34.93

u/l

0.31

759

2782

Disorders of calcium metabolism

301

2.89

17.92

1.3

24.49

35.02

u/l

0.80

259

Amputation

134

591

2.31

17.86

1.2

1.3

40.19

47.66

u/l

0.31

121

511

Atherosclerosis, excluding cerebral and coronary sclerosis

459

2356

1.57

17.81

1.3

1.4

33.52

41.30

u/l

0.92

395

2025

Arthropathies

858

3121

1.40

17.76

1.2

1.3

39.18

31.19

u/l

0.64

755

2720

Dental pulpitis 2, only avohilmo

734

2616

1.44

17.61

1.3

42.89

36.04

u/l

0.46

645

2246

Headache

547

3058

1.50

17.60

1.3

1.2

39.92

29.29

u/l

0.78

482

2641

Peripheral arterial reconstruction

208

1090

1.94

17.53

1.3

32.66

44.85

u/l

0.97

186

933

L01XE Protein kinase inhibitors

328

2.79

17.48

1.3

1.2

110.10

45.22

u/l

1.12

290

Other bacterial intestinal infections

194

993

1.98

17.48

1.3

69.37

35.35

u/l

1.54

169

862

Cytomegaloviral disease

112

4.29

17.45

1.5

1.2

92.26

16.47

u/l

1.28

Persons encountering health services in other circumstances

345

2093

1.66

17.44

1.3

51.93

28.69

u/l

0.96

292

1806

L04AA Selective immunosuppressants

218

1161

1.90

17.43

1.2

38.29

37.48

u/l

0.04

203

1005

Diabetic nephropathy

230

1233

1.88

17.42

1.2

30.30

31.59

u/l

0.08

205

1084

Bacterial intestinal infections, IBD co-morbidities

196

1009

1.97

17.37

1.3

69.09

39.28

u/l

1.25

171

874

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

154

727

2.15

17.36

1.3

1.2

78.61

28.08

u/l

2.98

134

617

Nausea and vomiting

259

1436

1.79

17.14

1.4

1.3

41.77

39.12

u/l

0.11

224

1219

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

932

4460

1.37

17.14

1.3

46.34

31.80

u/l

1.37

810

3883

COPD

484

2620

1.54

17.12

1.3

32.13

39.01

u/l

0.93

411

2247

Other intervertebral disc disorders

807

3546

1.40

16.96

1.3

38.02

33.79

u/l

0.29

720

3072

Dental caries 3 and operation codes

897

3343

1.38

16.96

1.3

37.97

34.75

u/l

0.22

779

2900

Dental caries 1

783

2841

1.41

16.93

1.3

41.74

35.08

u/l

0.48

686

2449

Sulfonylureas

384

1912

1.62

16.88

1.2

1.4

30.51

44.63

u/l

1.86

328

1636

Dental caries, including avohilmo

781

2838

1.41

16.77

1.3

41.74

35.07

u/l

0.48

686

2447

Covid-19 confirmed case

278

1612

1.74

16.75

1.3

54.89

36.96

u/l

0.98

256

1389

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

538

3647

1.48

16.67

1.3

44.78

36.24

u/l

0.50

465

3162

Arthrosis

728

2822

1.42

16.62

1.2

1.3

37.03

31.78

u/l

0.34

644

2451

Deposits [accretions] on teeth

307

2.76

16.58

1.4

1.2

93.65

37.83

u/l

1.26

264

Malignant neoplasm

849

3658

1.38

16.55

1.4

1.2

58.00

22.62

u/l

5.98

738

3188

Gonarthrosis

670

2677

1.44

16.51

1.2

1.3

30.54

31.58

u/l

0.08

582

2318

Dental caries 3, only avohilmo

840

3101

1.39

16.50

1.2

1.3

39.50

35.87

u/l

0.24

727

2688

Exposure to unspecified factor

882

5039

1.36

16.50

1.3

38.57

34.31

u/l

0.38

772

4391

Early onset COPD, excluding more controls

218

1182

1.86

16.48

1.4

1.3

31.93

24.39

u/l

0.70

185

1020

Respiratory insufficiency

103

419

2.50

16.42

1.1

1.2

64.72

25.80

u/l

1.28

361

Syncope and collapse

420

2396

1.56

16.37

1.2

1.3

35.46

31.82

u/l

0.27

350

2047

DVT of lower extremities and pulmonary embolism

415

2673

1.56

16.23

1.3

56.95

35.87

u/l

1.25

368

2292

Diaphragmatic hernia

357

2235

1.61

16.04

1.4

1.3

42.45

36.31

u/l

0.33

313

1928

Bacterial pneumoniae

399

2260

1.57

16.02

1.3

80.29

26.28

u/l

4.31

356

1961

Pain, not elsewhere classified

243

1376

1.78

15.93

1.2

1.3

40.48

29.47

u/l

0.34

227

1181

Lower back pain or/and sciatica

949

4918

1.34

15.89

1.3

37.93

34.25

u/l

0.36

835

4277

Disorders resulting from impaired renal tubular function

187

3.32

15.89

1.1

1.2

34.22

42.85

u/l

0.23

164

Malignant neoplasm, wide definition for exclusion

828

3565

1.38

15.88

1.4

1.2

59.65

21.52

u/l

6.15

726

3102

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

828

3565

1.38

15.88

1.4

1.2

59.65

21.52

u/l

6.15

726

3102

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

827

3564

1.38

15.78

1.4

1.2

59.71

21.53

u/l

6.15

725

3100

Codes for special purposes

393

2525

1.57

15.75

1.3

50.22

33.82

u/l

1.23

357

2193

Viral pneumonia

137

644

2.16

15.64

1.2

68.19

26.92

u/l

1.84

122

558

Provisional assignment of new diseases of uncertain etiology

392

2522

1.56

15.62

1.3

50.28

33.85

u/l

1.23

356

2190

Missing teeth due to accident, extraction or parodontitis

131

606

2.19

15.60

1.3

1.2

61.01

35.57

u/l

1.11

118

525

Asthma, hospital admissions 3, pneumonia

345

2154

1.61

15.58

1.4

1.3

61.09

36.07

u/l

1.42

302

1845

Asthma-related pneumonia or sepsis

345

2154

1.61

15.58

1.4

1.3

61.09

36.07

u/l

1.42

302

1845

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

102

426

2.44

15.48

1.3

1.2

96.38

47.51

u/l

0.98

362

Streptococcal septicaemia

109

469

2.37

15.47

1.5

1.2

60.62

32.33

u/l

1.01

102

404

Phlebitis and thrombophlebitis (not including DVT)

229

1288

1.80

15.43

1.4

1.2

55.68

36.07

u/l

0.71

199

1114

Bacterial pneumonia (organism specified)

440

2645

1.52

15.43

1.3

81.47

30.69

u/l

4.35

392

2277

Peripheral artery operations in Hilmo

154

761

2.05

15.40

1.2

1.3

37.78

43.55

u/l

0.28

137

646

Symptoms and signs involving the digestive system and abdomen

1001

3764

1.34

15.35

1.2

1.3

33.58

35.07

u/l

0.12

894

3251

Coronary revascularization (ANGIO or CABG)

492

2306

1.50

15.23

1.2

1.3

35.25

39.87

u/l

0.44

438

1975

Asthma-related pneumonia

343

2152

1.60

15.20

1.4

1.3

61.43

36.10

u/l

1.44

300

1843

Other chronic obstructive pulmonary disease, including avohilmo

554

3188

1.45

15.18

1.3

32.25

38.56

u/l

0.84

472

2754

Acute sinusitis

444

2752

1.51

15.06

1.3

1.2

37.60

33.41

u/l

0.28

392

2407

Nonalcoholic fatty liver disease

107

462

2.36

15.06

1.4

1.2

17.82

39.98

u/l

2.15

396

Symptoms and signs involving the skin and subcutaneous tissue

612

4317

1.42

15.00

1.3

50.78

33.41

u/l

1.54

550

3729

Presence of other functional implants

551

2692

1.46

14.93

1.2

1.3

53.79

34.45

u/l

1.36

463

2318

Osteomyelitis

356

2.56

14.87

1.5

1.2

35.62

40.55

u/l

0.16

310

Pulmonary heart disease, diseases of pulmonary circulation

319

1981

1.62

14.86

1.3

60.78

37.09

u/l

1.22

279

1693

Abnormal findings on diagnostic imaging of lung

478

3161

1.48

14.77

1.4

1.3

46.62

38.09

u/l

0.58

416

2732

Dipeptidyl peptidase 4 (DPP-4) inhibitors

137

660

2.11

14.74

1.2

1.3

24.76

42.44

u/l

1.83

123

562

Dorsopathies

966

3706

1.33

14.72

1.3

36.36

34.54

u/l

0.15

856

3216

Valvular operations

147

728

2.04

14.64

1.2

1.4

39.27

34.27

u/l

0.25

128

619

Bacterial pneumonia, not elsewhere classified

375

2141

1.56

14.58

1.3

77.73

26.85

u/l

4.03

334

1852

Sub-endpoint used in defining T1D endpoints

287

1715

1.66

14.55

1.2

35.41

35.48

u/l

0.00

258

1487

Chronic ulcer of skin, not elsewhere classified

366

2.51

14.51

1.3

1.2

25.13

40.03

u/l

1.15

312

Dental caries 1, only avohilmo

790

2954

1.37

14.45

1.2

1.3

41.35

35.76

u/l

0.38

686

2554

Other chronic obstructive pulmonary disease

456

2551

1.50

14.45

1.3

31.65

39.50

u/l

1.08

385

2184

Asthma (diagnoses ohter than nonallergic)

768

4853

1.36

14.34

1.3

40.93

34.52

u/l

0.48

688

4212

Injuries to the head

991

4922

1.32

14.31

1.3

35.06

35.02

u/l

0.00

868

4285

Vascular disorders of the intestines

345

2.54

14.26

1.3

1.2

48.57

48.05

u/l

0.01

288

Coxarthrosis [arthrosis of hip](FG)

530

2657

1.45

14.10

1.3

52.16

32.88

u/l

1.20

462

2285

Cough

351

2165

1.56

14.03

1.2

1.3

25.79

35.08

u/l

1.70

306

1851

Dizziness and giddiness

688

4069

1.38

13.97

1.3

31.35

35.52

u/l

0.54

596

3528

Care involving use of rehabilitation procedures

577

3890

1.41

13.96

1.4

1.3

47.42

29.46

u/l

1.47

530

3362

Elevated blood glucose level

422

2.36

13.93

1.2

26.85

47.63

u/l

1.13

365

Dental pulpitis 4, only avohilmo

1042

4171

1.31

13.91

1.3

39.48

34.01

u/l

0.46

913

3619

Other and unspecified polyneuropathies, also in other diseases

210

1190

1.79

13.89

1.3

29.54

39.38

u/l

1.06

191

1027

Disorders of parathyroid gland

204

1131

1.80

13.85

1.3

1.2

32.62

41.66

u/l

0.67

186

969

Viral hepatitis, IBD co-morbidity

146

3.40

13.83

1.3

55.48

44.70

u/l

0.14

123

Other diseases of urinary system

938

4002

1.32

13.76

1.3

33.76

36.76

u/l

0.32

816

3476

Spinal stenosis

507

2754

1.45

13.69

1.3

30.44

34.56

u/l

0.39

454

2365

Abdominal and pelvic pain

982

3764

1.32

13.57

1.2

1.3

31.70

35.07

u/l

0.33

882

3251

Other diseases of arteries and capillaries

107

484

2.25

13.55

1.2

38.40

42.69

u/l

0.12

413

Polyneuropathies and other disorders of the peripheral nervous system

232

1366

1.72

13.41

1.3

30.33

37.29

u/l

0.73

209

1179

Constipation

800

4293

1.34

13.33

1.2

1.3

39.63

34.63

u/l

0.41

701

3716

Coxarthrosis

501

2352

1.45

13.32

1.3

51.92

33.09

u/l

1.08

438

2033

Pneumonia due to other infectious organisms, not elsewhere classified

156

3.30

13.25

1.4

1.2

96.87

23.35

u/l

1.88

140

Other and unspecified dermatitis

447

3069

1.46

13.15

1.2

1.3

44.90

32.70

u/l

0.70

397

2641

Other cataract

416

2166

1.50

13.12

1.3

48.82

40.05

u/l

0.44

352

1872

Amiodarone users

129

640

2.05

12.93

1.2

1.3

23.08

45.90

u/l

2.52

115

556

Later onset COPD, excluding more controls

222

1007

1.74

12.88

1.1

1.3

31.80

33.28

u/l

0.09

188

858

Dental pulpitis 1, only avohilmo

1036

4194

1.29

12.78

1.3

39.23

34.07

u/l

0.42

906

3641

Symptoms and signs concerning food and fluid intake

107

498

2.17

12.60

1.2

25.38

33.86

u/l

0.49

423

Coronary angioplasty

397

2050

1.50

12.55

1.3

1.4

38.69

41.63

u/l

0.21

353

1752

Other disorders of kidney and ureter

142

741

1.94

12.30

1.1

1.3

24.22

43.19

u/l

1.76

125

645

Vitreous haemorrhage

116

564

2.09

12.28

1.2

1.3

71.56

39.07

u/l

0.66

101

495

Personality disorders, excluding more controls

202

1174

1.73

12.22

1.2

34.50

31.85

u/l

0.11

177

1043

Gastroduodenal ulcer

260

1616

1.62

12.07

1.4

1.3

59.13

35.31

u/l

0.78

224

1384

Other diseases of the respiratory system

209

1233

1.71

12.04

1.3

1.2

44.77

42.05

u/l

0.09

164

1061

Other respiratory disorders and diseases

209

1233

1.71

12.04

1.3

1.2

44.77

42.05

u/l

0.09

164

1061

Dermatitis

534

3849

1.39

12.02

1.2

1.3

40.87

33.92

u/l

0.42

478

3327

120

595

2.04

11.99

1.5

1.2

47.48

27.13

u/l

1.22

109

512

Asthma, including avohilmo

1063

4858

1.27

11.98

1.3

35.11

34.96

u/l

0.01

941

4223

Disorders of the thyroid gland

845

4229

1.31

11.96

1.3

31.52

36.96

u/l

0.52

749

3660

Other diseases of upper respiratory tract

1047

4279

1.28

11.91

1.3

39.47

34.63

u/l

0.39

920

3714

Second line medication for Crohn's disease

486

3457

1.41

11.82

1.2

1.3

45.71

32.71

u/l

1.91

439

3005

Dental operations, only avohilmo

707

2694

1.35

11.73

1.2

1.3

46.54

35.61

u/l

0.77

612

2323

Concussion

394

2330

1.47

11.69

1.3

33.80

37.99

u/l

0.24

343

2030

Artrosis, including avohilmo

810

3384

1.32

11.61

1.2

1.3

36.38

34.08

u/l

0.14

712

2942

L04AX Other immunosuppressants

475

3377

1.41

11.61

1.2

1.3

45.22

32.87

u/l

1.76

429

2933

Gastric ulcer

182

1045

1.76

11.57

1.4

1.3

74.93

38.66

u/l

0.88

159

895

Other specific joint derangements/joint disorders

612

3014

1.37

11.57

1.2

1.3

27.40

31.36

u/l

0.38

546

2629

Chronic periodontitis, complicated

113

557

2.06

11.57

1.2

1.3

54.58

42.09

u/l

0.37

486

Hypothyroidism, other/unspecified

776

3897

1.32

11.56

1.3

29.23

35.90

u/l

1.01

685

3370

Migraine

328

1841

1.52

11.52

1.3

1.2

21.84

37.66

u/l

2.40

298

1596

388

2505

1.47

11.47

1.3

47.40

38.78

u/l

0.51

343

2139

Asthma, hospital admissions , main diagnosis only

705

4774

1.33

11.46

1.3

39.70

33.93

u/l

0.39

629

4148

Endocarditis

171

3.00

11.39

1.3

63.87

37.59

u/l

0.31

142

Polycystic ovarian syndrome, consortium definition

464

1961

1.43

11.36

1.2

24.70

36.87

u/l

1.62

396

1714

Stroke, including SAH

612

3350

1.36

11.31

1.2

1.3

36.26

39.56

u/l

0.29

526

2889

Secondary right heart disease

216

2.75

11.30

1.1

1.2

40.68

43.07

u/l

0.06

186

Other diseases of pericardium

199

2.82

11.29

1.2

1.3

37.78

34.86

u/l

0.07

170

Non-allergic asthma (mode), excluding more controls

163

904

1.80

11.26

1.4

1.3

29.01

26.92

u/l

0.13

152

779

Other headache syndromes

323

2147

1.51

11.25

1.4

1.3

38.01

36.44

u/l

0.06

290

1854

Extreme obesity with alveolar hypoventilation

206

2.79

11.18

1.2

1.3

25.51

31.51

u/l

0.25

177

Glomerulonephritis

112

558

2.04

11.13

1.2

1.3

21.33

46.65

u/l

2.43

104

484

Gonarthrosis,primary

857

4177

1.30

11.09

1.3

35.54

34.73

u/l

0.05

749

3626

Other disorders of ear

844

4354

1.30

11.09

1.3

39.89

32.89

u/l

0.63

720

3800

Ischaemic Stroke, excluding all haemorrhages

552

3049

1.38

11.08

1.2

1.3

35.83

40.86

u/l

0.45

471

2622

Emergency coronary revascularization (for ACS)

560

2946

1.37

11.02

1.2

1.3

37.69

37.91

u/l

0.02

496

2518

Stroke, excluding SAH

581

3182

1.36

11.00

1.2

1.3

36.94

40.03

u/l

0.25

495

2741

COPD, hospital admissions

456

2744

1.41

10.97

1.2

1.3

31.89

40.88

u/l

1.28

383

2365

Pulmonary embolism

278

1802

1.55

10.94

1.3

55.38

37.25

u/l

0.86

245

1544

Cardiomyopathy, other and unspecified

390

2.24

10.92

1.1

1.3

32.51

34.99

u/l

0.07

327

Benign neoplasm of other and ill-defined parts of digestive system

163

923

1.78

10.91

1.4

1.2

40.05

27.35

u/l

0.87

150

788

Osteoporosis

225

1325

1.63

10.83

1.3

1.2

42.45

41.80

u/l

0.02

205

1122

Benzodiazepine use

889

4957

1.28

10.76

1.3

31.09

34.83

u/l

0.50

756

4335

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

460

2241

1.42

10.76

1.4

1.2

44.20

25.24

u/l

2.21

392

1924

Migraine with aura

161

911

1.78

10.75

1.3

1.2

21.89

37.41

u/l

1.03

139

784

Diseases of male genital organs

582

2155

1.37

10.74

1.3

35.47

34.66

u/l

0.04

508

1898

Other neurological diseases

662

4022

1.33

10.74

1.2

1.3

35.61

36.89

u/l

0.09

582

3481

Pulmonary heart disease

278

1810

1.55

10.73

1.3

55.38

38.46

u/l

0.77

245

1551

Coxibs

289

985

1.57

10.73

1.2

45.70

40.71

u/l

0.16

252

842

Other metabolic disorders

106

525

2.04

10.68

1.3

1.2

85.37

34.67

u/l

1.01

458

Asthma/COPD (KELA code 203)

831

4554

1.29

10.67

1.3

39.57

33.96

u/l

0.39

736

3970

Hyperparathyroidism

173

991

1.74

10.66

1.3

1.2

34.88

40.91

u/l

0.34

159

848

Benign neoplasm: Colon, unspecified

229

1422

1.62

10.65

1.3

1.2

46.76

26.22

u/l

1.13

193

1219

Skin changes due to chronic exposure to nonionizing radiation

364

2375

1.46

10.55

1.4

1.3

49.66

38.38

u/l

0.68

321

2024

Osteonecrosis

308

2.38

10.53

1.2

54.91

41.82

u/l

0.38

266

Charcot foot

3.99

10.51

1.1

1.4

19.09

54.96

u/l

0.88

Hypothyroidism, strict autoimmune

621

3074

1.34

10.50

1.3

31.57

31.79

u/l

0.02

542

2634

359

2453

1.46

10.49

1.2

1.3

41.08

33.69

u/l

0.32

318

2128

Hypothyreosis and Thyroxine purchase for inclusion criteria

792

4044

1.30

10.48

1.3

28.96

36.04

u/l

1.11

700

3502

COPD, early/later onset

457

2770

1.40

10.41

1.2

1.3

31.65

41.16

u/l

1.41

385

2389

Certain disorders involving the immune mechanism

181

1071

1.71

10.39

1.2

1.3

58.45

39.07

u/l

0.49

166

935

Depression or dysthymia

673

2844

1.33

10.34

1.2

1.3

28.03

37.79

u/l

1.60

579

2491

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

504

2507

1.38

10.20

1.3

1.2

54.88

24.56

u/l

2.99

437

2155

Hernia of abdominal wall

423

3022

1.41

10.17

1.2

1.3

35.80

33.19

u/l

0.16

367

2622

Accidents

778

3001

1.30

10.16

1.3

36.45

32.85

u/l

0.29

678

2606

Viral infections characterized by skin and mucous membrane lesions

357

2476

1.45

10.08

1.3

47.41

30.86

u/l

1.32

317

2160

Other joint disorders

760

3117

1.30

10.05

1.2

1.3

30.83

31.22

u/l

0.03

662

2716

Other pulmonary heart/vessel disease

242

2.53

10.00

1.1

1.2

73.84

42.38

u/l

0.41

210

Pruritus

102

512

2.01

9.96

1.2

65.53

33.85

u/l

0.62

434

Acute upper respiratory infections

923

4586

1.26

9.95

1.3

38.21

34.59

u/l

0.27

806

3987

COPD related to multimorbidity

390

2313

1.43

9.95

1.1

1.3

31.18

41.74

u/l

1.50

328

1990

Enlarged lymph nodes

145

816

1.79

9.95

1.2

108.63

31.02

u/l

1.82

135

700

Selective serotonin reuptake inhibitors

936

3904

1.27

9.88

1.2

1.3

32.71

36.17

u/l

0.26

803

3417

Insulin, fast-acting (human)

132

724

1.84

9.86

1.2

49.91

41.57

u/l

0.17

116

633

Cirrhosis of liver, NAS

287

2.39

9.82

1.3

1.2

52.89

41.88

u/l

0.28

248

All influenza (not pneumonia)

139

777

1.80

9.76

1.3

85.67

25.23

u/l

1.58

120

680

Visual disturbances and blindness

424

3053

1.40

9.74

1.2

1.3

37.81

35.84

u/l

0.10

366

2652

Shoulder lesions

713

3361

1.30

9.73

1.2

1.3

38.82

34.74

u/l

0.25

631

2906

Other functional intestinal disorders

366

2445

1.43

9.69

1.2

1.3

30.37

35.21

u/l

0.60

326

2090

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

438

2172

1.40

9.64

1.3

1.2

50.88

25.34

u/l

2.06

371

1866

Carpal tunnel syndrome

519

3483

1.35

9.62

1.2

1.3

29.54

34.14

u/l

0.36

459

3007

Actinic keratosis

351

2328

1.44

9.56

1.3

50.27

38.58

u/l

0.68

308

1986

COPD, hospital admission 2, with asthma infections

315

1834

1.48

9.56

1.3

32.68

38.95

u/l

0.62

263

1581

Mycoses

235

1516

1.56

9.54

1.3

1.2

42.84

34.86

u/l

0.52

200

1313

Irritable bowel syndrome

217

1374

1.59

9.53

1.2

1.3

23.96

35.17

u/l

1.46

194

1177

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

443

2200

1.39

9.52

1.3

1.2

51.17

25.19

u/l

2.16

376

1889

Traumatic subdural haemorrhage

134

735

1.81

9.49

1.4

1.3

56.86

44.38

u/l

0.29

116

624

Injuries to the abdomen, lower back, lumbar spine and pelvis

338

2337

1.44

9.42

1.3

33.97

u/l

0.00

291

2007

Disorders of eyelid, lacrimal system and orbit

733

4485

1.29

9.42

1.3

30.55

36.26

u/l

0.84

632

3892

Cholecystitis

137

772

1.79

9.40

1.2

1.3

63.86

42.30

u/l

0.33

119

668

COPD-related respiratory insufficiency

133

744

1.81

9.39

1.2

37.91

43.50

u/l

0.29

100

645

Postprocedural endocrine and metabolic disorders, not elsewhere classified

489

2.00

9.37

1.3

1.2

91.10

35.81

u/l

1.01

429

Vocal cord dysfunction

103

490

1.97

9.37

1.3

1.4

49.25

34.40

u/l

0.33

417

Fungal Sepsis

180

2.73

9.29

1.3

1.2

55.75

33.18

u/l

0.52

158

Acute upper respiratory infections of multiple and unspecified sites

611

3489

1.32

9.29

1.3

41.32

32.87

u/l

0.56

537

3040

Misadventures to patients during surgical and medical care

132

740

1.80

9.23

1.4

1.2

28.71

35.29

u/l

0.51

120

650

Ventral hernia

224

1441

1.57

9.23

1.2

1.3

30.51

36.60

u/l

0.46

189

1244

Psychiatric diseases

1015

4098

1.24

9.16

1.3

29.48

36.16

u/l

1.05

885

3582

Other noninfective gastroenteritis and colitis

208

1317

1.59

9.13

1.2

1.3

37.73

39.64

u/l

0.10

187

1148

Other systemic involvement of connective tissue (FG)

208

1309

1.59

9.13

1.2

36.05

35.52

u/l

0.02

184

1115

Cellulitis

197

1234

1.61

9.10

1.2

1.3

28.13

36.55

u/l

0.81

169

1071

Other benign neoplasms of skin

304

2050

1.46

9.07

1.2

50.33

25.18

u/l

1.34

263

1765

Special screening examination for other diseases and disorders

348

2.18

9.04

1.2

1.3

29.15

30.33

u/l

0.04

294

Mood disorders, excluding more controls

840

4058

1.26

9.00

1.2

1.3

31.59

35.80

u/l

0.51

735

3548

Hypothyroidism, strict autoimmune, 3 medication purchases required

688

3646

1.29

8.95

1.3

31.39

35.97

u/l

0.52

599

3151

Arthropathies in other diseases classified elsewhere

167

2.75

8.89

1.2

1.3

29.95

31.55

u/l

0.04

141

Zoster [herpes zoster]

166

1003

1.67

8.89

1.3

64.40

43.42

u/l

0.72

140

871

Diabetic retinopathy, excluding more controls

314

1210

1.48

8.86

1.1

1.2

35.40

25.76

u/l

0.83

277

1043

Non-allergic asthma (mode)

163

972

1.67

8.82

1.4

1.2

29.01

26.99

u/l

0.13

152

840

Sequelae of external causes of morbidity and mortality

225

1465

1.55

8.81

1.4

1.2

60.05

36.58

u/l

0.77

205

1272

In situ neoplasms

277

1793

1.48

8.81

1.2

52.99

25.63

u/l

1.85

244

1541

Pregnancy hypertension

234

1379

1.54

8.80

1.3

1.2

31.83

28.77

u/l

0.17

212

1207

Mood [affective] disorders

878

4630

1.25

8.77

1.2

1.3

30.71

34.02

u/l

0.40

769

4042

Mood disorders

880

4638

1.25

8.72

1.2

1.3

30.66

34.77

u/l

0.52

771

4049

Carcinoma in situ of skin of other and unspecified parts of face

394

2.09

8.71

1.3

1.2

31.96

23.44

u/l

0.71

337

Pain in joint

501

2477

1.34

8.66

1.2

1.3

29.76

33.69

u/l

0.29

449

2123

Other viral diseases

227

1482

1.54

8.64

1.4

1.3

68.70

33.25

u/l

1.16

200

1307

Vasculitis limited to skin, not elsewhere classified

131

2.98

8.63

1.2

82.73

41.32

u/l

0.44

117

Other external causes of accidental injury

762

3001

1.28

8.57

1.3

37.14

32.85

u/l

0.35

667

2606

Cystitis

697

3331

1.28

8.52

1.3

36.42

39.86

u/l

0.29

614

2879

Visual disturbances

386

2810

1.38

8.39

1.2

1.3

36.58

34.08

u/l

0.13

334

2442

Benign neoplasm of other and unspecified endocrine glands

115

638

1.82

8.38

1.2

26.60

27.77

u/l

0.06

104

552

Disorders of skin appendages

366

2640

1.39

8.37

1.2

1.3

38.51

32.70

u/l

0.26

333

2292

Unspecified acute lower respiratory infection

140

823

1.72

8.34

1.2

42.87

38.77

u/l

0.15

125

716

Early onset COPD

218

1429

1.54

8.32

1.4

1.3

31.93

36.93

u/l

0.34

185

1229

Disorders of lacrimal system

337

2403

1.41

8.30

1.4

1.2

34.05

39.59

u/l

0.36

288

2073

Any mental disorder

1027

4201

1.23

8.26

1.3

30.54

35.69

u/l

0.72

892

3670

Non-follicular lymphoma, hilmo, excluding all cancers

527

1.90

8.25

1.3

1.2

96.77

30.11

u/l

2.44

460

Other medical care

353

2482

1.40

8.19

1.6

1.3

83.03

33.75

u/l

6.21

312

2110

Disorders of adult personality and behaviour

212

1386

1.54

8.16

1.2

1.3

34.98

31.44

u/l

0.16

187

1215

Osteonecrosis due to drugs

3.80

8.14

1.3

1.2

76.34

17.52

u/l

1.72

Transient ischemic attack

481

3005

1.33

8.14

1.2

1.3

36.09

40.67

u/l

0.31

420

2583

Other disorders of lacrimal gland

279

1932

1.45

8.10

1.4

1.2

36.50

37.39

u/l

0.04

237

1671

Hyperkinetic disorders, excluding more controls

234

2.34

8.09

1.1

1.2

10.41

31.42

u/l

1.38

203

Diseases of the ear and mastoid process

1034

4288

1.22

8.09

1.3

33.70

33.16

u/l

0.04

897

3748

Basal cell carcinoma, including avohilmo

523

3142

1.32

8.07

1.3

50.18

37.79

u/l

0.84

446

2707

Bipolar affective disorders

146

876

1.68

8.05

1.2

1.3

33.99

34.95

u/l

0.03

123

768

Basal cell carcinoma

511

3099

1.32

8.04

1.3

49.12

38.31

u/l

0.68

435

2668

Problems related to lifestyle

496

1.91

8.03

1.2

1.3

31.21

31.64

u/l

0.02

427

Implicit fungal Sepsis

165

2.66

8.01

1.3

1.2

37.46

22.62

u/l

0.94

145

Other/unspecified dorsalgia

307

2157

1.42

7.99

1.3

27.91

33.66

u/l

0.63

273

1841

Polyarthrosis

172

1033

1.61

7.96

1.3

1.2

46.11

39.80

u/l

0.12

153

883

Other and unspecified vasculitis limited to skin

121

2.98

7.94

1.2

89.37

41.15

u/l

0.47

107

Unstable angina pectoris

377

2280

1.38

7.93

1.3

1.4

32.69

41.81

u/l

1.05

329

1948

Hyperplasia of prostate

404

1684

1.38

7.92

1.2

1.3

37.63

36.59

u/l

0.04

351

1475

Lumbar disc prolapse

552

3383

1.30

7.87

1.4

1.3

38.20

33.74

u/l

0.22

493

2935

Benign neoplasm: Caecum

101

550

1.86

7.87

1.3

1.2

30.40

27.81

u/l

0.14

472

Abnormal blood-pressure reading, without diagnosis

184

2.54

7.85

1.4

1.2

20.98

47.75

u/l

0.93

152

Renal tubulo-interstitial disorders in diseases classified elsewhere

4.36

7.84

1.1

14.47

50.37

u/l

0.77

Noninfective enteritis and colitis

381

2797

1.37

7.82

1.2

1.3

38.83

32.21

u/l

0.43

342

2434

DVT of lower extremities

175

1109

1.59

7.79

1.3

1.2

55.50

36.17

u/l

0.55

157

956

Benign neoplasm of other and ill-defined parts of digestive system

163

1016

1.62

7.79

1.4

1.3

40.05

40.23

u/l

0.01

150

881

External causes of morbidity and mortality

600

2323

1.30

7.78

1.3

1.2

44.12

29.25

u/l

1.29

526

2019

Other diseases of hard tissues of teeth

524

2993

1.31

7.78

1.3

43.53

30.20

u/l

0.85

451

2620

Other diseases of lip and oral mucosa

139

832

1.68

7.77

1.3

1.2

76.50

31.00

u/l

0.98

127

720

Personality disorders

202

1324

1.53

7.72

1.2

1.3

34.50

30.22

u/l

0.19

177

1161

Other and unspecified drugs and medicaments

399

2.00

7.70

1.7

1.2

50.21

41.39

u/l

0.24

339

Other skin changes

155

957

1.63

7.70

1.4

1.3

92.76

36.77

u/l

1.77

140

831

Candidiasis

113

641

1.78

7.67

1.4

1.2

39.40

38.27

u/l

0.04

554

Excessive, frequent and irregular menstruation

248

926

1.50

7.65

1.2

22.71

35.90

u/l

1.70

210

803

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

117

673

1.76

7.60

1.6

1.2

53.82

29.06

u/l

0.63

103

574

Other arthritis (FG)

250

1719

1.46

7.57

1.4

1.3

28.83

32.40

u/l

0.30

225

1478

Other specified/unspecified arthritis

223

1501

1.49

7.53

1.5

1.3

29.01

32.93

u/l

0.30

201

1292

Disorder of lipoprotein metabolism, unspecified

133

795

1.69

7.51

1.2

1.3

26.02

42.96

u/l

1.41

125

685

Secondary and unspecified malignant neoplasm of lymph nodes

480

1.90

7.51

1.2

129.77

42.53

u/l

1.23

412

Hypokalaemia

102

566

1.82

7.48

1.3

26.62

42.35

u/l

1.33

488

Idiopathic gout

546

1.84

7.44

1.3

1.2

44.96

47.06

u/l

0.04

477

Other malignant neoplasms of skin (=non-melanoma skin cancer)

496

3003

1.31

7.42

1.3

45.10

38.05

u/l

0.46

420

2582

Depression

786

4377

1.24

7.40

1.2

1.3

30.00

33.71

u/l

0.44

695

3821

Substance use, excluding alcohol

167

1060

1.59

7.40

1.1

1.3

64.44

32.42

u/l

0.83

135

933

Oter anti-inflammatory and antirheumatic agents, non-steroids

235

873

1.50

7.38

1.3

1.2

39.32

38.20

u/l

0.04

209

744

Autoimmune diseases related-to ILD

709

5008

1.25

7.37

1.2

1.3

39.93

33.44

u/l

0.57

625

4356

Other abnormal uterine and vaginal bleeding

167

747

1.60

7.36

1.3

1.2

30.16

33.23

u/l

0.21

145

638

Malignant neoplasm of skin

560

3286

1.29

7.36

1.3

50.98

36.82

u/l

1.03

476

2834

Mental and behavioural disorders due to opioids

143

2.70

7.35

1.1

1.2

109.42

40.41

u/l

0.48

124

Other pleural conditions

108

614

1.78

7.33

1.3

42.69

45.55

u/l

0.11

532

Myalgia

175

1127

1.56

7.28

1.3

1.2

20.14

38.70

u/l

3.06

152

973

Paracetamol of NSAID medication

163

504

1.64

7.27

1.2

41.54

35.55

u/l

0.20

147

426

Benign neoplasm: Stomach

500

1.86

7.24

1.6

1.2

43.80

22.72

u/l

1.14

429

Menorrhagia

235

875

1.49

7.18

1.2

32.82

32.38

u/l

0.02

200

755

Other gastritis (incl. Duodenitis)

203

1355

1.51

7.18

1.5

1.3

51.19

35.48

u/l

0.79

183

1168

Rheumatism, unspecified

112

647

1.74

7.17

1.2

34.86

33.99

u/l

0.03

558

Irregular menses

260

1468

1.44

7.16

1.2

24.72

32.05

u/l

0.47

224

1287

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

424

1.93

7.15

1.7

1.2

49.38

36.58

u/l

0.41

368

Systemic connective tissue disorders

285

2030

1.41

7.15

1.2

37.57

37.78

u/l

0.01

254

1750

Viral pneumonia (unknown virus, not influenza)

323

2.07

7.06

1.3

1.2

53.77

41.95

u/l

0.21

279

Chronic rhinitis, nasopharyngitis and pharyngitis

246

1712

1.44

7.02

1.2

1.3

26.63

30.88

u/l

0.43

225

1483

Other disorders of veins

310

2246

1.39

7.00

1.2

47.78

33.75

u/l

0.66

262

1935

ILD medications: azathioprine

117

690

1.71

6.96

1.2

35.86

23.26

u/l

0.74

101

596

Anxiety disorders, excluding more controls

675

3586

1.25

6.92

1.3

33.98

32.96

u/l

0.06

590

3132

Retention of urine

318

1960

1.38

6.82

1.5

1.3

38.00

43.33

u/l

0.35

275

1694

Other diseases of anus and rectum

247

1729

1.43

6.82

1.3

33.97

36.80

u/l

0.14

214

1475

Coronary artery bypass grafting

281

1524

1.41

6.81

1.1

1.4

37.16

46.65

u/l

0.72

251

1304

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

25.75

6.80

1.8

1.0

125.28

11.64

u/l

—

Other respiratory diseases principally affecting the interstitium

169

1100

1.55

6.77

1.2

1.3

55.18

39.06

u/l

0.43

144

951

COPD, hospital admissions 3, with asthma pneumonia sepsis

257

1540

1.43

6.75

1.3

33.14

39.44

u/l

0.64

211

1325

Other reaction to severe stress, and adjustment disorders

256

1810

1.42

6.71

1.4

1.2

32.90

31.81

u/l

0.05

229

1604

Benign neoplasm: Colon, unspecified

229

1589

1.45

6.70

1.3

46.76

37.59

u/l

0.36

193

1367

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

146

922

1.60

6.69

1.3

43.71

40.77

u/l

0.12

135

798

Malignant neoplasm of bronchus and lung

1154

0.52

6.68

1.1

1.3

40.44

40.36

u/l

0.00

990

Fibrosis and cirrhosis of liver

407

1.92

6.66

1.3

1.2

49.18

37.08

u/l

0.38

348

Allergic asthma (mode), excluding more controls

156

984

1.56

6.56

1.2

43.16

22.77

u/l

0.57

139

864

Benign neoplasm: Rectum, anus and anal canal

169

1108

1.54

6.56

1.3

1.2

46.63

25.77

u/l

0.84

145

949

Other coagulation defects

319

2.03

6.54

1.9

1.2

25.47

35.28

u/l

0.54

273

Abnormal findings on diagnostic imaging of other body structures

111

659

1.70

6.50

1.4

1.2

42.28

41.45

u/l

0.03

567

Injury, poisoning and certain other consequences of external causes

484

1870

1.30

6.49

1.2

1.3

46.44

31.33

u/l

1.04

419

1609

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

104

607

1.73

6.49

1.7

1.2

58.35

29.15

u/l

0.67

523

Fracture of lumbar spine and pelvis

187

1255

1.50

6.45

1.4

1.2

35.78

43.32

u/l

0.48

156

1082

Benign neoplasm: Ascending colon

117

706

1.67

6.45

1.7

1.2

50.10

28.96

u/l

0.58

103

608

Symptoms and signs involving the nervous and musculoskeletal systems

469

3658

1.29

6.41

1.2

1.3

23.07

37.50

u/l

4.95

415

3176

Specific personality disorders

167

1097

1.53

6.41

1.2

1.3

35.32

31.85

u/l

0.13

149

965

Impotence

336

2.00

6.40

1.2

1.3

25.66

48.96

u/l

0.91

298

Other disorders of glucose regulation and pancreatic internal secretion

413

1.88

6.36

1.6

1.2

24.66

42.61

u/l

1.15

360

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

111

665

1.68

6.29

1.5

1.2

59.46

24.19

u/l

2.00

562

Hypertrophic cardiomyopathy

231

2.21

6.28

1.2

1.3

54.89

45.19

u/l

0.13

198

Injuries to the shoulder and upper arm

716

4914

1.22

6.28

1.3

36.40

33.81

u/l

0.21

628

4274

Sequelae with surgical and medical care as external cause

173

1153

1.51

6.24

1.5

1.3

67.59

39.13

u/l

0.70

157

1003

Acute pancreatitis

174

1162

1.51

6.21

1.2

1.3

22.68

37.69

u/l

2.51

152

1000

Anxiety (asthma-related co-morbidities)

424

2576

1.30

6.19

1.2

1.3

27.86

33.11

u/l

0.33

377

2273

Pleural effusion

146

940

1.57

6.19

1.4

1.3

61.27

41.16

u/l

1.12

127

816

Falls/tendency to fall

960

4023

1.20

6.17

1.3

33.31

32.80

u/l

0.04

843

3501

Weight loss

513

1.77

6.13

1.2

24.86

39.53

u/l

1.04

442

Cardiac arrest

227

2.11

6.10

1.3

33.15

38.16

u/l

0.14

187

Amyloidosis

111

2.78

6.09

1.4

1.2

31.31

47.17

u/l

0.43

Spondylosis

459

3078

1.28

6.09

1.4

1.3

38.97

33.79

u/l

0.25

409

2655

Acetic acid derivatives and related substances

264

980

1.41

6.01

1.2

32.74

40.82

u/l

0.51

231

838

Dermatitis and eczema

912

5019

1.19

5.95

1.3

37.04

33.98

u/l

0.26

809

4365

Unspecified fall

392

2996

1.30

5.95

1.2

1.3

47.25

36.02

u/l

0.46

336

2585

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

132

839

1.59

5.93

2.8

1.2

95.32

27.57

u/l

1.52

114

716

Other CVD

169

1134

1.50

5.92

1.3

36.88

42.45

u/l

0.32

152

971

Functional dyspepsia

205

1428

1.44

5.91

1.3

1.2

37.39

34.96

u/l

0.07

182

1242

Unspecified dementia

587

0.38

5.86

1.2

31.61

48.55

u/l

1.02

497

Malignant neoplasm of respiratory system and intrathoracic organs

1320

0.58

5.81

1.1

1.3

45.31

38.02

u/l

0.28

1131

ILD, hospital admission 2, with pulmonary infections

507

1.75

5.80

1.3

1.2

38.28

28.23

u/l

0.49

437

Carcinoma in situ of skin of other and unspecified parts of face

456

1.80

5.79

1.3

1.2

31.96

46.33

u/l

0.82

395

Emotionally unstable personality disorder

455

1.79

5.79

1.2

1.3

42.56

26.76

u/l

0.40

391

Follow-up examination after treatment for conditions other than malignant neoplasms

321

1568

1.34

5.78

1.3

33.12

28.16

u/l

0.27

281

1339

Non-follicular lymphoma

592

1.69

5.72

1.3

96.77

44.15

u/l

1.63

514

Degenerative diseases of the nervous system

153

1716

0.67

5.71

1.3

46.31

41.58

u/l

0.16

126

1471

Other diseases of jaws

329

1.94

5.69

1.2

1.3

23.80

41.26

u/l

1.05

287

Sensorineural hearing loss

666

3822

1.22

5.67

1.3

30.77

35.39

u/l

0.59

571

3326

Conductive and sensorineural hearing loss

696

3969

1.22

5.67

1.3

38.34

34.65

u/l

0.33

599

3457

Thoracic aortic aneurysm

138

897

1.55

5.66

1.4

36.75

40.34

u/l

0.18

119

781

Malignant neoplasm of digestive organs

187

2628

0.70

5.66

1.3

43.66

38.97

u/l

0.27

161

2258

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

251

1592

1.38

5.66

1.3

1.2

30.53

29.19

u/l

0.07

228

1381

Other disorders of bone

157

1048

1.51

5.66

1.2

1.3

22.06

34.11

u/l

1.36

131

907

Any dementia

185

1872

0.69

5.64

1.2

1.3

44.10

39.95

u/l

0.17

154

1609

Benign neoplasm: Adrenal gland

395

1.85

5.61

1.3

1.2

29.44

20.62

u/l

0.48

347

Injuries to the thorax

385

2985

1.29

5.61

1.4

1.3

52.84

33.03

u/l

0.99

333

2588

Benign neoplasm of other and unspecified endocrine glands

115

718

1.62

5.60

1.2

1.3

26.60

40.39

u/l

1.03

104

624

Tobacco use

242

2.09

5.59

1.2

42.68

38.42

u/l

0.10

207

Asthma mixed form (mode), excluding more controls

209

2.17

5.57

1.1

1.2

39.67

23.51

u/l

0.81

182

Malignant neoplasm of breast, HER-positive

111

1726

0.63

5.54

1.2

31.20

33.77

u/l

0.13

1502

Benign neoplasm: Rectum

149

989

1.52

5.54

1.3

1.2

34.51

25.72

u/l

0.63

128

849

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

101

554

1.67

5.54

1.2

1.3

33.67

38.81

u/l

0.08

484

Other benign neoplasms of skin

304

2287

1.34

5.53

1.2

1.3

50.33

33.74

u/l

0.72

263

1968

Abnormal weight loss

485

1.75

5.52

1.2

25.27

39.59

u/l

0.92

417

ILD, hospital admissions

139

913

1.54

5.45

1.2

1.3

45.85

40.29

u/l

0.13

122

789

COPD, hospital admissions 1, only main diagnosis

321

2073

1.33

5.43

1.3

30.72

37.97

u/l

0.91

267

1788

Redundant prepuce, phimosis and paraphimosis

189

1314

1.44

5.43

1.4

1.3

20.56

34.43

u/l

2.51

166

1156

Other systemic involvement of connective tissue

216

1545

1.40

5.42

1.2

36.85

38.17

u/l

0.05

192

1339

Pre-eclampsia or eclampsia

121

770

1.58

5.42

1.4

1.2

47.78

28.19

u/l

0.81

108

674

Right bundle-branch block

167

2.31

5.40

1.1

1.3

36.24

37.54

u/l

0.03

143

Exposure to other specified factors

581

4446

1.23

5.40

1.3

37.50

33.97

u/l

0.20

507

3881

Other embolism and thrombosis

114

717

1.60

5.40

1.6

1.2

48.04

41.83

u/l

0.13

105

617

Azathioprine

117

740

1.59

5.40

1.2

35.86

35.57

u/l

0.01

101

639

Other interstitial pulmonary diseases

140

923

1.53

5.40

1.2

1.3

45.54

38.46

u/l

0.17

123

800

Thyrotoxicosis, other and/or unspecified

143

946

1.52

5.40

1.3

1.2

21.80

37.36

u/l

1.75

131

811

Recurrent or chronic depression

299

1616

1.34

5.39

1.2

1.3

26.51

30.94

u/l

0.30

258

1421

Malignant neoplasm of breast, HER2-negative

184

1927

0.70

5.39

1.2

30.92

33.41

u/l

0.17

153

1675

Disturbances of skin sensation

198

1396

1.42

5.39

1.3

1.2

26.38

31.06

u/l

0.35

179

1213

Neurotic, stress-related and somatoform disorders

691

4065

1.21

5.39

1.3

1.2

33.52

32.70

u/l

0.05

604

3562

Benign neoplasm: Caecum

101

618

1.65

5.37

1.3

1.2

30.40

43.90

u/l

0.93

531

Umbilical hernia

236

1717

1.38

5.36

1.3

32.85

32.25

u/l

0.02

211

1492

Intracranial injury

464

3575

1.26

5.36

1.3

40.54

35.77

u/l

0.27

413

3095

Rotator cuff syndrome

532

3189

1.24

5.34

1.3

40.17

34.85

u/l

0.26

472

2756

Drug-induced adrenocortical insufficiency

3.05

5.31

1.5

1.2

26.98

30.60

u/l

0.07

Benign neoplasm: Sigmoid colon

152

1023

1.50

5.31

1.2

33.47

25.77

u/l

0.66

137

873

Poisoning by drugs, medicaments and biological substances

172

1186

1.46

5.29

1.2

1.3

28.79

32.50

u/l

0.16

142

1041

N06DA Anticholinesterases

146

1745

0.67

5.27

1.2

1.3

32.83

40.12

u/l

0.54

113

1497

Use of anticholinesterases

146

1745

0.67

5.27

1.2

1.3

32.83

40.12

u/l

0.54

113

1497

Injuries to the hip and thigh

384

2745

1.28

5.25

1.3

37.03

35.98

u/l

0.04

343

2348

Interstitial lung disease

140

929

1.52

5.25

1.2

1.3

45.54

40.31

u/l

0.12

123

803

Interstitial lung disease endpoints

140

929

1.52

5.25

1.2

1.3

45.54

40.31

u/l

0.12

123

803

Use of pramipexole

184

1288

1.44

5.25

1.2

1.3

30.21

42.26

u/l

0.99

149

1124

Ovarian cyst

220

905

1.41

5.23

1.3

1.2

33.25

32.88

u/l

0.01

194

785

Allergic asthma (mode)

156

1038

1.48

5.22

1.2

43.16

21.54

u/l

0.62

139

914

Substance abuse, excluding more controls

468

3277

1.25

5.20

1.2

1.3

41.76

34.43

u/l

0.40

390

2874

ILD, hospital admissions 1, main diag only

125

812

1.55

5.18

1.2

1.3

48.89

41.43

u/l

0.16

108

700

Retinal haemorrhage

121

2.53

5.17

1.2

86.57

37.36

u/l

0.78

107

Persons encountering health services for specific procedures, not carried out

355

1.85

5.16

1.3

1.2

107.93

39.64

u/l

0.76

301

Anxiety disorders

699

4123

1.20

5.15

1.3

1.2

33.19

32.64

u/l

0.03

612

3605

Diabetic retinopathy, strict definition

205

1287

1.41

5.15

1.1

1.2

37.37

29.09

u/l

0.29

179

1140

Other and unspecified disorders of skin and subcutaneous tissue

320

1.90

5.13

1.3

1.2

24.09

35.47

u/l

0.97

270

Fracture of rib(s), sternum and thoracic spine

256

1901

1.35

5.13

1.3

56.68

35.95

u/l

0.62

220

1643

In situ neoplasms

277

2081

1.34

5.13

1.2

1.3

52.99

34.80

u/l

0.97

244

1795

Benign neoplasm: Transverse colon

557

1.67

5.11

1.6

1.2

71.99

30.86

u/l

0.84

480

Other peripheral vascular diseases

385

1.81

5.11

1.2

26.19

34.49

u/l

0.50

332

Malignant neoplasm of breast

192

1941

0.71

5.11

1.2

30.32

33.37

u/l

0.23

160

1687

Hypotension

144

967

1.50

5.10

1.3

34.24

43.33

u/l

0.53

128

828

Other anxiety disorders

300

2018

1.32

5.09

1.2

31.75

34.10

u/l

0.09

265

1791

Hodgkin lymphoma, hilmo

134

2.43

5.09

1.1

1.2

81.87

35.91

u/l

0.68

116

Disorders of synovium and tendon

413

2943

1.27

5.09

1.2

1.3

35.01

34.24

u/l

0.04

372

2545

Dentofacial anomalies [including malocclusion]

174

1199

1.44

5.07

1.2

36.02

28.21

u/l

0.38

154

1055

Undetermined asthma, excluding more controls

550

1.66

5.05

1.6

1.3

72.45

28.48

u/l

0.64

478

Excessive attrition of teeth

289

1172

1.34

5.04

1.3

26.10

27.42

u/l

0.08

244

1048

Undefined dementia

584

0.42

5.04

1.1

1.2

31.27

48.96

u/l

1.11

489

Other diseases of intestine

106

667

1.60

5.04

1.2

1.3

37.87

45.00

u/l

0.28

572

Hodgkin lymphoma

135

2.41

5.01

1.1

1.2

81.87

19.45

u/l

1.09

116

Migraine with aura and triptan purchases

521

1.68

5.01

1.3

26.05

27.08

u/l

0.02

452

Benign neoplasm: Stomach

561

1.66

4.99

1.6

1.2

43.80

41.54

u/l

0.06

479

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

523

1.68

4.98

1.4

1.2

110.21

41.07

u/l

1.17

455

Other viral diseases, not elsewhere classified

137

913

1.50

4.97

1.5

1.3

87.97

37.32

u/l

0.97

120

800

Disturbance of activity and attention

270

1.95

4.97

1.1

1.4

10.79

24.71

u/l

0.90

238

Emphysema

389

1.79

4.96

1.4

1.2

38.26

49.95

u/l

0.45

337

Sciatica+with lumbago

394

2955

1.27

4.96

1.3

36.84

31.63

u/l

0.29

358

2553

Leiomyoma of uterus

391

1739

1.28

4.95

1.2

36.72

31.71

u/l

0.27

340

1514

Pre-eclampsia

110

701

1.58

4.94

1.4

1.2

49.77

28.97

u/l

0.79

612

Bronchitis, not specified as acute or chronic

456

1.73

4.94

1.2

1.3

73.44

35.45

u/l

0.65

392

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

179

1261

1.42

4.93

1.3

1.2

23.85

35.48

u/l

0.68

148

1119

Disorders of vitreous body and globe

410

3179

1.26

4.93

1.3

59.63

35.43

u/l

1.64

354

2750

Diagnoses used for exclusion with ILD

218

1592

1.38

4.88

1.3

39.88

37.74

u/l

0.08

188

1365

Other symptoms and signs involving the circulatory and respiratory systems

290

1.91

4.88

1.2

1.3

20.40

56.62

u/l

1.68

246

Hypoparathyroidism

175

2.21

4.88

1.3

1.2

20.86

21.44

u/l

0.04

151

Parodontitis, under 40 years and operation codes

248

1.99

4.87

1.2

89.74

37.70

u/l

0.47

219

Parodontitis, under 40 years

269

1.94

4.86

1.2

84.27

35.67

u/l

0.47

237

Urticaria and erythema

254

1901

1.34

4.84

1.3

1.2

30.44

34.59

u/l

0.18

224

1655

Benign neoplasm: Adrenal gland

415

1.76

4.82

1.3

1.2

29.44

40.91

u/l

0.49

360

Parodontitis, operation under 40 years and operation codes

249

1.98

4.82

1.2

89.74

37.58

u/l

0.47

220

Anti-inflammatory and antirheumatic products, non-steroids

270

1009

1.35

4.81

1.2

43.99

39.87

u/l

0.15

236

865

Hyperkinetic disorders

294

1.89

4.81

1.1

1.4

10.41

23.86

u/l

0.98

262

Parodontitis, under 40 years, or operation codes

270

1.94

4.81

1.2

84.27

35.55

u/l

0.47

238

ILD, hospital admissions 3, with pneumonia sepsis

460

1.71

4.81

1.3

1.2

40.96

26.75

u/l

0.73

398

All anxiety disorders

425

2731

1.26

4.80

1.2

27.84

32.62

u/l

0.30

378

2420

Oxicams

224

924

1.38

4.79

1.4

1.2

24.81

42.66

u/l

2.07

191

790

Disorders of vitreous body

397

3089

1.26

4.79

1.3

54.00

35.80

u/l

1.24

343

2676

Cholangitis (primary sclerosing, PSC)

300

1.89

4.76

1.2

55.86

38.87

u/l

0.30

254

Any dementia, excluding more controls

179

1737

0.71

4.75

1.2

1.3

44.87

41.18

u/l

0.14

150

1487

ILD-related respiratory insufficiency

184

2.16

4.74

1.2

29.42

43.12

u/l

0.51

156

Other arthrosis

446

2564

1.25

4.70

1.3

39.31

31.71

u/l

0.40

400

2223

Pre-eclampsia or poor fetal growth

148

1014

1.46

4.68

1.3

1.2

40.14

28.65

u/l

0.51

134

893

Unspecified privation

587

1.61

4.65

1.2

22.47

44.50

u/l

2.13

511

Inflammatory diseases of female pelvic organs

351

2071

1.28

4.64

1.3

1.2

29.82

35.47

u/l

0.34

301

1810

Other extrapyramidal and movement disorders in other diseases

183

1311

1.40

4.63

1.2

1.3

42.91

38.63

u/l

0.11

155

1141

Acute pancreatitis (for exclusion)

174

1236

1.42

4.63

1.2

1.3

22.68

38.25

u/l

2.72

152

1066

Stomatitis and related lesions

383

1.76

4.61

1.4

1.2

100.39

34.35

u/l

1.06

335

Leiomyoma of uterus

280

1193

1.33

4.57

1.2

39.02

21.47

u/l

1.20

250

1039

Diseases of salivary glands

144

993

1.46

4.51

1.2

28.05

28.94

u/l

0.04

122

856

Congenital malformations, deformations and chromosomal abnormalities

413

3182

1.25

4.50

1.3

40.06

31.72

u/l

0.41

371

2787

Acute generalized exanthematous pustulosis

208

2.05

4.49

1.3

1.2

49.52

27.09

u/l

0.40

180

Restless leg syndrome

632

1.58

4.48

1.2

45.36

43.44

u/l

0.03

537

Alzheimer’s disease, wide definition

1263

0.65

4.47

1.2

36.59

42.43

u/l

0.25

1068

Meniscus derangement

483

2695

1.23

4.45

1.2

1.3

26.71

31.30

u/l

0.45

408

2339

Other disorders starting during childhood or adolecense, excluding more controls

2.79

4.44

1.2

12.94

44.77

u/l

0.55

Migraine without aura

101

649

1.56

4.42

1.3

1.2

18.12

30.11

u/l

1.53

557

Other disorders of penis

572

1.60

4.41

1.4

1.2

23.84

41.50

u/l

0.97

496

Asthma mixed form (mode)

230

1.97

4.40

1.1

1.2

39.67

24.45

u/l

0.75

202

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

404

1.72

4.40

1.7

1.2

25.02

35.89

u/l

0.80

346

Sequelae of cerebrovascular disease

305

2086

1.29

4.33

1.2

1.3

34.94

37.53

u/l

0.20

262

1786

Myocardial infarction, with ST-elevation

166

1185

1.41

4.33

1.2

1.3

33.51

39.76

u/l

0.39

150

1011

Localized swelling, mass and lump of skin and subcutaneous tissue

244

1851

1.32

4.30

1.4

1.2

44.65

32.31

u/l

0.53

217

1597

Other or ill-defined heart diseases

239

1.94

4.30

1.1

1.3

14.64

45.09

u/l

1.79

199

Amenorrhoea

184

2.08

4.30

1.1

1.4

65.23

20.59

u/l

0.46

161

Postmenopausal bleeding

190

751

1.40

4.29

1.3

1.2

39.18

33.28

u/l

0.14

171

644

Persistent mood disorders

146

1020

1.44

4.28

1.3

28.42

35.50

u/l

0.45

123

888

Fissure and fistula of anal and rectal regions

195

1433

1.37

4.26

1.3

23.77

35.20

u/l

1.62

168

1234

Chronic sinusitis

321

2532

1.27

4.19

1.4

1.3

31.47

31.95

u/l

0.03

289

2187

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

120

785

1.49

4.17

1.1

1.3

31.98

38.31

u/l

0.29

106

684

Thyroiditis, ILD-related definition

510

1.62

4.16

1.2

30.88

37.63

u/l

0.29

439

Dementia

229

2083

0.76

4.15

1.2

1.3

30.47

41.35

u/l

1.49

190

1794

Paralytic ileus and intestinal obstruction

201

1491

1.35

4.14

1.2

1.3

29.08

37.78

u/l

0.62

175

1270

Deforming dorsopathies

207

1544

1.35

4.12

1.6

1.2

33.90

32.07

u/l

0.12

188

1332

Use of other anti-dementia drugs

107

1383

0.67

4.12

1.3

1.2

29.76

41.32

u/l

1.16

1173

Use of memantine

107

1383

0.67

4.12

1.3

1.2

29.76

41.32

u/l

1.16

1173

243

1641

1.32

4.11

1.4

1.3

44.76

40.84

u/l

0.22

198

1424

Other retinal artery occlusion

117

2.35

4.05

1.1

1.2

56.53

35.31

u/l

0.35

100

Other bursopathies

111

745

1.50

4.04

1.2

22.76

44.61

u/l

2.45

643

Undetermined asthma

585

1.56

4.01

1.6

1.3

72.45

23.10

u/l

0.76

509

Unspecific neurodegenerative disorder

215

1959

0.75

4.00

1.2

1.3

42.06

40.90

u/l

0.05

177

1685

Soft tissue disorders related to use, overuse and pressure

212

1595

1.33

4.00

1.2

1.3

22.46

39.46

u/l

3.20

192

1371

Aortic aneurysm

208

1534

1.34

3.99

1.4

34.05

36.88

u/l

0.19

173

1320

Diabetes mellitus in pregnancy

133

593

1.46

3.99

1.2

1.3

21.02

31.61

u/l

0.60

119

535

Alzheimer disease

137

1459

0.70

3.98

1.3

47.94

40.34

u/l

0.25

112

1241

severe traumatic brain injury, does not include concussion

188

1391

1.36

3.97

1.4

1.3

48.19

41.77

u/l

0.19

161

1194

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

3.34

3.94

3.2

1.2

32.03

21.65

u/l

0.36

Peritonsillar abscess

150

1071

1.41

3.93

1.2

1.3

27.95

30.64

u/l

0.10

133

934

Injuries to the knee and lower leg

977

4888

1.15

3.91

1.3

28.17

36.34

u/l

1.23

840

4273

Alzheimer disease, including avohilmo

171

1679

0.73

3.91

1.2

1.3

41.36

40.84

u/l

0.02

144

1434

Superficial injury of lower leg

178

1309

1.37

3.91

1.3

36.61

36.15

u/l

0.02

160

1142

Benign neoplasm: Ascending colon

117

800

1.47

3.91

1.7

1.2

50.10

39.76

u/l

0.23

103

694

Coxarthrosis, primary

506

3662

1.20

3.90

1.3

48.21

36.35

u/l

0.72

441

3159

Propionic acid derivatives

262

1009

1.31

3.90

1.2

43.71

39.87

u/l

0.14

228

865

Urticaria

197

1472

1.34

3.90

1.3

27.16

33.49

u/l

0.24

174

1286

Squamous cell neoplasms and carcinomas of the skin

111

752

1.49

3.88

1.5

1.3

59.46

42.99

u/l

0.60

646

Degeneration of macula and posterior pole

392

2629

1.23

3.87

1.4

1.3

44.20

40.73

u/l

0.23

331

2264

Gestational [pregnancy-induced] hypertension

119

816

1.46

3.84

1.2

36.52

28.32

u/l

0.29

109

715

Abnormal results of function studies

436

1.64

3.83

1.4

1.2

57.37

38.58

u/l

0.25

379

Other disorders of the musculoskeletal system and connective tissue

121

836

1.46

3.83

1.7

1.2

45.95

40.80

u/l

0.11

112

728

Cervical disc disorders

295

2334

1.27

3.82

1.3

21.63

33.59

u/l

3.34

257

2011

Familial hypercholesterolemia

132

929

1.43

3.79

1.2

1.3

36.39

39.89

u/l

0.15

117

806

Other diseases of pancreas

407

1.66

3.79

1.2

19.87

43.61

u/l

1.95

347

Generalized anxiety disorder

594

1.54

3.78

1.2

12.47

30.69

u/l

2.85

514

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

407

3269

1.22

3.78

1.2

1.3

39.69

33.27

u/l

0.40

362

2843

Subjective visual disturbances

179

1326

1.36

3.77

1.2

1.3

30.68

36.86

u/l

0.42

154

1160

SLE (Finngen)

147

2.13

3.76

1.1

1.2

125.97

18.36

u/l

1.11

128

L02BA Anti-estrogens

747

0.55

3.76

1.3

1.2

15.29

25.42

u/l

2.36

649

Mental and behavioural disorders due to use of other stimulants, including caffeine

102

2.38

3.75

1.1

1.2

19.84

36.48

u/l

0.33

Complications of internal orthopaedic prosthetic devices, implants and grafts

180

1336

1.35

3.75

1.4

1.2

48.03

36.72

u/l

0.26

153

1149

Gestational diabetes (for exclusion)

148

747

1.40

3.72

1.2

16.43

31.28

u/l

1.66

131

671

Alzheimer’s disease (Late onset)

1159

0.66

3.72

1.2

38.35

42.08

u/l

0.13

983

Diplopia

104

702

1.49

3.72

1.3

1.2

41.23

45.74

u/l

0.07

608

Other symptoms and signs involving cognitive functions and awareness

359

2731

1.24

3.72

1.2

1.3

35.13

35.31

u/l

0.01

319

2349

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1078

0.65

3.71

1.1

1.2

42.44

27.02

u/l

0.75

923

Non-small cell lung cancer

1020

0.61

3.70

1.1

1.3

39.18

39.30

u/l

0.00

874

Acute appendicitis

539

4292

1.19

3.68

1.2

1.3

41.95

31.74

u/l

0.62

482

3743

Cervicalgia

156

1137

1.38

3.66

1.4

1.2

24.68

33.92

u/l

1.09

134

968

Non-selective monoamine reuptake inhibitors

301

2329

1.26

3.64

1.2

1.3

23.97

36.31

u/l

2.48

254

2017

Abnormalities of gait and mobility

104

706

1.48

3.63

1.2

23.76

40.10

u/l

1.85

604

Hydronephrosis

553

1.55

3.62

1.7

1.3

55.97

37.54

u/l

0.29

473

Malignant neoplasm of kidney, except renal pelvis

578

1.54

3.61

1.6

1.2

65.42

47.58

u/l

0.28

501

Noninfectious colitis NAS

104

707

1.48

3.60

1.3

1.2

38.86

44.08

u/l

0.18

615

Superficial injury of abdomen, lower back and pelvis

110

757

1.46

3.57

1.2

33.04

43.59

u/l

0.48

661

Intestinal adhesions without obstruction

429

1.62

3.57

1.3

1.2

35.96

42.07

u/l

0.13

366

Other complications of surgical and medical care, not elsewhere classified

468

1.59

3.57

1.2

51.16

36.71

u/l

0.48

405

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

103

702

1.47

3.49

1.1

1.2

29.74

26.67

u/l

0.14

598

Somatoform disorder

117

819

1.44

3.48

1.2

44.53

36.11

u/l

0.16

710

Retinal vascular disorders

106

729

1.46

3.48

1.3

45.11

46.58

u/l

0.04

641

Dementia, including avohilmo

254

2220

0.79

3.47

1.2

1.3

30.47

41.32

u/l

1.58

211

1916

Maternal care for other conditions predominantly related to pregnancy

582

1.51

3.47

1.2

30.93

31.17

u/l

0.01

515

Benign neoplasm: Transverse colon

616

1.51

3.46

1.6

1.3

71.99

43.26

u/l

0.51

533

Use of rivastigmine

813

0.59

3.45

1.2

38.90

45.84

u/l

0.20

687

Polyuria

184

1390

1.33

3.45

1.2

1.3

28.56

38.71

u/l

0.96

156

1212

Medicines for HER+ breast cancer

135

1806

0.73

3.42

1.2

28.55

34.24

u/l

0.41

111

1571

Recurring oral aphthae, including avohilmo

100

683

1.47

3.40

1.3

1.2

72.52

38.58

u/l

0.78

590

Internal derangement of knee

292

2337

1.25

3.40

1.2

1.3

22.30

30.32

u/l

1.75

255

2033

Vitamin B12 deficiency anaemia

602

1.50

3.40

1.3

1.2

101.09

38.41

u/l

0.90

516

Dermatitis due to substances taken internally

260

1.79

3.40

1.3

1.2

47.53

43.44

u/l

0.05

217

Excessive vomiting in pregnancy

245

1.81

3.39

1.2

12.35

17.66

u/l

1.18

207

Collagenous colitis

443

1.59

3.39

1.2

29.01

40.52

u/l

0.54

380

Retinal vascular occlusion

104

717

1.46

3.38

1.3

45.77

47.09

u/l

0.03

629

Diabetic retinopathy

366

1890

1.23

3.38

1.2

34.50

29.73

u/l

0.37

320

1659

Transport accidents

337

2433

1.23

3.37

1.2

24.82

31.81

u/l

0.88

300

2114

Malignant neoplasm of urinary organs

620

1.50

3.36

1.6

1.3

63.03

45.47

u/l

0.29

537

Other or unspecified ileus, impaction or obstruction

142

1036

1.38

3.34

1.2

1.3

25.46

39.13

u/l

1.86

124

885

Viral warts

453

1.58

3.32

1.3

1.2

26.23

38.70

u/l

0.68

390

Fracture of femur

208

1465

1.30

3.32

1.3

34.02

41.37

u/l

0.52

189

1250

Heartburn

533

1.53

3.31

1.3

1.2

18.31

34.96

u/l

2.02

458

Artificial joint operation, meniscal resection

786

4571

1.15

3.31

1.4

1.3

28.28

35.27

u/l

1.53

695

3961

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

219

1.85

3.29

1.2

38.60

22.38

u/l

0.92

190

Open wound of forearm

486

1.55

3.29

1.2

50.75

49.76

u/l

0.01

422

Mixed and other personality disorders

353

1.65

3.29

1.3

1.2

33.62

34.72

u/l

0.03

302

Carcinoma in situ of skin of trunk

142

2.07

3.29

1.4

1.2

22.28

21.26

u/l

0.09

125

Hypoglycaemia, other or unspecified

338

1.67

3.29

1.7

1.2

28.86

44.17

u/l

0.67

292

Benign neoplasm: Rectum, anus and anal canal

169

1272

1.34

3.27

1.3

46.63

38.83

u/l

0.23

145

1100

Haemorrhoids and perianal venous thrombosis

227

1776

1.28

3.27

1.5

1.3

25.48

36.79

u/l

1.77

200

1519

Viral hepatitis

346

1.66

3.27

1.3

1.2

51.86

38.37

u/l

0.24

293

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

109

763

1.43

3.27

1.2

1.3

31.18

35.67

u/l

0.12

661

Appendectomy

472

3839

1.19

3.26

1.2

1.3

35.38

32.19

u/l

0.19

422

3351

Other disorders starting during childhood or adolescence

2.35

3.26

1.2

1.7

12.94

39.33

u/l

0.59

Polyp of the female genital tract

192

848

1.32

3.22

1.3

1.2

38.11

31.42

u/l

0.17

175

732

Hypoplasia of dental enamel, including avohilmo

6.49

3.20

1.1

1.4

28.33

23.83

u/l

—

Appendicitis, broad definition

572

4494

1.17

3.19

1.2

1.3

41.58

32.09

u/l

0.61

511

3918

Injuries to unspecified part of trunk, limb or body region

514

1.53

3.18

1.2

17.62

50.36

u/l

3.19

440

Mental and behavioural disorders due to sedatives or hypnotics

326

1.67

3.18

1.1

1.2

63.15

36.23

u/l

0.52

277

Budesonide

652

1.46

3.18

1.6

1.2

52.27

37.99

u/l

0.36

558

L02BG Aromatase inhibitors

106

1493

0.71

3.17

1.1

1.2

32.79

35.84

u/l

0.15

1301

Disorders of conjunctiva

592

4269

1.16

3.17

1.3

33.71

34.35

u/l

0.05

511

3728

Phobic anxiety disorders

514

1.52

3.17

1.2

47.70

25.35

u/l

0.62

444

Disorders of oesophagus in diseases classified elsewhere

2.28

3.15

1.1

1.2

30.85

25.72

u/l

0.13

Benign neoplasm: Skin of eyelid, including canthus

111

786

1.42

3.15

1.3

1.2

53.92

28.24

u/l

0.61

679

Neuromuscular dysfunction of bladder

500

1.53

3.14

1.1

1.2

30.99

42.18

u/l

0.42

436

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

113

1278

0.72

3.13

1.2

31.09

23.75

u/l

0.51

1108

Endometriosis

197

898

1.31

3.11

1.2

24.92

33.21

u/l

0.65

163

778

Other diseases of oesophagus

533

1.51

3.11

1.3

1.2

46.06

36.48

u/l

0.35

458

Thyrotoxicosis

171

1300

1.32

3.10

1.2

38.89

35.99

u/l

0.06

155

1132

Conjunctivitis (acute, non atopic)

192

1478

1.30

3.10

1.2

1.3

26.02

32.67

u/l

0.54

165

1296

Benign neoplasm: Sigmoid colon

152

1137

1.34

3.09

1.2

1.3

33.47

38.99

u/l

0.37

137

988

Hepatic failure, not elsewhere classified

188

1.89

3.08

1.8

1.3

94.52

44.26

u/l

0.58

159

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

153

1133

1.34

3.07

1.2

29.66

35.61

u/l

0.28

135

996

KRA_PSY_EATING, excluding more controls

180

1.89

3.06

1.1

1.2

36.35

31.27

u/l

0.07

152

Molar incisor enamel hypoplasia, with caries

7.61

3.06

1.2

1.6

9.88

28.07

u/l

—

Paralytic strabismus

400

1.59

3.05

1.3

1.2

59.05

42.54

u/l

0.18

348

Diseases of appendix

575

4522

1.16

3.04

1.2

1.3

42.03

32.00

u/l

0.66

514

3943

Open wound of lower leg

112

800

1.41

3.04

1.2

1.3

70.49

40.48

u/l

0.52

687

Cerebral cysts

262

1.73

3.04

1.4

1.2

28.64

38.88

u/l

0.30

223

Mental and behavioural disorders due to psychoactive substance use

484

3892

1.18

3.03

1.2

1.3

41.20

32.13

u/l

0.57

404

3401

Pilonidal cyst

424

1.57

3.03

1.2

18.17

37.17

u/l

1.37

362

Follicular cysts of skin and subcutaneous tissue

140

1038

1.35

3.03

1.2

1.3

42.85

37.08

u/l

0.16

123

902

Other enthesopathies

218

1718

1.27

3.01

1.2

1.3

42.82

35.30

u/l

0.18

197

1485

Pain in thoracic spine

106

751

1.42

3.01

1.2

1.3

35.86

32.64

u/l

0.11

100

649

Other and unspecified types of non-Hodgkin lymphoma, hilmo

226

1.79

3.01

1.2

38.60

45.55

u/l

0.20

195

Other noninflammatory disorders of uterus, except cervix

145

732

1.36

3.00

1.2

39.36

33.58

u/l

0.19

129

626

Shock, not elsewhere classified

3.07

3.00

1.0

1.2

10.26

11.58

u/l

—

Diseases of peritoneum

554

1.49

3.00

1.2

20.55

40.64

u/l

2.28

478

Open wound of head

419

3481

1.19

2.99

1.3

27.00

33.90

u/l

1.02

363

3016

Secondary uncertain malignant neoplasm

107

761

1.41

2.99

1.2

1.3

121.49

40.75

u/l

1.40

659

Papilloedema, unspecified

2.27

2.98

1.0

1.1

27.50

18.34

u/l

0.27

Benign neoplasm: Rectum

149

1119

1.34

2.97

1.3

34.51

39.31

u/l

0.26

128

975

Crohn disease

654

1.44

2.96

1.2

51.29

42.13

u/l

0.15

567

Lesion of ulnar nerve

115

830

1.39

2.95

1.3

30.59

38.81

u/l

0.46

106

718

Primary gonarthrosis, bilateral

413

3046

1.19

2.94

1.4

1.3

33.76

36.97

u/l

0.23

361

2629

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

446

0.49

2.93

1.1

1.2

17.42

22.40

u/l

0.37

389

Acute appendicitis, no complications

405

3408

1.19

2.90

1.2

1.3

35.45

30.12

u/l

0.32

364

2983

Other specified/unspecified soft tissue disorders

229

1.76

2.88

1.3

1.2

28.00

35.30

u/l

0.25

196

Disorders of sclera, cornea, iris and ciliary body

406

3430

1.19

2.87

1.3

36.38

33.00

u/l

0.25

358

2975

Visual impairment including blindness (binocular or monocular)

328

1.63

2.87

1.2

40.93

37.87

u/l

0.08

284

Left bundle-branch block

328

1.63

2.87

1.2

1.3

29.40

29.88

u/l

0.02

275

Later onset COPD

244

1536

1.25

2.87

1.1

1.3

31.21

40.15

u/l

0.95

204

1325

Erectile dysfunction

569

1.47

2.86

2.2

1.3

29.48

50.16

u/l

1.48

506

Viral infections of the central nervous system

344

1.61

2.85

1.2

58.19

37.31

u/l

0.27

290

Female infertility, associated with anovulation

164

1.90

2.85

1.5

1.2

9.21

33.94

u/l

1.44

147

Injuries to the ankle and foot

481

3754

1.17

2.83

1.2

1.3

39.48

32.19

u/l

0.51

423

3291

Schizophrenia or delusion, excluding more controls

209

1640

1.27

2.83

1.2

1.3

29.17

31.88

u/l

0.13

176

1431

Substance abuse

468

3827

1.17

2.83

1.2

1.3

41.76

32.13

u/l

0.59

390

3353

Other and unspecified hereditary haemolytic anaemias

9.16

2.82

8.8

1.0

53.44

6.15

u/l

—

Other disorders of pigmentation

194

1.82

2.81

1.1

1.2

57.97

33.70

u/l

0.46

168

Open wound of ankle and foot

538

1.48

2.80

1.2

21.81

42.69

u/l

1.53

464

Abscess of anal and rectal regions

449

1.52

2.80

1.2

1.3

20.65

47.33

u/l

1.96

388

Arterial embolism and thrombosis of lower extremity artery

180

1.85

2.79

1.2

1.3

33.37

46.13

u/l

0.39

159

Systemic lupus erythematosus

166

1.89

2.77

1.1

1.2

125.97

21.02

u/l

1.07

143

Otalgia

331

1.61

2.77

1.4

1.2

41.17

32.84

u/l

0.13

281

Arterial embolism and thrombosis

324

1.62

2.75

1.1

1.2

29.73

51.88

u/l

1.09

280

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

179

1395

1.29

2.74

1.3

23.85

31.81

u/l

0.44

148

1227

Chronic laryngitis and laryngotracheitis

103

740

1.40

2.74

1.2

1.3

29.27

34.42

u/l

0.26

631

Dementia in Alzheimer disease

933

0.68

2.74

1.2

25.72

43.96

u/l

1.95

788

Other inflammation of eyelid

682

1.42

2.73

1.6

1.2

42.56

37.48

u/l

0.10

596

Sarcoidosis

104

750

1.39

2.71

1.2

28.90

46.17

u/l

1.16

653

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

992

0.67

2.71

1.9

1.2

41.65

26.45

u/l

0.55

844

Polymyalgia rheumatica

108

785

1.38

2.70

1.2

31.28

45.19

u/l

1.11

683

Other shoulder lesions

438

1.52

2.67

1.2

44.62

45.02

u/l

0.01

377

Wide developmental disorders

2.35

2.65

1.4

1.2

80.06

41.95

u/l

0.22

Other infectious diseases

455

1.51

2.65

1.2

121.05

40.26

u/l

1.53

392

Malignant neoplasm of breast, HER-negative

1057

0.69

2.64

1.2

30.52

33.25

u/l

0.14

912

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

112

1269

0.74

2.63

1.1

1.2

46.68

26.38

u/l

1.36

1084

Supervision of normal pregnancy

437

0.63

2.62

1.1

1.2

23.72

42.66

u/l

0.76

388

Ganglion

139

1055

1.32

2.61

1.2

33.72

37.68

u/l

0.17

124

910

Diseases of external ear

248

2021

1.23

2.61

1.6

1.3

32.90

33.70

u/l

0.04

212

1743

Other viral hepatitis

282

1.64

2.61

1.3

1.2

57.69

35.12

u/l

0.36

238

Parkinson's disease, strict definition

898

0.66

2.59

1.1

1.3

35.00

41.51

u/l

0.19

776

Poisoning by medicine

139

1057

1.32

2.58

1.2

1.3

29.23

34.29

u/l

0.18

114

926

Superficial injury of hip and thigh

106

774

1.38

2.57

1.2

59.25

46.69

u/l

0.17

664

Malignant neoplasm of stomach

303

0.43

2.57

1.2

51.20

42.12

u/l

0.22

259

Presence of other devices

167

1303

1.29

2.56

1.3

32.04

34.92

u/l

0.20

153

1121

Erosion of teeth

2.46

2.56

1.3

179.27

50.05

u/l

0.74

Wet age-related macular degeneration

137

1023

1.32

2.55

1.3

49.14

44.18

u/l

0.18

111

876

Viral and other specified intestinal infections

121

882

1.34

2.55

1.2

44.78

30.68

u/l

0.24

112

775

Left ventricular outflow tract obstruction (LVOTO), broad definition

575

1.43

2.53

1.3

27.28

43.65

u/l

0.95

498

Conjunctivitis

507

3839

1.15

2.51

1.3

28.04

34.30

u/l

0.94

435

3352

Post-traumatic stress disorder

254

1.66

2.51

1.1

1.2

11.91

23.91

u/l

1.53

218

Fentanyl

510

1.46

2.50

1.3

1.2

37.17

44.49

u/l

0.35

435

Kela-code for severe mental illness

263

2168

1.22

2.49

1.2

1.3

28.49

32.07

u/l

0.23

227

1905

Superficial injury of head

160

1247

1.29

2.49

1.2

1.3

23.93

41.16

u/l

2.58

144

1073

Aortic valve malfunction, age under 60 years

545

1.44

2.47

1.3

27.27

44.45

u/l

0.97

471

Other symptoms and signs involving the nervous and musculoskeletal systems

295

2462

1.20

2.46

1.2

1.3

21.42

36.15

u/l

3.49

267

2135

Unspecified mental disorder

287

2391

1.20

2.44

1.2

1.3

33.76

31.88

u/l

0.10

250

2089

Injuries to the wrist and hand

764

4944

1.12

2.43

1.2

1.3

31.01

35.56

u/l

0.42

668

4324

Hallux valgus (acquired)

237

1397

1.23

2.43

1.2

36.64

35.21

u/l

0.05

203

1204

Temporomandibular joint disorders

689

1.38

2.43

1.2

32.98

37.36

u/l

0.17

589

Deviated nasal septum

272

2256

1.21

2.42

1.3

29.17

29.62

u/l

0.03

241

1956

Covid-19 suspected case

130

990

1.32

2.42

1.2

45.64

35.90

u/l

0.29

117

857

Crohn's disease of small intestine

312

1.58

2.41

1.2

73.93

37.17

u/l

0.38

266

Carbimazole or st.post thyroidectomy, condition for graves disease

130

991

1.32

2.40

1.2

25.53

33.52

u/l

0.57

112

861

Secondary sideroblastic anaemia

6.50

2.40

1.4

1.1

43.53

12.64

u/l

—

Suppurative and unspecified otitis media

218

1568

1.23

2.38

1.2

1.3

43.02

35.52

u/l

0.24

189

1369

Other abnormalities of plasma proteins

2.29

2.36

1.0

1.1

56.38

41.83

u/l

0.23

Parkinson's disease

974

0.69

2.36

1.1

1.3

32.24

40.71

u/l

0.30

843

Fibromyalgia

314

1.57

2.35

1.1

1.2

23.07

20.58

u/l

0.16

271

Benign lipomatous neoplasm

204

1650

1.24

2.35

1.4

1.2

31.94

23.48

u/l

0.43

182

1423

Acute and transient psychotic disorders

559

1.42

2.34

1.2

18.06

41.98

u/l

2.02

477

Unspecified misadventure during surgical and medical care

299

1.59

2.34

1.1

1.2

31.74

41.88

u/l

0.37

256

Suicide or other Intentional self-harm

162

1277

1.27

2.33

1.2

1.3

25.35

32.18

u/l

0.32

132

1122

Hyphaema and other vascular disorders of iris and ciliary body

105

2.03

2.33

1.2

44.74

34.60

u/l

0.19

Retinal detachments and breaks

275

2296

1.20

2.32

1.2

1.3

43.83

36.96

u/l

0.34

237

1982

Trochanteric bursitis

670

1.38

2.32

1.2

20.93

37.18

u/l

1.73

578

Other sleep disorders

569

1.41

2.31

1.2

22.70

45.48

u/l

1.85

489

Congenital malformations of the circulatory system

665

1.37

2.31

1.1

1.3

38.30

41.85

u/l

0.12

582

Carcinoma in situ of skin

429

1.48

2.30

1.2

28.11

23.21

u/l

0.30

374

Erosion of teeth, including avohilmo

122

896

1.32

2.30

1.5

1.3

68.75

25.40

u/l

1.41

109

800

Medial epicondylitis

185

1.75

2.29

1.2

14.16

28.66

u/l

1.19

157

Fibroblastic disorders

185

1486

1.25

2.28

1.4

1.3

52.26

35.19

u/l

0.40

165

1274

Diseases of inner ear

409

3459

1.16

2.28

1.2

1.3

28.50

36.69

u/l

1.06

356

2992

Benign neoplasm: Skin of trunk

208

1.70

2.28

1.2

16.24

20.00

u/l

0.48

179

Adenocarcinoma and papillary adenocarcinoma of stomach

157

0.32

2.28

1.2

20.22

39.09

u/l

—

134

Cerebral palsy and other paralytic syndromes

588

1.40

2.27

1.3

1.2

46.73

43.39

u/l

0.05

505

Non-allergic asthma

463

1.45

2.27

1.2

29.00

40.08

u/l

0.47

400

Persistent delusional disorders

390

1.50

2.26

1.2

20.58

43.22

u/l

1.32

330

Other and unspecified urticaria

123

940

1.31

2.26

1.3

1.2

32.50

36.12

u/l

0.08

110

812

Varicose veins

487

3215

1.15

2.25

1.3

44.61

32.71

u/l

0.74

427

2769

Other maternal disorders predominantly related to pregnancy

289

1522

1.20

2.21

1.2

22.36

30.68

u/l

0.99

257

1333

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

659

1.37

2.21

1.6

1.2

20.50

28.71

u/l

0.78

570

Dermatophytosis

102

762

1.35

2.21

1.2

1.3

30.21

42.77

u/l

0.90

660

Acute suppurative otitis media

143

1043

1.28

2.21

1.2

36.63

35.68

u/l

0.03

123

909

Dislocation, sprain and strain of joints and ligaments of knee

429

3462

1.15

2.20

1.4

1.3

18.79

32.84

u/l

4.34

378

3040

Persons with potential health hazards related to communicable diseases

215

1748

1.22

2.19

1.5

1.3

34.11

36.69

u/l

0.12

197

1540

Other female pelvic inflammatory diseases

694

1.36

2.19

1.2

21.20

24.74

u/l

0.29

599

Rheumatoid arthritis

228

1709

1.22

2.18

1.2

1.3

70.41

34.85

u/l

1.14

208

1466

Use of levodopa decarboxylase inhibitor

829

0.68

2.18

1.0

1.3

30.34

40.93

u/l

0.35

716

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

369

1.50

2.17

1.3

1.2

18.90

24.50

u/l

0.56

314

Chronic viral hepatitis

234

1.64

2.17

1.2

69.45

36.04

u/l

0.44

197

Carcinoma in situ of skin of trunk

166

1.77

2.17

1.4

1.2

22.28

45.86

u/l

1.08

143

Other and unspecified injuries of head

297

1.56

2.17

1.1

1.3

19.46

43.74

u/l

1.40

256

Colonic or urogenital fistula

201

1640

1.23

2.17

1.3

1.2

23.47

35.07

u/l

1.88

173

1428

Convulsions, not elsewhere classified

153

1196

1.27

2.15

1.3

30.00

28.01

u/l

0.11

129

1032

Other and unspecified tonsillitis

211

1466

1.22

2.14

1.2

1.3

38.71

29.70

u/l

0.20

181

1300

Coeliac disease

595

1.38

2.14

1.2

28.74

34.23

u/l

0.26

517

Other and unspecified nonorganic psychotic disorders

120

923

1.30

2.12

1.3

1.2

33.93

35.52

u/l

0.04

101

806

Acute gastritis

404

1.47

2.12

1.3

1.2

99.60

31.13

u/l

0.57

342

Smoking dependency

454

1.44

2.11

1.2

85.57

45.11

u/l

0.51

389

Mouth breathing

314

2675

1.18

2.11

1.3

25.47

30.27

u/l

0.75

282

2342

Polycystic ovarian syndrome, broad definition

267

1.58

2.11

1.4

1.2

10.37

23.64

u/l

1.74

232

Other specified disorders of kidney and ureter

175

1.73

2.11

1.3

35.81

38.11

u/l

0.04

156

Iridocyclitis

163

1305

1.25

2.10

1.6

1.2

49.85

36.65

u/l

0.53

144

1129

Dental caries 2 and operation codes

519

3638

1.13

2.10

1.3

25.57

32.93

u/l

1.03

438

3196

Artificial joint re-operation

389

1.48

2.09

1.2

32.26

39.03

u/l

0.20

328

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

841

0.70

2.08

1.1

1.2

39.18

26.72

u/l

0.56

716

Frostbite

0.00

2.07

0.0

1.2

—

14.64

—

Calculus of kidney and ureter

240

2004

1.20

2.06

1.3

56.75

34.98

u/l

0.71

209

1733

Seronegative rheumatoid arthritis

574

1.38

2.06

1.1

1.3

122.72

34.34

u/l

0.99

504

Duodenal ulcer

651

1.36

2.05

1.4

1.2

20.73

40.00

u/l

2.52

562

Asthma and allergy, excluding more controls

434

1.44

2.05

1.3

1.2

14.63

16.94

u/l

0.28

379

Special screening examination for infectious and parasitic diseases

133

775

1.29

2.05

1.3

32.44

21.07

u/l

0.32

107

685

Dental pulpitis 3

197

1.57

2.05

1.1

1.4

10.96

67.54

u/l

1.58

174

Other specified/unspecified systemic involvement of connective tissue

270

1.57

2.03

1.3

1.2

74.60

23.87

u/l

0.63

231

Kela reimbursement Agammaglobulinemia (D80-84)

2.69

2.03

1.5

1.3

304.79

13.36

u/l

—

Other specified and unspecified personality disorders

408

1.45

2.03

1.1

1.2

43.07

40.34

u/l

0.06

350

Intestinal stricture

228

1900

1.20

2.01

1.2

1.3

30.07

37.45

u/l

0.56

199

1634

Mental and behavioural disorders due to tobacco

459

1.42

2.01

1.2

85.57

45.26

u/l

0.50

395

Recurring oral aphthae

224

1.62

2.00

1.3

1.2

145.64

33.46

u/l

0.99

192

Cervicobrachial syndrome

151

1206

1.26

2.00

1.3

24.00

31.31

u/l

0.62

135

1037

Encephalopathy

2.33

2.00

1.0

1.1

60.23

21.98

u/l

0.48

Recurrent dislocation and subluxation of joint

295

1.53

2.00

1.2

1.3

41.00

38.37

u/l

0.04

253

162

1234

1.25

2.00

1.4

1.3

44.30

42.46

u/l

0.07

127

1064

Injury of unspecified body region

393

1.46

2.00

1.2

1.3

17.88

40.45

u/l

2.09

334

Other and unspecified rosacea

393

1.46

2.00

1.2

22.50

28.81

u/l

0.46

338

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

360

1.48

1.99

1.2

1.3

39.39

35.62

u/l

0.08

309

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

176

1414

0.81

1.99

1.2

26.56

22.63

u/l

0.39

144

1228

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

176

1414

0.81

1.99

1.2

26.56

22.63

u/l

0.39

144

1228

5-aminosalicylic acid

143

1136

1.26

1.99

1.2

29.56

30.05

u/l

0.02

130

979

Abnormal serum enzyme levels

257

2140

1.19

1.98

1.6

1.3

39.08

39.93

u/l

0.03

231

1838

Lung cancer and mesothelioma

1003

0.75

1.98

1.1

1.3

43.14

31.11

u/l

0.54

857

Dysphagia

181

1477

1.23

1.98

1.5

1.3

30.38

39.11

u/l

0.67

159

1245

Coxarthrosis, primary, with hip surgery

368

3027

1.15

1.98

1.4

1.3

59.33

38.06

u/l

1.05

315

2599

Benign neoplasm: Skin of trunk

217

1.63

1.98

1.2

16.24

43.89

u/l

1.74

190

Correction of physiology of bite - demanding therapy visit

296

1.53

1.98

1.3

1.2

44.54

24.28

u/l

0.50

257

Disorders of tooth development and eruption

166

1.71

1.98

1.2

1.3

121.71

21.24

u/l

0.58

142

Fitting and adjustment of other devices

266

2093

1.18

1.97

1.4

1.3

48.25

36.09

u/l

0.38

232

1777

Tinnitus

171

1388

1.24

1.97

1.3

33.44

34.10

u/l

0.02

146

1211

Lung diseases due to external agents

109

838

1.31

1.97

1.4

1.2

54.66

45.50

u/l

0.21

720

Antenatal screening

454

0.69

1.95

1.1

1.2

10.29

41.67

u/l

2.62

401

Other hearing loss

213

1740

1.21

1.94

1.2

1.3

51.81

37.38

u/l

0.44

184

1499

Male infertility

226

1.60

1.94

1.3

19.60

24.20

u/l

0.17

198

Other congenital malformations

338

1.48

1.93

1.2

64.64

39.70

u/l

0.24

290

Dental pulpitis 3, only avohilmo

186

1.57

1.92

1.1

1.4

11.05

70.74

u/l

1.58

165

Infections with a predominantly sexual mode of transmission

164

1328

1.24

1.92

1.3

1.2

19.13

32.63

u/l

2.09

138

1164

Spondylolisthesis/Spondylolysis

129

1018

1.27

1.91

1.5

1.2

30.36

31.74

u/l

0.07

118

872

Achilles tendinitis

591

1.36

1.91

1.6

1.3

15.52

29.60

u/l

2.05

513

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

217

1811

1.20

1.90

1.2

1.3

32.13

31.46

u/l

0.04

199

1576

Inflammatory bowel disease

224

1876

1.20

1.89

1.2

1.3

39.09

33.19

u/l

0.22

198

1630

Complications predominantly related to the puerperium

117

913

1.28

1.89

1.2

31.45

29.98

u/l

0.05

102

803

Abnormal involuntary movements

722

1.32

1.88

1.3

1.2

28.88

41.67

u/l

0.91

623

Nontoxic multinodular goitre

128

1013

1.27

1.86

1.3

1.2

28.63

40.03

u/l

0.82

108

863

Disorders of vestibular function (Vertigo)

337

2903

1.16

1.86

1.2

1.3

27.74

38.23

u/l

1.27

298

2505

Certain conditions originating in the perinatal period

195

1.60

1.84

2.4

1.2

37.77

17.76

u/l

0.41

169

Monoamine oxidase A inhibitors

655

1.33

1.84

1.2

1.3

18.20

35.89

u/l

2.38

574

Sicca syndrome [Sjögren]

417

1.42

1.84

1.2

23.17

30.12

u/l

0.59

361

Fracture of skull and facial bones

156

1267

1.23

1.82

1.2

45.72

36.30

u/l

0.35

133

1098

Asthma and allergy

446

1.40

1.81

1.3

1.2

14.63

17.15

u/l

0.31

390

Enthesopathies of lower limb, excluding foot

151

1223

1.24

1.80

1.4

1.2

13.93

29.89

u/l

4.89

128

1054

Acute lymphadenitis

263

1.53

1.79

1.2

76.79

45.03

u/l

0.33

225

Endometriosis of pelvic peritoneum

539

1.36

1.78

1.2

19.40

29.32

u/l

0.78

468

Pain associated with micturition

590

1.34

1.78

1.4

1.2

24.31

42.72

u/l

1.05

510

Parkinson's disease, including avohilmo

1013

0.75

1.78

1.1

1.3

31.19

42.92

u/l

0.51

876

Benign neoplasm of major salivary glands

505

1.37

1.77

1.2

30.68

26.71

u/l

0.14

435

Benign neoplasm: Skin of eyelid, including canthus

111

870

1.28

1.77

1.3

53.92

40.21

u/l

0.27

761

Otitis externa

148

1200

1.24

1.76

1.5

1.3

18.63

38.05

u/l

4.07

129

1038

Eating disorder

216

1.58

1.75

1.1

1.4

36.35

30.22

u/l

0.09

181

Glaucoma

436

3391

1.13

1.75

1.3

25.54

39.47

u/l

4.09

365

2927

Strabismus

172

1416

1.22

1.74

1.4

1.3

32.48

35.58

u/l

0.09

157

1237

Hypertrophy of breast in women and men

110

863

1.28

1.74

1.3

1.2

26.29

33.91

u/l

0.40

757

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

322

0.56

1.74

2.3

1.2

42.78

21.24

u/l

1.07

274

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

306

1.48

1.73

1.1

1.2

13.57

35.60

u/l

1.64

267

Urolithiasis

257

2199

1.17

1.73

1.3

54.50

34.89

u/l

0.67

221

1901

Blepharochalasis

212

1785

1.19

1.73

1.2

1.3

32.54

40.46

u/l

0.64

180

1536

Myocardial infarction, unclassifiable

182

1346

1.21

1.72

1.3

33.49

42.26

u/l

0.52

153

1147

Acute and subacute iridocyclitis

136

1096

1.24

1.72

1.6

1.2

53.97

38.69

u/l

0.50

118

947

Melanocytic naevi

176

1457

1.21

1.72

1.2

47.25

22.86

u/l

1.05

154

1266

Synovial cyst of popliteal space [Baker]

373

1.43

1.71

1.1

1.2

24.28

41.03

u/l

1.08

316

Gonarthrosis, primary, with knee surgery

447

3244

1.13

1.71

1.4

1.3

29.77

37.87

u/l

1.34

388

2793

Pulmonary oedema

1.97

1.70

1.3

1.1

48.93

48.06

u/l

0.01

Acute laryngitis and tracheitis

450

1.38

1.70

1.2

92.72

27.85

u/l

0.69

388

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

332

1.45

1.70

1.4

1.2

16.67

22.13

u/l

0.64

284

Nontoxic goitre/thyroid nodule

198

1660

1.20

1.69

1.3

1.2

27.29

39.54

u/l

1.35

171

1432

Exposure to other specified electric current

2.41

1.68

1.5

1.2

10.84

10.91

u/l

—

Decubitus ulcer and pressure area

300

1.48

1.68

1.2

51.73

46.93

u/l

0.07

256

Postviral fatigue syndrome

3.20

1.67

1.5

1.3

10.44

7.82

u/l

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

276

1448

1.17

1.66

2.1

1.2

39.79

23.45

u/l

1.20

236

1245

Puerperal sepsis

512

1.35

1.64

1.2

44.67

24.12

u/l

0.61

445

Follow-up examination after treatment for malignant neoplasms

495

1.36

1.64

1.1

1.2

72.10

30.86

u/l

0.74

411

Orchitis and epididymitis

564

1.34

1.64

1.8

1.2

51.78

41.33

u/l

0.13

489

Pyothorax

237

1.53

1.63

1.3

53.66

47.48

u/l

0.10

203

Seborrhoeic dermatitis

556

1.34

1.63

1.3

37.12

34.77

u/l

0.07

480

Other and unspecified nerve root and plexus disorders, also in other diseases

130

1050

1.24

1.63

1.5

1.2

26.76

36.50

u/l

0.87

112

916

Mixed connective tissue disease

294

1.47

1.63

1.3

1.2

56.67

28.48

u/l

0.34

250

Rosacea

539

1.34

1.62

1.2

20.96

32.53

u/l

1.27

468

Other disorders originating in the perinatal period

3.61

1.62

8.8

1.1

177.14

11.10

u/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

134

0.37

1.61

1.2

20.22

23.14

u/l

—

116

Other/unspecified enthesopathies, not elsewhere classified

454

1.37

1.61

1.2

102.37

48.15

u/l

0.42

387

Anterior Iridocyclitis

142

1160

1.23

1.61

1.6

1.2

53.04

38.32

u/l

0.51

124

1010

Complications following infusion, transfusion and therapeutic injection

1.98

1.60

1.3

1.2

49.57

14.86

u/l

0.49

Dental caries 2

525

3713

1.11

1.60

1.3

25.47

32.76

u/l

1.03

443

3263

Open wound of wrist and hand

322

2792

1.14

1.60

1.3

33.92

30.43

u/l

0.17

278

2439

Presbycusis

104

817

1.27

1.59

1.2

70.82

40.54

u/l

0.49

693

Suppurative and necrotic conditions of lower respiratory tract

322

1.44

1.56

1.4

1.2

44.44

43.88

u/l

0.01

280

480

3862

1.11

1.56

1.2

1.3

31.50

33.67

u/l

0.19

410

3381

Familial hypercholesterolemia, with ischemic heart disease

578

1.32

1.56

1.2

1.3

30.84

52.89

u/l

1.29

495

Fracture of shoulder and upper arm

250

2154

1.16

1.56

1.4

1.3

52.89

35.52

u/l

0.72

220

1858

Use of donepezil

1137

0.78

1.55

1.2

1.3

31.29

42.28

u/l

0.73

966

Autism

2.12

1.55

1.5

1.2

107.98

51.77

u/l

0.23

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

328

2834

1.14

1.55

1.3

1.2

28.95

36.47

u/l

0.81

281

2481

Use of entacapone

0.00

1.53

0.0

1.1

—

30.15

—

Noninflammatory disorders of female genital tract

219

934

1.18

1.52

1.2

18.81

35.65

u/l

2.74

181

810

Other symptoms and signs involving the urinary system

615

1.31

1.52

1.5

1.3

56.18

45.33

u/l

0.20

539

Symptoms and signs involving appearance and behaviour

0.00

1.52

0.0

1.2

—

13.49

—

Panic disorder

580

1.31

1.52

1.1

1.2

21.12

29.02

u/l

0.52

502

Postprocedural musculoskeletal disorders, not elsewhere classified

392

1.39

1.50

2.0

1.2

35.44

37.43

u/l

0.06

336

Conductive hearing loss, unspecified

426

1.37

1.50

1.7

1.2

103.49

45.93

u/l

0.75

368

Chronic pancreatitis

740

1.28

1.50

1.2

1.3

20.22

40.58

u/l

2.30

641

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

269

1398

1.16

1.48

2.2

1.2

39.78

23.59

u/l

1.14

228

1199

Vasomotor and allergic rhinitis

226

1913

1.17

1.48

1.3

1.2

21.70

32.76

u/l

1.82

203

1669

Idiopathic pulmonary fibrosis

462

1.35

1.47

1.2

59.30

46.74

u/l

0.14

396

Hypothyroidism due to medicaments and other exogenous substances

2.26

1.47

1.1

1.2

14.10

13.75

u/l

—

Alzheimer’s disease, wide definition, excluding more controls

709

0.77

1.47

1.2

40.48

45.73

u/l

0.17

596

Other nutritional anaemias

2.25

1.47

1.0

1.2

217.21

26.67

u/l

—

Dental caries 3 and operation codes, only avohilmo

233

1002

1.17

1.46

1.2

1.3

41.79

40.77

u/l

0.03

201

886

Other abnormal immunological findings in serum

1.89

1.45

1.5

1.2

22.08

21.32

u/l

0.03

Dental caries 1 and operation codes, only avohilmo

206

878

1.18

1.45

1.2

1.4

44.40

40.76

u/l

0.09

174

773

Disorders of ocular muscles, binocular movement, accommodation and refraction

295

2567

1.14

1.45

1.3

43.55

35.17

u/l

0.27

265

2247

Allergic conjunctivitis

342

2982

1.13

1.45

1.3

1.2

28.91

36.24

u/l

0.82

291

2610

Seropositive rheumatoid arthritis

165

1381

1.19

1.45

1.3

79.54

34.01

u/l

1.03

148

1183

Behavioural syndromes associated with physiological disturbances and physical factors

181

1530

1.18

1.45

1.3

25.64

33.87

u/l

0.72

162

1341

Delivery

183

1146

0.84

1.44

1.2

26.95

40.08

u/l

1.06

155

998

459

3797

1.11

1.44

1.2

1.3

32.12

32.64

u/l

0.04

392

3324

Congenital malformations of heart and great arteries

592

1.30

1.44

1.3

31.72

45.24

u/l

0.63

514

Oligomenorrhoea

110

1.74

1.43

1.1

1.2

14.23

23.85

u/l

0.64

Nonorganic sleeping disorders, excluding more controls

106

852

1.25

1.42

1.3

1.2

23.25

38.00

u/l

1.36

745

Other disorders of eyelid

329

2813

1.13

1.42

1.3

32.63

39.80

u/l

0.78

282

2425

Premature rupture of membranes

495

0.73

1.42

1.1

1.2

14.97

31.47

u/l

1.37

443

Diseases of middle ear and mastoid

368

2683

1.12

1.42

1.2

1.3

42.40

34.28

u/l

0.42

320

2346

Carcinoma in situ of rectum

2.29

1.41

1.4

1.2

203.54

19.41

u/l

—

Neovascular glaucoma

213

1.51

1.41

1.2

1.3

23.96

45.88

u/l

1.07

185

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

2.29

1.41

1.4

1.1

25.17

30.44

u/l

—

Acute pharyngitis

662

1.28

1.40

1.3

1.2

46.17

28.29

u/l

0.56

584

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

622

0.72

1.40

1.1

1.3

52.45

39.91

u/l

0.24

545

Carcinoma in situ of skin

475

1.33

1.40

1.2

28.11

39.97

u/l

0.67

415

Sequelae of infectious and parasitic diseases

406

1.36

1.40

1.9

1.2

25.54

35.12

u/l

0.54

347

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

553

1.30

1.39

1.3

25.67

20.55

u/l

0.50

482

Unknown and unspecified causes of morbidity

347

1.39

1.38

1.1

1.2

37.38

34.49

u/l

0.08

293

Chronic diseases of tonsils and adenoids

564

3251

1.10

1.38

1.4

1.3

34.86

31.70

u/l

0.14

496

2838

Other/unspecified rheumatoid arthritis

696

1.27

1.37

1.3

1.2

90.17

38.71

u/l

0.62

597

Impingement syndrome of shoulder

182

1550

1.18

1.37

1.3

22.97

36.42

u/l

2.40

160

1338

Respiratory conditions due to other external agents

112

1.72

1.36

1.3

1.2

92.13

28.66

u/l

0.67

Moderate visual impairment, binocular

135

1.64

1.36

1.3

1.2

27.80

29.82

u/l

0.07

116

Chondropathies

101

813

1.25

1.36

1.1

1.3

13.98

39.98

u/l

4.87

707

Sequelae of injuries of upper limb

521

1.31

1.36

1.7

1.2

28.30

44.35

u/l

0.91

448

Ulcerative enterocolitis

151

1.60

1.35

1.1

1.3

41.37

36.98

u/l

0.08

127

Diseases of the myoneural junction and muscle

698

1.27

1.35

1.2

21.60

47.20

u/l

3.09

606

Carcinoma in situ of breast, lobular

0.00

1.35

0.0

1.2

—

20.95

—

Hirsutism in women

2.16

1.34

1.0

1.1

13.71

11.02

u/l

—

Cushing syndrome

2.07

1.34

1.6

1.1

28.91

13.75

u/l

0.41

Alzheimer’s disease (Late onset), excluding more controls

648

0.78

1.33

1.2

41.63

46.50

u/l

0.14

545

Schizophrenia, schizotypal and delusional disorders

210

1813

1.16

1.33

1.2

28.91

33.99

u/l

0.27

177

1588

Benign neoplasm of mouth and pharynx

549

1.30

1.33

1.7

1.2

49.19

25.35

u/l

0.48

474

Autism spe

1.98

1.33

1.5

1.2

107.98

48.97

u/l

0.25

Radiculopathy

118

969

1.22

1.33

1.3

32.91

35.72

u/l

0.10

108

826

Invasive ventilation

393

1.36

1.33

1.2

58.74

45.49

u/l

0.25

344

Schizophrenia or delusion

209

1805

1.16

1.32

1.2

1.3

29.17

33.88

u/l

0.24

176

1580

Alcohol use disorder, Swedish definition

440

3695

1.11

1.31

1.2

1.3

30.54

32.53

u/l

0.18

376

3228

Striking against or struck by other objects

219

1899

1.15

1.31

1.4

1.3

48.60

31.32

u/l

0.64

191

1661

Benign neoplasm of brain and other parts of central nervous system

326

1.39

1.30

1.6

1.2

31.31

19.53

u/l

0.66

282

Haemangioma and lymphangioma, any site

403

1.35

1.30

1.2

44.01

21.56

u/l

0.91

349

Vestibular neuronitis

497

0.70

1.29

1.3

1.2

20.47

42.88

u/l

1.86

428

Spinal osteochondrosis

2.11

1.28

1.3

1.2

17.94

11.93

u/l

—

Single spontaneous delivery

184

1145

0.85

1.28

1.2

27.02

40.11

u/l

1.06

156

997

Papulosquamous disorders

279

2465

1.13

1.28

1.2

1.3

34.31

32.52

u/l

0.10

246

2154

Parkinson's disease, strict definition, excluding more controls

767

0.76

1.28

1.1

1.3

35.00

42.72

u/l

0.22

649

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.95

1.28

1.0

1.2

11.37

20.44

u/l

0.92

Pyoderma gangrenosum

2.33

1.28

1.4

1.2

44.68

15.05

u/l

—

Intercostal neuropathy

2.08

1.28

1.1

1.2

104.56

13.14

u/l

—

2.31

1.27

1.1

10.61

11.62

u/l

—

conjunctival haemorrhage

423

1.33

1.26

1.1

1.2

50.96

38.53

u/l

0.28

364

Extrapyramidal and movement disorders

265

2338

1.14

1.25

1.2

1.3

39.90

38.14

u/l

0.06

224

2008

Benign paroxysmal vertigo

196

1694

1.16

1.25

1.2

27.19

39.40

u/l

1.32

171

1459

Deep bite

377

1.33

1.24

1.3

16.87

31.47

u/l

1.23

326

Flat foot [pes planus] (acquired)

450

1.32

1.24

1.2

1.3

34.53

32.67

u/l

0.05

386

Hereditary corneal dystrophies

163

1.55

1.24

1.2

44.29

32.86

u/l

0.15

140

Epilepsy

198

1710

1.16

1.23

1.3

54.73

35.55

u/l

0.77

170

1475

Benign neoplasm of ovary

761

1.24

1.23

1.2

24.83

25.80

u/l

0.05

658

Psoriasis

199

1725

1.16

1.22

1.2

34.82

33.18

u/l

0.07

180

1495

Pollen allergy

700

1.25

1.22

1.4

1.3

20.06

29.81

u/l

0.77

600

Occupational exposure to risk-factors

188

1.50

1.22

1.2

1.3

33.84

42.63

u/l

0.17

164

Other neurotic disorders

263

1.41

1.21

1.8

1.2

39.33

40.08

u/l

0.01

224

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

727

1.24

1.21

1.6

1.3

20.50

40.46

u/l

2.32

629

Other disorders of bladder

728

1.24

1.20

1.2

1.3

23.69

43.43

u/l

1.79

637

Benign leiomyoma with endometriosis

719

1.24

1.19

1.3

1.2

40.79

27.39

u/l

0.50

625

Pain and other conditions associated with female genital organs and menstrual cycle

603

1.26

1.19

1.4

1.3

17.91

35.24

u/l

1.78

529

Contact with other and unspecified heat and hot substances

2.34

1.19

1.7

1.2

6.71

13.87

u/l

—

Oral leukoplakia and related diseases, including avohilmo

489

1.29

1.18

1.8

1.2

38.25

34.16

u/l

0.11

427

Social phobias

298

1.38

1.18

1.2

55.53

29.22

u/l

0.35

255

Embedded and impacted teeth

117

826

1.21

1.18

1.2

79.90

35.81

u/l

0.71

101

721

Injury of muscle and tendon at shoulder and upper arm level

279

2482

1.13

1.18

1.3

26.82

32.02

u/l

0.61

244

2167

Other and unspecified vascular occlusions

551

1.28

1.18

1.4

1.2

32.87

50.65

u/l

0.86

482

Sequelae of injuries, of poisoning and of other consequences of external causes

162

1388

1.17

1.4

1.2

23.58

34.41

u/l

1.36

145

1209

Other papulosquamous disorders

2.03

1.17

1.4

1.1

79.69

17.17

u/l

—

Other prurigo

2.03

1.17

1.4

1.2

11.47

24.38

u/l

—

Tetraplegia

0.00

1.17

0.0

1.1

—

13.86

—

Hypertrichosis

2.01

1.17

1.0

1.1

14.00

11.39

u/l

—

Cardiac murmurs and other cardiac sounds

346

1.35

1.16

1.3

1.4

66.79

40.92

u/l

0.57

294

Failed attempted abortion

0.00

1.16

0.0

1.1

—

12.54

—

Malignant neoplasm of rectum

589

0.74

1.16

1.1

1.3

48.51

40.93

u/l

0.12

516

False labour

613

0.80

1.16

1.2

1.3

13.26

32.76

u/l

2.03

549

Fall on and from stairs and steps

169

1455

1.16

1.2

1.3

31.69

37.63

u/l

0.33

146

1262

Seborrhoeic keratosis

155

1326

1.17

1.15

1.3

55.55

37.96

u/l

0.70

142

1150

TMD related operations

804

1.22

1.15

1.3

1.2

38.77

39.38

u/l

0.02

698

Chronic conjunctivitis

150

1.54

1.15

1.1

1.2

74.12

20.20

u/l

0.80

129

Unspecified urinary incontinence

421

1.31

1.14

1.2

30.94

30.39

u/l

0.02

359

Colorectal adenocarcinoma

106

1275

0.83

1.14

1.2

1.3

40.92

39.78

u/l

0.04

1102

Other symptoms and signs involving the digestive system and abdomen

100

823

1.22

1.14

1.2

21.28

39.70

u/l

1.99

711

Assault by bodily force

352

1.34

1.13

1.4

1.2

17.26

36.72

u/l

1.43

305

Perforation of oesophagus

2.39

1.13

1.0

1.1

23.87

26.71

u/l

—

Other/unspecified synovitis and tenosynovitis

590

1.26

1.13

1.3

1.2

60.37

47.60

u/l

0.16

509

Preterm labour and delivery

118

988

1.20

1.12

1.2

37.81

23.99

u/l

0.79

101

861

Superficial injury of ankle and foot

520

1.27

1.11

1.1

1.3

59.78

42.69

u/l

0.36

453

Single delivery by caesarean section

386

0.76

1.10

1.1

1.2

12.67

35.65

u/l

2.30

344

Sudden idiopathic hearing loss

575

1.26

1.09

1.3

1.2

40.38

43.31

u/l

0.08

499

Lichen simplex chronicus and prurigo

320

1.35

1.09

1.4

1.2

24.72

41.43

u/l

0.95

271

Other disorders of eye and adnexa

656

1.24

1.09

1.2

50.33

39.96

u/l

0.14

567

Fracture of foot, except ankle

149

1278

1.17

1.09

1.1

1.3

44.00

33.69

u/l

0.34

124

1114

Voice disturbances

174

1511

1.15

1.08

1.3

35.24

36.37

u/l

0.06

157

1317

Other otitis externa (chronic)

338

1.34

1.08

1.2

18.56

39.04

u/l

1.57

285

Glaucoma secondary to other eye disorders

227

1.42

1.08

1.2

23.96

43.48

u/l

0.97

195

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

169

1.49

1.07

2.0

1.2

57.67

21.17

u/l

0.49

147

Drug-induced neutropenia

365

1.32

1.06

1.2

152.28

37.52

u/l

2.53

313

Dislocation, sprain and strain of joints and ligaments at neck level

703

1.23

1.06

1.2

1.3

16.77

37.60

u/l

3.02

609

Ulcer of oesophagus

418

1.30

1.06

1.8

1.2

42.18

36.91

u/l

0.18

360

Bell's palsy

632

1.24

1.05

1.5

1.2

29.96

47.41

u/l

1.03

545

Other disorders of conjunctiva

100

832

1.21

1.05

1.2

1.3

58.86

40.10

u/l

0.47

724

Ill-defined and unknown causes of mortality

418

0.71

1.04

1.1

1.2

56.35

49.22

u/l

0.15

358

Unspecified parasitic disease

1.99

1.04

1.4

1.1

93.29

38.59

u/l

—

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

2.09

1.04

6.9

1.2

20.73

13.70

u/l

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

350

1.32

1.02

1.2

72.21

19.97

u/l

0.78

300

Diabetic neuropathy

107

894

1.20

1.02

1.3

1.2

26.63

27.27

u/l

0.03

785

Carcinoma in situ of rectum

1.91

1.01

1.4

1.2

203.54

26.03

u/l

—

Other (seronegative) rheumatoid arthritis, wide

126

1074

1.18

1.01

1.2

98.28

40.44

u/l

0.96

112

937

Adenocarcinoma and papilloma adenocarcinoma of rectum

586

0.76

1.01

1.1

1.3

52.45

40.78

u/l

0.22

511

Injury of muscle and tendon at forearm level

1.66

1.01

1.5

1.1

22.54

21.26

u/l

0.05

Follow-up care involving plastic surgery

180

1.45

1.01

1.6

1.2

32.60

19.92

u/l

0.47

153

Benign neoplasm of ovary

781

1.21

1.00

1.2

24.83

28.98

u/l

0.23

678

Other disorders of iris and ciliary body

139

1.52

1.00

1.2

44.74

31.93

u/l

0.27

124

Other predominantly sexually transmitted diseases, not elsewhere classified

672

1.22

1.00

1.4

1.2

20.71

25.53

u/l

0.35

585

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

254

2211

0.89

1.00

1.3

1.2

66.08

25.45

u/l

1.99

223

1894

Corns and callosities

343

1.32

1.00

1.1

1.2

19.18

34.66

u/l

1.77

288

Mucinous and mucinous cystic tumor of rectum

0.00

0.99

0.0

1.1

—

14.62

—

Other surgical follow-up care

148

1.49

0.98

1.2

35.07

30.79

u/l

0.07

128

Frontotemporal dementia

0.00

0.98

0.0

1.1

—

23.06

—

Symptoms and signs involving speech and voice

218

1938

1.13

0.98

1.2

1.3

40.12

34.13

u/l

0.27

193

1680

Pneumonitis due to solids and liquids

459

1.27

0.98

1.6

1.2

21.38

48.20

u/l

2.65

398

Benign lipomatous neoplasm

204

1807

1.13

0.97

1.4

1.2

31.94

34.58

u/l

0.10

182

1568

Secondary parkinsonism, excluding more controls

132

1.53

0.97

1.1

1.2

22.94

53.96

u/l

0.84

116

Oesophageal obstruction

190

1.43

0.97

1.3

1.2

19.32

33.14

u/l

0.76

164

Keratitis

235

2102

1.12

0.96

1.2

1.3

33.92

34.15

u/l

0.01

207

1828

Adhesive capsulitis of shoulder

116

988

1.18

0.96

1.2

54.09

36.49

u/l

0.26

108

847

Benign neoplasm: Skin of other and unspecified parts of face

550

1.24

0.95

1.1

1.2

22.63

27.35

u/l

0.45

471

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1044

0.84

0.95

1.2

28.39

25.80

u/l

0.17

901

Cutis laxa senilis

1.92

0.94

1.6

1.2

53.48

19.00

u/l

—

Acute alcohol intoxication

144

1656

0.87

0.94

1.3

33.85

33.22

u/l

0.03

116

1442

Organic, including symptomatic, mental disorders

325

2576

0.91

0.94

1.2

1.3

30.50

43.25

u/l

2.18

276

2211

Injury of muscle and tendon at wrist and hand level

797

1.20

0.94

1.2

1.3

27.82

42.12

u/l

0.95

693

Ulcerative colitis, NAS

733

1.20

0.93

1.2

25.09

41.00

u/l

1.53

634

Sleep disorders

126

1083

1.17

0.93

1.3

1.2

23.80

36.79

u/l

1.33

115

946

Parkinson's disease, excluding more controls

812

0.81

0.93

1.1

1.3

32.24

44.68

u/l

0.45

688

Benign neoplasm: Parotid gland

409

1.28

0.93

1.2

23.72

20.05

u/l

0.20

353

Melanocytic naevi, other sites/unspecified

356

1.30

0.93

1.2

25.90

20.43

u/l

0.18

306

Chorioretinal inflammation

146

0.54

0.93

1.3

1.2

17.74

32.39

u/l

—

128

Intentional self-harm by sharp object

1.72

0.93

1.2

1.3

11.03

21.58

u/l

0.84

Abnormal spermatozoa

100

845

1.19

0.92

1.9

1.3

63.34

44.57

u/l

0.21

731

Dental caries 2, only avohilmo

496

3628

1.08

0.92

1.3

24.87

33.10

u/l

1.17

417

3187

Varicose veins of other sites

366

1.29

0.91

1.2

105.14

49.15

u/l

0.31

305

Glucosamine medication

376

2754

1.09

0.91

1.3

50.77

36.49

u/l

0.68

329

2376

Mucosal proctocolitis

654

1.21

0.90

1.2

26.12

41.88

u/l

1.15

563

Assault

654

1.21

0.90

1.3

1.2

35.78

40.99

u/l

0.14

566

Malignant neoplasm of oropharynx

101

0.49

0.90

1.2

37.62

49.07

u/l

—

Benign neoplasm of major salivary glands

564

1.23

0.90

1.2

30.69

37.97

u/l

0.27

485

Melanocytic naevi of trunk

546

1.23

0.89

1.2

23.66

26.56

u/l

0.16

472

Other abnormal findings in urine

1.71

0.89

1.3

1.1

16.42

42.43

u/l

0.77

Salpingitis and oophoritis

783

1.19

0.89

1.3

1.2

51.47

24.55

u/l

0.58

686

Impacted teeth

592

1.21

0.89

1.1

1.3

100.31

33.13

u/l

0.70

513

Benign neoplasm of brain and other parts of central nervous system

350

1.29

0.89

1.6

1.2

31.31

43.72

u/l

0.47

297

Primary coxarthrosis, bilateral

207

1849

1.12

0.89

1.2

1.3

62.99

35.82

u/l

0.76

180

1590

Dysplasia of cervi uteri

100

654

1.18

0.88

1.2

26.80

29.97

u/l

0.09

571

Pediculosis, acariasis and other infestations

280

1.33

0.88

2.0

1.2

49.27

41.34

u/l

0.12

237

Congenital malformations of cardiac septa

279

1.32

0.88

1.1

1.4

43.00

48.36

u/l

0.10

240

Other/unspecified crystal arthropathies

2.03

0.87

1.3

1.2

14.82

16.05

u/l

—

Reactive arthropathies, FINNGEN

342

1.29

0.87

2.1

1.2

25.18

38.22

u/l

0.55

292

Adenomyosis (Endometriosis of uterus)

575

1.22

0.87

1.3

1.2

27.28

37.67

u/l

0.39

487

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

285

2276

1.10

0.86

2.5

1.2

71.96

25.09

u/l

2.71

250

1952

Alzheimer disease, excluding more controls

101

792

0.85

0.86

1.2

1.3

55.74

45.04

u/l

0.26

670

therapeutic use

153

1.45

0.86

1.0

1.2

14.21

22.59

u/l

1.09

135

Schizophrenia

104

888

1.17

0.86

1.2

1.3

19.19

38.94

u/l

2.04

776

Barrett oesophagus

273

1.33

0.86

2.1

1.2

48.15

39.05

u/l

0.17

232

Alcohol use disorder, ICD-based

312

2854

1.09

0.85

1.2

1.3

32.49

30.72

u/l

0.12

263

2490

Anomalies of dental arch relationship, including avohilmo

731

1.18

0.85

1.6

1.2

36.85

37.37

u/l

0.01

638

Benign neoplasm: Other and unspecified parts of small intestine

1.61

0.85

1.1

1.2

69.75

17.44

u/l

0.57

Ménière disease

532

1.23

0.85

1.2

35.74

35.26

u/l

0.01

457

Inguinal hernia

490

3074

1.08

0.84

1.4

1.3

38.67

33.25

u/l

0.33

429

2683

Dependence on enabling machines and devices, not elsewhere classified

1.78

0.84

1.1

13.95

13.29

u/l

—

Adult respiratory distress syndrome

1.77

0.84

1.6

1.1

189.40

36.13

u/l

—

Alzheimer’s disease (Atypical or mixed)

489

0.77

0.84

1.3

1.2

39.27

53.54

u/l

0.38

419

Haemangioma, any site

380

1.27

0.83

1.2

45.29

22.22

u/l

0.81

327

Other keratitis

551

1.22

0.83

1.3

1.2

39.51

45.81

u/l

0.10

479

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

1.76

0.83

1.4

1.2

11.71

16.29

u/l

—

Purulent endophthalmitis

1.90

0.82

1.0

1.1

21.56

18.60

u/l

—

Superficial injury of thorax

100

855

1.17

0.82

1.5

1.2

55.61

43.65

u/l

0.41

735

Benign neoplasm: Other and unspecified parts of small intestine

1.59

0.82

1.1

69.75

22.95

u/l

0.49

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.62

0.81

1.4

1.2

36.25

36.46

u/l

0.00

Endometriosis ASRM stages 1,2

644

1.20

0.81

1.2

18.95

20.45

u/l

0.10

567

Post-traumatic wound infection, not elsewhere classified

130

1.47

0.81

1.2

23.22

41.07

u/l

0.62

111

Isolated proteinuria with specified morphological lesion

1.74

0.80

1.1

18.98

17.50

u/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

341

3140

1.09

0.80

1.2

1.3

32.10

30.65

u/l

0.10

287

2752

Colorectal cancer

133

1514

0.88

0.79

1.2

1.3

36.85

40.89

u/l

0.18

114

1298

Ankylosis of joint

0.00

0.79

0.0

1.2

—

12.35

—

Reactive arthropathies

446

1.24

0.79

1.9

1.3

28.14

45.04

u/l

0.90

385

Nonorganic sleeping disorders

106

914

1.16

0.79

1.3

23.25

38.06

u/l

1.51

797

Effects of air pressure and water pressure

0.00

0.79

0.0

1.1

—

12.09

—

Unspecified/other endometriosis

268

1.31

0.79

1.1

1.2

17.91

19.14

u/l

0.06

238

Perforation of tympanic membrane

519

1.22

0.79

1.2

25.44

40.19

u/l

0.64

446

Fall on same level involving ice and snow

386

3580

1.08

0.78

1.3

44.90

34.42

u/l

0.42

351

3093

Special screening examination for neoplasms

225

1.34

0.78

1.2

73.05

34.93

u/l

0.73

184

Pleural plaque

657

1.19

0.78

1.2

25.44

42.40

u/l

2.01

576

Benign leiomyoma with endometriosis

758

1.18

0.78

1.3

1.2

40.79

34.41

u/l

0.19

660

Juvenile Open Angle Glaucoma

0.00

0.78

0.0

1.3

—

11.87

—

IBD patients in KELA-register

146

1290

1.13

0.78

1.2

1.3

43.72

35.01

u/l

0.23

134

1130

Placenta praevia

125

0.56

0.77

1.4

1.2

9.21

20.59

u/l

—

103

Otitis media, unspecified

370

1.25

0.77

1.3

44.56

36.75

u/l

0.11

324

Olecranon bursitis

394

1.25

0.77

1.2

1.3

29.36

49.89

u/l

1.12

343

Sequelae of other and unspecified infectious and parasitic diseases

287

1.29

0.77

2.2

1.2

26.26

25.98

u/l

0.01

244

Contusion of other and unspecified parts of foot

191

1.37

0.77

1.2

50.32

37.11

u/l

0.20

162

Other deformity of hallux (acquired)

1.78

0.76

1.0

1.3

33.84

12.40

u/l

—

Other ill-defined and unspecified causes of mortality

371

0.75

0.76

1.1

1.2

47.60

46.75

u/l

0.02

319

Dependent personality disorder

107

1.51

0.76

1.1

1.2

84.13

29.28

u/l

0.34

Carcinoma in situ of breast, lobular

0.00

0.76

0.0

1.1

—

26.60

—

Triptan medication for migraine, min. 3 purchases

287

2075

1.09

0.76

1.2

20.47

34.13

u/l

1.71

254

1819

Other and unspecified nail disorders

1.53

0.76

1.3

140.73

16.09

u/l

0.48

Flatulence and related conditions

1.71

0.76

1.2

1.1

14.64

23.06

u/l

—

Other specified/unspecified necrotizing vasculopathies

1.66

0.75

1.5

1.2

93.47

22.71

u/l

0.60

Nasal polyp

135

1190

1.14

0.75

1.5

1.3

32.14

33.12

u/l

0.03

119

1021

Preparation and fitting of bite rail to mouth

641

1.19

0.75

1.4

1.2

32.79

38.22

u/l

0.20

556

Pregnancy, childbirth and the puerperium

138

820

0.88

0.75

1.2

46.80

36.44

u/l

0.18

119

704

Other and unspecified disorders of vitreous body

280

2555

1.09

0.75

1.4

1.3

46.51

34.64

u/l

0.77

240

2218

Carcinoma in situ, bladder

184

1.37

0.74

1.2

49.81

20.25

u/l

0.53

162

Benign neoplasm: Bone and articular cartilage, unspecified

1.86

0.74

1.4

1.3

397.97

11.60

u/l

—

Other encephalitis

133

1.44

0.74

1.2

134.94

37.64

u/l

0.37

117

Scabies

210

1.34

0.74

2.1

1.2

32.04

31.56

u/l

0.01

179

Primary open-angle glaucoma

226

2003

1.10

0.73

1.3

27.08

41.85

u/l

2.71

190

1722

Colon adenocarcinoma

743

0.83

0.73

1.3

1.2

35.72

45.83

u/l

0.51

638

Benign neoplasm: Bone and articular cartilage, unspecified

1.82

0.73

1.4

1.3

397.97

12.70

u/l

—

Early lumbar disc prolapse, operated

433

1.23

0.73

1.2

11.76

33.66

u/l

2.14

379

Ocular pain

361

1.25

0.73

1.2

70.89

33.26

u/l

0.33

308

Mental and behavioural disorders due to alcohol

387

3506

1.08

0.73

1.2

1.3

32.81

30.42

u/l

0.19

326

3076

Foreign body in alimentary tract

281

1.29

0.72

1.2

25.86

38.89

u/l

0.69

243

Tularaemia

1.68

0.72

1.2

67.84

11.96

u/l

—

Car occupant injured in other and unspecified transport accidents

111

970

1.15

0.71

1.2

1.3

30.51

40.47

u/l

0.49

102

842

Schizoaffective disorder

353

1.25

0.71

1.1

1.2

42.33

35.83

u/l

0.14

305

Oral leukoplakia, including avohilmo

151

1.40

0.71

2.9

1.2

39.54

29.91

u/l

0.26

129

Cauda equina syndrome

1.59

0.71

1.3

1.1

202.27

21.04

u/l

—

Severe visual impairment, binocular

1.95

0.71

1.0

1.1

23.98

17.76

u/l

—

Haemangioma and lymphangioma, any site

444

1.22

0.71

1.2

44.01

32.65

u/l

0.34

380

Other and unspecified myopathies

490

1.21

0.70

1.2

22.94

45.98

u/l

2.08

422

Use of antiglaucoma preparations and miotics

472

1.21

0.70

1.3

1.2

35.60

45.40

u/l

0.33

405

Supervision of high-risk pregnancy

436

0.83

0.70

1.2

10.46

42.38

u/l

2.55

385

Caught, crushed, jammed or pinched in or between objects

221

1.32

0.70

1.2

35.35

43.31

u/l

0.12

189

Bronchiectasis

436

1.22

0.69

1.2

1.3

18.68

43.45

u/l

2.38

374

All dysplastic lesions of the cervix uteri

784

1.16

0.69

1.3

1.2

28.60

30.84

u/l

0.06

689

Cyst of kidney

409

1.23

0.69

1.1

1.2

18.62

42.70

u/l

2.13

355

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

120

1358

0.88

0.69

4.0

1.2

47.35

26.55

u/l

1.50

108

1165

Other misadventures during surgical and medical care

110

1.46

0.69

1.2

1.1

29.92

28.52

u/l

0.03

Drug-induced osteoporosis

1.54

0.69

1.3

234.04

18.01

u/l

—

Benign neoplasm: Spinal meninges

1.68

0.69

1.3

1.2

34.20

19.65

u/l

—

Persons encountering health services in circumstances related to reproduction

324

2369

0.93

0.68

1.3

1.2

33.29

30.02

u/l

0.17

287

2080

Otitis externa, unspecified

528

1.20

0.68

1.4

1.2

18.23

40.34

u/l

2.29

458

Migraine without aura, drug-induced

1.68

0.68

1.6

1.2

18.95

17.21

u/l

—

Other and unspecified effects of external causes

155

1389

1.12

0.68

1.5

1.3

39.44

34.10

u/l

0.14

135

1209

Inflammatory bowel disease, strict (require KELA)

146

1304

1.12

0.68

1.2

1.3

43.72

36.17

u/l

0.19

134

1137

Status post-ami

381

0.79

0.68

1.2

37.90

55.36

u/l

0.72

321

Benign neoplasm of middle ear and respiratory system

401

1.23

0.68

1.2

41.28

25.01

u/l

0.43

344

Other and unspecified visual disturbances

474

1.21

0.68

1.3

1.2

36.97

38.98

u/l

0.06

413

Other osteochondropathies

365

1.24

0.67

1.1

1.2

13.88

44.18

u/l

2.50

313

Other disorders of patella

863

1.15

0.67

1.5

1.3

18.98

33.02

u/l

1.88

747

Other disorders of amniotic fluid and membranes

393

0.78

0.67

1.2

8.16

30.16

u/l

2.99

348

Adverse effects, not elsewhere classified

106

929

1.14

0.67

1.6

1.3

48.44

35.49

u/l

0.27

801

Inflammatory diseases of the central nervous system

429

1.22

0.67

1.2

61.48

40.25

u/l

0.23

369

Insomnia

761

1.16

0.67

1.3

1.2

25.80

41.34

u/l

1.14

657

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

0.52

0.67

1.0

1.1

33.86

17.33

u/l

—

Early lumbar disc prolapse operation

457

1.21

0.66

1.2

11.95

34.96

u/l

2.42

394

Glaucoma suspect

247

2271

1.09

0.66

1.3

24.22

38.11

u/l

2.73

211

1960

Infective bursitis

171

1.35

0.66

1.0

1.3

13.58

53.12

u/l

2.01

146

Other specified and unspecified disorders of conjunctiva

1.60

0.65

1.1

1.2

214.31

14.48

u/l

—

Uterine polyps

403

1.22

0.65

1.3

1.2

23.13

29.40

u/l

0.39

348

Acute appendicitis, with complications

134

1195

1.12

0.65

1.1

1.3

61.98

36.31

u/l

0.48

118

1036

Melanocytic naevi

176

1594

1.11

0.65

1.2

1.3

47.25

33.89

u/l

0.45

154

1391

Ulcerative colitis

158

1423

1.11

0.65

1.2

31.73

32.90

u/l

0.06

140

1241

Pedal cyclist injured in noncollision transport accidents

581

0.82

0.65

1.2

14.81

43.93

u/l

3.91

508

Spontaneous abortion

181

1358

0.91

0.64

1.2

51.40

30.40

u/l

0.56

155

1197

Dysplastic lesion of unknown severity of the cervix uteri

1.73

0.64

1.0

1.1

14.77

16.75

u/l

—

Congenital malformations and deformations of the musculoskeletal system

321

1.24

0.64

2.1

1.2

100.56

31.89

u/l

0.42

276

Toxic effect of carbon monoxide

1.50

0.63

1.4

1.2

39.72

19.84

u/l

0.35

Spondyloarthritis

119

1056

1.13

0.63

1.3

53.17

38.07

u/l

0.38

104

912

malignant neoplasm of male genital organs

360

2134

1.07

0.63

2.3

1.2

42.24

38.77

u/l

0.18

307

1849

Female genital prolapse

158

820

1.11

0.63

1.2

42.94

31.73

u/l

0.23

134

705

Allergic rhinitis

160

1431

1.11

0.63

1.3

1.2

23.88

31.10

u/l

0.70

144

1252

Lichen sclerosus et atrophicus

451

1.20

0.62

1.7

1.2

17.89

30.24

u/l

1.92

380

Hydrocephalus

447

0.80

0.62

1.4

1.2

11.02

44.76

u/l

4.27

381

Carcinoma in situ of other and unspecified sites

199

1.31

0.62

1.2

49.91

20.48

u/l

0.56

173

Other bursitis of elbow

1.65

0.62

1.6

1.2

17.79

21.56

u/l

—

Unspecified lump in breast

676

0.84

0.62

1.3

1.2

20.06

25.16

u/l

0.49

580

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1.65

0.62

1.4

1.3

11.75

13.75

u/l

—

Maze procedure for atrial fibrillation

1.69

0.62

1.2

32.58

11.97

u/l

—

Cramp and spasm

217

1.30

0.62

1.3

1.2

29.26

40.64

u/l

0.38

184

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

1.61

0.61

1.1

11.54

17.06

u/l

—

Burns and corrosions

749

1.15

0.61

1.3

1.2

38.25

39.88

u/l

0.03

650

Atopic conjunctivitis

191

1.31

0.61

1.2

42.17

28.30

u/l

0.31

167

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

576

0.83

0.61

1.1

1.2

51.18

30.30

u/l

0.47

500

Benign neoplasm: salivary glands, exclude unknown (D119)

490

1.19

0.60

1.2

22.62

39.92

u/l

1.19

424

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

715

0.85

0.59

1.2

127.75

28.80

u/l

0.90

615

Benign neoplasm: Short bones of upper limb

1.54

0.59

1.3

1.2

22.87

15.77

u/l

0.25

Pedal cyclist injured in transport accident

108

1215

0.89

0.59

1.3

24.71

36.77

u/l

1.05

1063

Melanocytic naevi, other sites/unspecified

381

1.21

0.59

1.2

25.90

35.59

u/l

0.32

327

Female infertility

128

706

1.12

0.59

1.3

1.2

15.78

29.79

u/l

2.49

115

615

Kyphosis

1.57

0.59

1.1

1.2

44.57

15.82

u/l

—

Fenamates

101

600

1.14

0.59

1.5

1.2

25.24

49.34

u/l

1.91

510

Encephalitis

140

1.36

0.58

1.2

134.94

36.57

u/l

0.38

124

Calcific tendinitis of shoulder

273

1.25

0.58

1.2

13.66

38.06

u/l

1.78

238

Inflammatory diseases of prostate (prostatitis)

866

1.13

0.58

1.3

18.75

40.11

u/l

4.06

749

Other bursitis, not elsewhere classified

1.49

0.57

1.1

17.46

20.00

u/l

—

Haemorrhage in early pregnancy

113

983

1.12

0.57

1.3

1.2

24.97

29.60

u/l

0.26

866

Pyoderma

1.49

0.57

1.3

1.2

18.66

17.67

u/l

0.05

Other and unspecified abdominal hernia

211

1.28

0.57

1.1

1.2

77.73

36.63

u/l

0.35

185

Disorders of parathyroid gland, other and/or unspecified

1.68

0.57

1.8

1.1

32.67

14.99

u/l

—

Oral leukoplakia and related diseases

310

1.23

0.57

1.3

1.2

53.62

38.16

u/l

0.30

268

Trichomoniasis

1.68

0.57

1.2

1.1

14.52

39.58

u/l

—

Psoriasis (vulgaris), strict definition

167

1.32

0.57

1.5

1.3

15.06

40.90

u/l

1.60

143

Other benign neoplasms of uterus

247

1.26

0.56

1.3

1.2

26.39

27.28

u/l

0.05

209

Spontaneous rupture of synovium and tendon

429

1.19

0.56

1.2

1.3

16.76

43.76

u/l

2.67

367

Benign neoplasm: Short bones of upper limb

1.52

0.56

1.3

1.2

22.87

15.83

u/l

0.25

Carcinoma in situ of skin, other sites/unspecified

1.46

0.56

1.1

32.00

27.81

u/l

—

Alcohol abuse counselling and surveillance

0.55

0.56

1.0

1.2

14.44

31.87

u/l

—

Psoriasis vulgaris

125

1124

1.11

0.56

1.3

27.14

36.97

u/l

0.60

112

983

Benign neoplasm: Parotid gland

439

1.19

0.56

1.2

23.72

41.24

u/l

1.03

378

Muscular dystrophy

1.63

0.56

1.0

1.2

11.08

14.99

u/l

—

Nontoxic single thyroid nodule

329

1.22

0.56

1.3

1.2

21.64

44.05

u/l

1.17

281

Failed induction of labour

124

1.37

0.55

1.3

1.2

13.52

17.27

u/l

0.57

104

Bacterial, viral and other infectious agents

449

1.18

0.55

1.4

1.2

58.99

41.97

u/l

0.28

386

Other and unspecified degenerative diseases of nervous system

123

0.65

0.55

1.1

1.2

49.71

54.59

u/l

—

107

Carcinoma in situ of breast, intraductal

373

0.80

0.55

1.2

45.04

25.05

u/l

0.68

321

Benign neoplasm: Prostate

1.59

0.54

1.2

12.28

22.01

u/l

—

Deep endometriosis

384

0.81

0.54

1.1

1.2

28.92

23.83

u/l

0.14

327

Occlusion and stenosis of arteries, not leading to stroke

1.51

0.54

1.1

20.52

34.87

u/l

—

malignant neoplasm of female genital organs

708

0.86

0.54

1.2

76.62

29.53

u/l

0.41

614

Lesion of plantar nerve

317

0.79

0.54

1.1

1.2

14.94

27.36

u/l

1.44

269

Endometriosis of ovary

653

1.15

0.54

1.3

1.2

34.29

34.55

u/l

0.01

566

Ethmoidectomy

684

1.14

0.53

1.8

1.3

22.83

40.70

u/l

1.29

598

Early complications of trauma

205

1.27

0.52

1.2

25.19

51.63

u/l

1.10

175

!Aliquae complicationes praecoces traumatis

205

1.27

0.52

1.2

25.19

51.63

u/l

1.10

175

Non-Hodgkin lymphoma, all

232

1.26

0.52

1.4

1.2

66.95

46.57

u/l

0.26

204

Inguinal of femoral hernia, unilateral

146

0.68

0.52

1.1

1.2

11.71

36.97

u/l

—

129

Femoral hernia, unilateral

146

0.68

0.52

1.1

1.2

11.71

36.97

u/l

—

129

Inguinal hernia, unilateral

146

0.68

0.52

1.1

1.2

11.71

36.97

u/l

—

129

Benign neoplasm: Prostate

1.51

0.52

1.2

1.1

12.28

27.72

u/l

—

Hydrocele

789

1.13

0.52

1.4

1.3

34.20

43.25

u/l

0.42

688

Malignant neoplasm of lip

1.51

0.52

5.8

1.2

26.51

61.47

u/l

—

Eating disorders

341

1.20

0.52

1.1

1.3

34.59

32.60

u/l

0.04

291

Atrophic disorders of skin

648

1.14

0.51

1.6

1.2

18.00

34.29

u/l

2.38

564

Colectomy operation

115

1036

1.11

0.51

1.3

26.21

42.64

u/l

2.27

102

898

Maternal care related to the fetus and amniotic cavity and possible delivery problems

160

1030

0.91

0.51

1.2

12.94

32.10

u/l

3.36

139

905

Burns and corrosions of external body surface, specified by site

565

1.15

0.50

1.4

1.2

46.22

45.61

u/l

0.01

490

Torsion of ovary, ovarian pedicle and fallopian tube

1.39

0.50

1.2

228.32

26.99

u/l

—

Scissor bite

1.38

0.50

5.3

1.2

20.14

11.62

u/l

—

Benign neoplasm of mouth and pharynx

622

1.14

0.50

1.7

1.2

49.19

36.11

u/l

0.22

535

Other hammer toe(s) (acquired)

105

884

1.12

0.49

1.3

1.2

43.41

40.11

u/l

0.06

759

Other benign neoplasms of uterus

252

1.23

0.49

1.3

1.2

26.39

27.71

u/l

0.07

218

Inflammatory disease of uterus

482

1.16

0.49

1.5

1.2

17.55

19.29

u/l

0.14

424

Astigmatism

270

1.22

0.49

1.2

39.57

42.15

u/l

0.04

237

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

562

0.85

0.49

1.1

1.2

51.18

29.63

u/l

0.49

487

Overexertion and strenuous or repetitive movements

520

1.16

0.49

1.2

36.98

44.48

u/l

0.16

448

Alzheimer’s disease (Atypical or mixed), excluding more controls

393

0.83

0.49

1.3

1.2

39.27

52.52

u/l

0.32

330

Personal history of risk-factors, not elsewhere classified

1.56

0.49

1.6

1.2

15.67

11.06

u/l

—

Injuries to the elbow and forearm

461

3965

1.05

0.49

1.6

1.2

48.83

33.18

u/l

0.97

403

3439

Chronic suppurative otitis media

344

1.19

0.49

1.2

90.44

45.71

u/l

0.35

295

Brachial plexus disorders

418

1.17

0.48

1.2

16.69

39.66

u/l

1.74

361

Supplementary factors related to causes of morbidity and mortality classified elsewhere

191

1769

1.08

0.48

1.4

1.3

29.25

33.23

u/l

0.30

158

1546

Focal epilepsy

132

1203

1.10

0.48

1.4

1.2

61.56

38.24

u/l

0.62

115

1048

Benign neoplasm: Spinal meninges

1.50

0.48

1.3

1.1

34.20

20.70

u/l

—

Malignant neoplasm of prostate

350

2088

1.06

0.47

2.4

1.2

43.21

38.39

u/l

0.26

297

1808

Colitis, primary sclerosing

1.48

0.47

1.0

1.2

29.85

11.23

u/l

—

Secondary parkinsonism

155

1.30

0.47

1.1

1.2

22.94

36.29

u/l

0.69

135

Other abnormal products of conception

699

0.90

0.47

1.1

1.2

32.98

24.51

u/l

0.23

619

Renal cell carcinoma of kidney

200

1.25

0.46

2.0

1.2

57.67

46.46

u/l

0.12

174

Alcoholic gastritis

0.61

0.46

1.4

1.3

32.74

22.43

u/l

—

Sequelae of other accidents

0.61

0.46

1.2

55.30

47.37

u/l

—

Ptosis of eyelid

646

1.13

0.46

1.2

1.3

28.76

39.98

u/l

0.68

561

Infective dermatitis

646

1.13

0.45

1.2

1.3

30.66

37.28

u/l

0.25

560

Other obstructed labour

254

0.79

0.45

1.1

1.2

13.90

21.52

u/l

0.96

215

Rash and other nonspecific skin eruption

496

1.15

0.45

1.3

1.2

77.10

41.22

u/l

0.69

426

Colitis, primary sclerosing, strict definition

1.41

0.45

1.0

1.3

36.86

10.92

u/l

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

141

0.71

0.45

1.1

1.2

31.04

17.83

u/l

—

123

Triptan medication for migraine, single purchase ok

482

3116

1.05

0.44

1.2

1.3

18.71

35.40

u/l

5.71

426

2740

Migraine, single triptan purchase ok & required. ICD-code if available is included

482

3116

1.05

0.44

1.2

1.3

18.71

35.40

u/l

5.71

426

2740

Malignant neoplasm of bladder

450

1.16

0.44

1.1

1.2

25.05

48.99

u/l

1.79

386

Childhood asthma (age<16), excluding more controls

312

1.17

0.44

1.2

1.1

84.66

18.95

u/l

0.42

278

Anankastic personality disorder

163

0.73

0.43

1.1

1.2

27.80

29.57

u/l

0.04

137

Benign neoplasm: Long bones of lower limb

157

1.28

0.43

1.4

1.2

16.48

18.01

u/l

0.12

136

Other diseases of biliary tract

442

1.16

0.43

1.2

68.80

35.78

u/l

0.65

378

Thiamine deficiency

1.63

0.43

1.6

1.0

23.70

27.08

u/l

—

Focal epilepsy, strict definition

122

1116

1.09

0.43

1.4

1.2

65.19

39.31

u/l

0.64

106

975

Ectropion of eyelid

221

1.23

0.42

2.7

1.2

35.54

43.82

u/l

0.25

191

Carcinoma in situ of skin, other sites/unspecified

1.41

0.42

1.1

32.00

18.58

u/l

—

Acquired absence of organs, not elsewhere classified

1.41

0.42

1.3

1.2

245.79

12.19

u/l

—

Benign neoplasm of eye and adnexa

553

0.87

0.42

1.1

1.2

65.60

43.51

u/l

0.38

478

Carcinoma in situ of other and unspecified digestive organs

140

1.29

0.42

1.2

147.48

21.13

u/l

0.76

122

Malignant melanoma, excluding all cancers (controls excluding all cancers)

106

965

1.10

0.42

1.2

94.32

26.80

u/l

1.40

832

Motorcycle rider injured in other and unspecified transport accidents

258

1.20

0.42

1.2

13.31

39.56

u/l

1.44

224

Ectopic pregnancy

670

1.12

0.41

1.1

1.2

49.64

25.57

u/l

0.37

593

Follicular adenocarcinoma of thyroid gland

1.53

0.41

1.4

1.1

9.44

15.87

u/l

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

21.71

—

Hemiplegia

249

1.21

0.41

1.2

27.72

37.20

u/l

0.40

215

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

13.70

—

Atopic dermatitis

279

2516

0.95

0.41

1.3

1.2

34.84

30.58

u/l

0.14

247

2209

Sequelae of injuries of head

268

1.20

0.41

1.2

27.63

54.45

u/l

0.86

231

Endometriosis of rectovaginal septum and vagina

326

0.83

0.41

1.1

1.2

31.89

30.12

u/l

0.04

279

Childhood asthma (age<16)

315

1.16

0.40

1.2

84.66

18.87

u/l

0.43

281

Microscopic polyangiitis

1.48

0.40

1.0

1.1

21.46

21.74

u/l

—

Other acquired deformities of ankle and foot

1.48

0.40

1.0

1.2

23.64

15.14

u/l

—

Carcinoma in situ of other and unspecified digestive organs

141

1.28

0.40

1.2

1.3

147.48

35.14

u/l

0.65

120

Melanocytic naevi of trunk

596

1.13

0.40

1.2

23.66

45.23

u/l

1.53

515

Benign neoplasm: Long bones of lower limb

159

1.26

0.40

1.4

1.2

16.48

24.64

u/l

0.49

138

Unspecified organic or symptomatic mental disorder

0.00

0.40

0.0

1.1

—

13.89

—

Procreative management

177

1392

1.07

0.40

1.5

1.2

49.51

33.20

u/l

0.54

155

1226

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

343

1.17

0.40

1.1

1.2

17.02

23.26

u/l

0.60

294

Delivery, wide proxy

166

950

0.93

0.39

1.2

26.68

42.01

u/l

1.08

138

818

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

214

1.22

0.39

1.2

18.82

19.36

u/l

0.05

189

Use of biperiden

281

0.82

0.39

1.1

1.2

49.86

40.09

u/l

0.09

239

Other condition

721

1.11

0.39

1.2

1.3

30.88

41.17

u/l

0.53

625

Other sexually transmitted chlamydial diseases

196

1.23

0.39

1.1

1.2

10.33

30.40

u/l

0.95

172

Haemangioma, any site

419

1.15

0.38

1.2

45.29

33.64

u/l

0.31

359

Atopic dermatitis, strict definition

118

1256

0.92

0.38

1.5

1.2

54.51

33.55

u/l

0.34

104

1101

Other and unspecified primary disorders of muscles

1.40

0.38

1.0

1.2

10.62

12.47

u/l

—

TMD muscular pain linked with fibromyalgia

1.39

0.38

1.0

1.2

9.96

12.42

u/l

—

Tic disorders

1.39

0.38

1.0

1.2

26.84

18.03

u/l

—

Carcinoma in situ, bladder

206

1.22

0.38

1.2

49.81

56.06

u/l

0.08

181

Herpesviral [herpes simplex] infections

561

1.12

0.38

1.2

26.57

39.04

u/l

0.83

487

Chronic mastoiditis

136

0.73

0.38

1.2

32.21

37.36

u/l

—

118

Other strabismus

118

1084

1.09

0.37

1.4

1.3

18.30

35.84

u/l

2.66

111

950

Hypersomnia

1.31

0.37

1.0

1.1

11.11

29.90

u/l

—

Ankle and foot

1.36

0.37

1.0

1.2

72.98

15.03

u/l

—

Respiratory tuberculosis

327

1.16

0.37

1.1

1.2

40.72

41.90

u/l

0.03

283

Respiratory tuberculosis, confirmed and not-confirmed

327

1.16

0.37

1.1

1.2

40.72

41.80

u/l

0.03

282

Abnormal findings on antenatal screening of mother

169

0.77

0.37

1.3

1.2

7.29

23.89

u/l

1.35

144

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

801

1.10

0.36

1.2

98.89

27.63

u/l

1.19

686

Contact with and exposure to communicable diseases

142

1315

1.08

0.36

1.6

1.2

24.95

36.18

u/l

0.96

132

1154

Traction detachment of retina

1.47

0.36

1.3

20.97

12.03

u/l

—

Foreign body on external eye

933

0.91

0.36

1.2

1.3

18.95

34.91

u/l

2.04

819

Assault by blunt object

0.65

0.36

1.0

1.2

19.92

27.38

u/l

—

Unspecified abortion

180

1.22

0.36

1.3

1.2

12.63

20.25

u/l

0.96

161

Patellar tendinitis

0.65

0.36

1.2

1.1

9.72

31.54

u/l

—

Other meningitis

0.64

0.36

1.2

39.10

29.12

u/l

—

Entropion and trichiasis of eyelid

512

0.88

0.35

1.2

34.87

40.10

u/l

0.11

442

Other disorders of binocular vision

1.37

0.34

1.2

9.31

13.33

u/l

—

Injury of eye and orbit

826

0.91

0.34

1.3

33.92

40.09

u/l

0.20

708

Crushing injury of wrist and hand

1.35

0.34

1.1

1.2

67.05

37.74

u/l

0.26

Secondary parkinsonism+Parkinsonism in other disease

163

1.23

0.34

1.1

1.2

22.94

35.22

u/l

0.65

143

Torsion of testis

1.35

0.34

1.3

10.85

30.00

u/l

0.78

Lyme disease

138

1479

0.93

0.34

1.6

1.3

33.19

35.81

u/l

0.11

120

1286

Atypical facial pain

246

1.18

0.34

1.4

1.2

20.78

24.52

u/l

0.23

208

Postpartum haemorrhage

664

0.90

0.34

1.2

36.04

24.16

u/l

0.36

582

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

145

1.25

0.34

1.6

1.1

58.07

21.57

u/l

0.72

128

Glaucoma-related operations

321

1.16

0.33

1.5

1.2

31.22

38.59

u/l

0.26

273

Stenosis and insufficiency of lacrimal passages

491

1.12

0.33

1.5

1.2

20.42

32.79

u/l

1.29

418

Other degenerative diseases of the basal ganglia

0.69

0.33

1.0

1.2

64.23

38.88

u/l

—

Viral conjunctivitis

0.68

0.33

1.5

1.2

11.40

19.21

u/l

—

Use of interferon beta-1a

0.67

0.33

1.2

12.27

11.62

u/l

—

Type of accident

175

1648

1.06

0.33

1.4

1.3

30.48

34.30

u/l

0.26

145

1439

Tonsillectomy and adenotomy

308

2050

1.05

0.32

1.5

1.2

35.38

32.02

u/l

0.11

266

1823

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

388

1.14

0.32

1.6

1.2

18.72

21.82

u/l

0.36

334

Urethral stricture

379

1.14

0.32

1.5

1.2

48.93

50.01

u/l

0.02

333

Benign neoplasm: Skin of scalp and neck

119

1.26

0.32

1.1

1.2

114.97

38.37

u/l

0.34

101

Benign neoplasm: Skin of scalp and neck

119

1.26

0.32

1.1

1.2

114.97

19.03

u/l

0.46

102

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

807

0.91

0.31

1.2

66.83

28.71

u/l

0.42

690

Tuberculosis, IBD comorbidity

427

1.13

0.31

1.2

35.88

41.91

u/l

0.20

365

Visual field defects

465

1.12

0.31

1.1

1.2

40.05

41.99

u/l

0.03

402

Other disorders of cornea

513

1.11

0.31

1.2

36.86

40.31

u/l

0.08

440

Focal brain injury

352

1.14

0.30

1.1

1.3

34.29

51.79

u/l

0.56

300

Cysts of oral region, not elsewhere classified

221

1.18

0.30

1.2

13.40

46.34

u/l

2.18

190

Other acute viral hepatitis

1.30

0.30

1.4

1.3

14.70

14.33

u/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

106

1140

0.93

0.30

1.2

40.92

27.06

u/l

0.75

969

Unspecified jaundice

296

1.15

0.30

1.1

1.2

35.63

34.75

u/l

0.03

253

Cerebral atherosclerosis

1.27

0.30

1.1

1.2

20.66

60.38

u/l

—

Acute alcohol intoxication, ICD10

111

1191

0.93

0.30

1.3

25.46

36.38

u/l

0.69

1049

Chronic suppurative otitis media, including avohilmo

410

1.12

0.29

1.2

80.51

42.20

u/l

0.34

353

Carcinoma in situ of other and unspecified sites

222

1.18

0.29

1.2

49.91

59.68

u/l

0.13

195

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.25

0.29

1.6

1.2

12.47

12.24

u/l

—

Tuberculosis

373

1.13

0.29

1.1

1.2

39.25

46.74

u/l

0.22

321

Abnormal findings in secretions and smears from cervix uteri vagina vulva

187

1548

0.95

0.28

1.2

31.42

28.11

u/l

0.15

164

1352

Spondylopathies (FG)

689

1.09

0.28

1.4

1.3

41.55

36.85

u/l

0.11

600

Abscess of lung

1.32

0.28

1.7

1.2

20.84

39.60

u/l

—

Endovascular or surgical operations to intracerebral aneurysms

333

0.87

0.28

1.1

1.2

18.28

34.02

u/l

1.28

281

Tuberculosis, wide

441

1.11

0.27

1.2

36.73

47.13

u/l

0.36

377

Pregnancy examination and test

327

0.90

0.27

1.2

19.64

44.35

u/l

0.93

294

Sleep disorders, other/unspecified

131

1.22

0.27

1.4

1.2

12.96

28.39

u/l

0.93

109

Injuries to the neck

131

1233

1.06

0.27

1.2

1.3

18.39

36.69

u/l

4.07

116

1072

Fracture at wrist and hand level

217

2071

1.05

0.27

1.2

1.3

37.49

31.96

u/l

0.20

195

1802

Benign neoplasm: Skin of other and unspecified parts of face

624

1.09

0.27

1.1

1.2

22.63

42.17

u/l

2.03

536

Struck by thrown, projected or falling objec

236

0.85

0.26

1.4

1.2

14.89

53.47

u/l

2.13

205

Alcohol abuse, main dg

905

0.93

0.26

1.4

1.3

25.81

41.27

u/l

0.77

787

Superficial injury of wrist and hand

103

964

1.07

0.25

1.1

1.3

18.63

39.62

u/l

2.47

837

Palmar fascial fibromatosis [Dupuytren]

111

1042

1.07

0.25

1.3

74.45

39.87

u/l

0.50

882

Effects of foreign body entering through natural orifice

157

1490

1.05

0.25

1.2

1.3

31.53

34.35

u/l

0.09

143

1304

Bitten or struck by other mammals

463

1.10

0.25

1.4

1.2

15.85

36.95

u/l

2.19

402

Spirochaetal infections, other/unspecified

445

1.10

0.24

1.2

29.07

45.45

u/l

0.65

385

Thyrotoxicosis with diffuse goitre

618

1.09

0.24

1.2

18.41

32.85

u/l

1.37

526

Eustachian salpingitis and obstruction

329

0.88

0.24

1.2

22.98

35.93

u/l

0.44

281

Dissection of aorta

189

1.17

0.24

1.1

1.3

47.84

45.05

u/l

0.04

166

HSIL lesion of the cervix uteri

551

1.09

0.24

1.2

15.13

21.19

u/l

0.85

479

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

0.70

0.24

1.0

1.1

35.42

20.42

u/l

—

Nontraumatic intracranial haemmorrhage

130

1230

1.06

0.24

1.3

1.2

29.94

40.94

u/l

0.73

118

1055

Dissection of cerebral arteries, nonruptured

1.32

0.23

1.2

30.32

14.88

u/l

—

Tic and related disorders

1.32

0.23

1.0

1.2

26.84

18.14

u/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

161

1535

1.05

0.23

1.3

1.2

80.58

37.53

u/l

0.91

144

1333

Contact with machinery

733

0.93

0.23

1.1

1.3

35.82

45.54

u/l

0.41

644

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.29

0.23

1.0

1.1

14.77

16.20

u/l

—

Allergic contact dermatitis

619

0.92

0.23

1.2

19.72

30.17

u/l

0.83

531

Varicella [chickenpox]

247

1.14

0.22

1.3

1.2

37.79

28.36

u/l

0.21

213

Exposure to uncontrolled fire in building or structure

1.25

0.22

1.2

1.3

16.60

13.87

u/l

—

Pedestrian injured in collision with car, pick-up truck or van

125

1.20

0.22

1.1

1.2

92.12

24.67

u/l

0.65

107

Faecal incontinence

452

0.91

0.22

1.2

24.20

28.25

u/l

0.31

386

Carcinoma in situ of breast, intraductal

337

0.89

0.22

1.2

45.04

24.77

u/l

0.69

291

Malignant neoplasm of colon

907

0.94

0.22

1.3

32.70

43.07

u/l

0.71

782

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

192

1838

1.04

0.22

1.2

1.3

41.59

34.25

u/l

0.23

172

1624

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.21

0.0

1.0

—

24.50

—

Other spirochaetal diseases

142

1490

0.95

0.21

1.6

1.3

32.47

35.58

u/l

0.14

124

1297

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.21

0.0

1.1

—

22.31

—

Benign neoplasm: Lymph nodes

0.00

0.21

0.0

1.4

—

7.72

—

Other fall from one level to another

121

1274

0.95

0.21

1.4

1.3

29.95

36.56

u/l

0.40

112

1107

Benign neoplasm: Lymph nodes

0.00

0.21

0.0

1.3

—

10.25

—

Vertical strabismus

156

0.83

0.21

2.0

1.2

16.39

36.26

u/l

0.94

137

Injury of urinary and pelvic organs

102

0.78

0.21

1.0

1.2

10.12

34.18

u/l

—

Hepatocellular carcinoma

103

0.77

0.21

2.0

1.2

84.94

46.17

u/l

—

Complications following abortion and ectopic and molar pregnancy

154

1.17

0.21

1.2

15.65

24.36

u/l

0.57

134

Disorders of optic nerve and visual pathways

440

1.09

0.21

1.2

26.95

40.35

u/l

0.65

380

Other and unspecified pemphigoid

1.17

0.21

1.0

1.1

19.62

56.05

u/l

—

Hypertrophy of breast

663

1.07

0.20

1.3

1.2

25.76

24.20

u/l

0.06

581

Other injuries of upper limb, level unspecified

1.25

0.20

1.2

11.05

13.16

u/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

693

1.07

0.20

1.2

25.89

47.66

u/l

1.51

596

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

1.23

0.20

1.3

1.1

24.97

14.32

u/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

112

1063

1.05

0.20

1.5

1.3

66.33

39.88

u/l

0.59

928

Other inflammation of vagina/vulva

114

0.79

0.20

1.2

12.66

21.65

u/l

—

Pedestrian injured in other and unspecified transport accidents

1.20

0.20

1.0

1.2

14.45

15.74

u/l

—

Operations for atrial fibrillation

1.22

0.19

1.3

1.1

26.33

37.91

u/l

0.41

Macular pucker

908

1.06

0.19

1.3

37.52

37.58

u/l

0.00

800

Spermatocele

510

1.08

0.19

1.1

1.3

22.36

45.92

u/l

2.28

440

Universal erythroderma, KELA reimbursement

1.24

0.19

1.0

1.2

14.44

56.47

u/l

—

Postmenopausal atrophic vaginitis

118

746

0.95

0.19

1.2

55.56

33.06

u/l

0.41

107

641

Myositis

137

1.17

0.19

1.3

19.77

54.72

u/l

1.24

119

Combined immunodeficiencies

1.13

0.18

1.3

1.2

723.92

16.13

u/l

—

Myopia

519

0.92

0.18

1.2

105.69

30.99

u/l

0.57

453

Other/unspecified reactive arthropathies

328

1.10

0.18

2.4

1.2

27.58

37.00

u/l

0.33

283

All dysplastic lesions of the cervix uteri, vagina or vulva

101

953

1.05

0.18

1.3

1.2

27.51

29.27

u/l

0.05

839

Benign lipomatous neoplasm of other sites/unspecified

518

0.93

0.18

1.1

1.2

29.01

39.48

u/l

0.56

445

D07AA Corticosteroids, weak (group I)

686

1.06

0.18

1.2

1.3

32.81

35.48

u/l

0.10

592

Postpartum hemorraghe, all women as controls

731

0.94

0.18

1.2

36.04

28.29

u/l

0.21

645

Exfoliative dermatitis

1.17

0.18

2.1

1.1

36.74

53.86

u/l

—

Nonsuppurative otitis media

108

889

1.05

0.17

1.2

71.38

41.50

u/l

0.45

775

Thyroiditis, unspecified

1.15

0.17

1.1

1.3

16.28

15.07

u/l

—

Sequelae of injuries of lower limb

484

1.08

0.17

1.4

1.2

17.44

45.08

u/l

2.56

414

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

368

1.09

0.17

1.1

1.2

17.02

44.65

u/l

2.50

316

Retinal breaks without detachment

913

1.05

0.17

1.2

1.3

58.79

37.64

u/l

0.48

800

Rheumatoid arthritis, including avohilmo

242

2348

1.03

0.17

1.2

67.98

36.09

u/l

1.06

220

2024

Contact with other hot metals

1.22

0.17

1.6

1.2

15.57

32.57

u/l

—

Corneal ulcer

1019

0.95

0.17

1.3

1.2

26.17

38.16

u/l

1.04

886

Early syphilis

1.11

0.17

1.1

1.2

11.53

17.06

u/l

—

Right hemicolectomy

349

1.09

0.17

1.1

1.2

33.46

46.93

u/l

0.60

303

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

0.75

0.17

1.4

1.2

8.58

17.88

u/l

—

Lagophthalmos

0.74

0.17

1.4

1.2

79.68

44.28

u/l

—

Shoulder region

0.74

0.17

1.0

1.2

128.00

20.13

u/l

—

Ankylosing spondylitis, ICD10

475

0.93

0.17

1.5

1.2

36.95

45.95

u/l

0.23

409

Melanoma in situ of trunk

0.73

0.17

1.6

1.1

363.22

20.17

u/l

—

Malignant neoplasm of mesothelium and soft tissue

253

1.11

0.17

1.2

67.45

43.64

u/l

0.20

222

Other salmonella infections

194

0.87

0.16

1.2

1.3

57.26

27.71

u/l

0.50

168

L02BB Anti-androgens

602

1.06

0.16

3.5

1.3

60.49

45.41

u/l

0.41

523

Ulcerative colitis (strict definition, all Crohn cases excluded)

758

1.06

0.16

1.2

33.01

39.39

u/l

0.23

657

Abdominal aortic aneurysm (AAA)

623

0.94

0.16

1.2

1.3

30.43

43.75

u/l

0.65

535

Fistulae involving female genital tract

1.14

0.16

1.5

1.2

9.96

25.54

u/l

—

Sequelae of tuberculosis

1.20

0.16

1.2

1.1

30.12

43.93

u/l

0.39

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

130

0.84

0.16

1.1

1.2

22.07

41.95

u/l

0.62

113

Other disorders of the genitourinary system

642

1.06

0.16

1.2

24.64

35.69

u/l

1.13

558

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

658

0.94

0.16

1.3

1.2

35.72

28.63

u/l

0.37

562

Transient global amnesia

545

0.93

0.15

1.3

1.2

15.77

45.12

u/l

3.67

470

Burn and corrosion of ankle and foot

0.79

0.15

1.0

1.2

78.90

17.10

u/l

—

Hallux rigidus

791

0.95

0.15

1.2

1.3

42.43

39.87

u/l

0.07

679

Beningn neoplasm: Meninges, unspecified

0.78

0.15

1.0

1.2

40.45

17.79

u/l

—

Beningn neoplasm: Meninges, unspecified

0.77

0.15

1.0

1.2

40.45

18.55

u/l

—

Dental caries 2 and operation codes, only avohilmo

480

2920

1.02

0.15

1.3

25.28

38.51

u/l

2.04

403

2591

Desensitization to allergens

182

0.88

0.15

2.4

1.2

70.08

36.38

u/l

0.23

160

Benign neoplasm of breast

513

0.94

0.15

1.1

1.2

26.70

28.19

u/l

0.06

446

Complications of labour and delivery

282

1613

0.97

0.15

1.2

26.80

32.84

u/l

0.62

245

1413

Fracture of lower leg, including ankle

349

3552

0.98

0.15

1.3

21.90

33.74

u/l

2.77

295

3100

Seropositive rheumatoid arthritis, wide

164

1587

1.03

0.14

1.3

1.2

79.77

37.22

u/l

0.92

147

1377

Additional codes for the location of defect, injury or illness

275

0.91

0.14

1.1

1.3

84.65

47.97

u/l

0.49

239

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

227

1.10

0.14

1.4

1.2

13.93

20.57

u/l

0.87

194

Mumps

141

1.14

0.14

1.2

10.91

31.50

u/l

1.42

120

Demyelinating diseases of the central nervous system

363

1.08

0.13

1.1

1.2

14.69

36.00

u/l

1.80

315

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

587

1.06

0.13

1.7

1.2

25.49

29.63

u/l

0.30

509

Impacted cerumen

568

1.06

0.13

1.3

1.2

48.37

45.41

u/l

0.04

491

Injury of muscle and tendon at lower leg level

919

0.96

0.13

1.5

1.2

26.36

37.48

u/l

0.67

805

Contraceptive management

228

1645

0.97

0.13

1.2

19.23

30.89

u/l

1.98

202

1453

FESS (DNB20)

667

1.05

0.13

1.8

1.3

23.89

41.46

u/l

1.14

584

Methotrexate

736

1.05

0.12

1.2

51.23

37.36

u/l

0.22

637

Benign neoplasm of eye and adnexa

509

0.94

0.12

1.1

1.2

65.60

27.50

u/l

0.80

437

Alcohol dependence

190

1850

1.03

0.12

1.2

1.3

39.26

31.62

u/l

0.42

160

1614

Residual foreign body in soft tissue

262

0.92

0.12

1.5

1.2

16.76

60.71

u/l

2.26

226

Normotensive glaucoma

488

0.94

0.12

1.5

1.2

24.94

44.88

u/l

1.33

422

Benign neoplasm of meninges

482

1.06

0.12

1.1

1.2

34.32

24.67

u/l

0.47

417

Other facial nerve disorders

152

1.12

0.12

1.1

1.2

25.56

40.39

u/l

0.44

127

Glaucoma, exfoliation

649

1.05

0.12

1.2

32.67

49.09

u/l

0.97

560

Inguinal or femoral hernia, bilateral

732

0.96

0.12

1.2

1.3

97.07

36.82

u/l

0.56

642

Autonomic disorders

116

0.86

0.12

1.1

1.2

81.69

24.37

u/l

—

Mild mental retardation

116

0.86

0.12

1.5

1.2

24.67

22.44

u/l

—

104

Suppurative otitis media, unspecified

1.16

0.11

1.2

13.81

62.89

u/l

1.14

Other obstetric conditions, not elsewhere classified

562

1.04

0.11

1.1

1.3

16.76

36.15

u/l

1.47

502

Other/unspecified seropositive rheumatoid arthritis

161

1567

1.03

0.11

1.3

1.2

80.58

37.50

u/l

0.91

144

1359

Fracture of forearm

325

3097

0.98

0.11

1.7

1.2

54.23

34.42

u/l

0.99

281

2674

Other disorders of nervous system

387

1.06

0.10

1.2

57.79

42.67

u/l

0.29

328

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

102

987

1.03

0.10

1.2

1.3

30.53

35.92

u/l

0.26

857

Alcoholic liver disease

637

0.96

0.10

1.3

37.54

39.79

u/l

0.06

549

Ulcerative colitis (strict definition, require KELA)

889

1.04

0.10

1.2

1.3

33.02

37.10

u/l

0.17

776

Dislocation, sprain and strain of joint and ligaments of hip

183

1.09

0.10

1.1

1.2

19.06

48.49

u/l

1.42

159

Vascular dementia

448

0.95

0.10

1.3

1.2

26.43

55.15

u/l

1.51

383

Other specified disorders of external ear

222

1.08

0.10

3.0

1.2

38.84

48.95

u/l

0.17

192

Inhalation and ingestion of food causing obstruction of respiratory tract

1.14

0.10

1.2

30.00

43.78

u/l

—

Speech disturbances, not elsewhere classified

504

0.95

0.10

1.1

1.2

56.48

37.60

u/l

0.21

435

Malignant neoplasm of parotid gland

1.09

0.09

1.2

1.1

28.49

15.80

u/l

—

Benign neoplasm of middle ear and respiratory system

467

1.05

0.09

1.2

41.28

41.16

u/l

0.00

402

Benign neoplasm: Rectum/anal canal icd-9

1.06

0.09

1.2

1.1

30.59

47.91

u/l

—

Other immunodeficiencies

1.06

0.09

1.2

1.1

22.00

13.50

u/l

—

Iliotibial band syndrome

1.06

0.09

1.4

1.2

8.42

26.37

u/l

—

Ankylosing spondylitis

483

0.95

0.09

1.5

1.3

35.91

38.72

u/l

0.07

419

Acute nasopharyngitis (common cold)

702

0.96

0.09

1.0

1.3

19.91

26.53

u/l

0.70

613

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

310

2490

1.02

0.09

1.5

1.2

41.11

33.59

u/l

0.25

273

2161

Benign neoplasm: Appendix

1.11

0.09

1.2

76.82

14.58

u/l

—

Anorexia

1.11

0.09

1.0

1.1

19.55

13.42

u/l

—

Disorders of refraction and accommodation

136

1322

1.02

0.09

1.3

55.09

33.03

u/l

0.45

120

1154

1.09

0.09

1.0

1.2

6.35

12.27

u/l

—

Calculus of lower urinary tract

331

1.06

0.09

1.1

1.2

91.63

49.84

u/l

0.28

292

Other benign neoplasms of connective and other soft tissue

512

0.96

0.08

1.3

1.2

15.91

37.36

u/l

2.90

438

Benign mammary dysplasia

644

0.96

0.08

1.2

18.42

32.52

u/l

1.44

560

Benign neoplasm: Parathyroid gland

1.05

0.08

1.2

58.88

18.57

u/l

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

1.05

0.08

1.2

14.00

15.01

u/l

—

LSIL lesion of the cervix uteri, vagina or vulva

461

0.95

0.08

1.3

1.2

45.73

19.60

u/l

0.40

405

Atypical mycobacterium lung infection

1.03

0.08

1.2

21.77

18.02

u/l

—

Benign neoplasm: Skin of lower limb, including hip

144

0.90

0.08

1.2

261.94

26.57

u/l

—

129

Golimumab

144

0.90

0.08

1.2

20.98

27.41

u/l

0.20

126

Malignant neoplasm of heart, mediastinum and pleura

0.83

0.08

1.0

1.1

24.76

47.76

u/l

—

Benign neoplasm: Tonsil

0.80

0.08

1.0

1.1

19.98

16.11

u/l

—

Melanoma in situ of trunk

0.80

0.08

1.6

1.1

363.22

50.94

u/l

—

Vascular dementia (multiple infarctions)

0.83

0.08

1.2

1.1

9.08

56.06

u/l

—

Benign neoplasm: Tonsil

0.79

0.08

1.0

1.2

19.98

14.56

u/l

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

0.79

0.08

1.8

1.2

18.10

18.82

u/l

—

Otosclerosis

430

0.95

0.08

1.2

1.3

40.94

37.27

u/l

0.08

370

Family history of malignant neoplasm

430

0.95

0.08

1.1

1.3

31.20

27.53

u/l

0.10

375

Other and unspecified injuries of thorax

1.14

0.08

1.0

1.1

23.81

24.15

u/l

—

Vitamin D deficiency

1.03

0.08

2.1

1.2

58.64

13.15

u/l

—

Primary open-angle glaucoma, strict

170

1664

1.02

0.07

1.3

27.56

42.44

u/l

2.05

138

1436

Benign neoplasm: Oesophagus

0.86

0.07

1.2

123.92

17.26

u/l

—

Postpartum hemorraghe, parous women as controls

624

0.97

0.07

1.2

36.04

23.72

u/l

0.37

564

Bicipital tendinitis

276

0.94

0.07

1.2

48.49

46.34

u/l

0.03

238

Atopic dermatitis, strict definition with reimbursement

135

1281

1.02

0.07

1.4

1.2

49.03

32.40

u/l

0.30

120

1125

Carcinoma in situ of colon

1.05

0.07

1.0

1.2

99.41

17.17

u/l

—

Carcinoma in situ of colon

1.03

0.07

1.0

1.2

99.41

16.62

u/l

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

0.84

0.07

1.0

1.1

29.48

21.67

u/l

—

Other lack of coordination

0.84

0.07

1.4

1.2

7.69

37.90

u/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

104

679

1.03

0.07

1.3

1.2

17.44

29.79

u/l

1.79

591

Other noninflammatory disorders of vagina

304

1.05

0.07

1.3

1.2

45.64

24.33

u/l

0.31

262

Injury of intra-abdominal organs

122

0.90

0.07

1.0

1.2

10.69

52.37

u/l

1.32

105

HSIL lesion of the cervix uteri, vagina or vulva

620

1.03

0.07

1.2

14.94

26.26

u/l

1.46

540

Malignant neoplasm of testis

0.85

0.06

1.0

1.2

12.00

49.97

u/l

—

Medical abortion

311

1711

0.99

0.06

1.2

46.70

33.61

u/l

0.47

265

1499

Temporomandibular joint disorders, including avohilmo

198

1947

1.02

0.06

1.2

26.81

36.11

u/l

0.85

169

1711

Campylobacter enteritis

138

1.09

0.06

1.5

1.3

13.31

37.10

u/l

1.19

118

Contact with sharp object, undetermined intent

103

0.87

0.06

1.0

1.2

27.88

29.71

u/l

—

Medical treatment for female infertility

577

0.97

0.06

1.3

1.2

13.07

32.05

u/l

2.48

515

Speech therapy

166

1633

1.02

0.06

1.3

1.2

86.99

38.60

u/l

1.18

157

1417

Pneumothorax

406

0.96

0.06

1.2

24.39

47.32

u/l

1.45

362

Disorders of breast

230

2103

1.01

0.06

1.2

23.58

33.92

u/l

1.25

200

1825

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

538

1.03

0.06

1.2

1.3

17.07

37.31

u/l

1.46

481

Leisure time condition

959

1.02

0.06

1.6

1.3

29.48

41.68

u/l

0.72

840

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

110

1078

1.02

0.06

1.2

38.14

28.04

u/l

0.62

915

Benign lipomatous neoplasm of other sites/unspecified

464

1.03

0.05

1.1

1.2

29.01

28.14

u/l

0.04

398

Injury of other and unspecified intrathoracic organs

385

1.04

0.05

1.5

1.2

27.37

53.77

u/l

1.00

336

Pedal cyclist injured in other and unspecified transport accidents

567

0.97

0.05

1.4

1.2

31.47

42.96

u/l

0.43

488

Delirium, not induced by alcohol and other psychoactive substances

681

1.03

0.05

1.3

1.2

30.25

53.07

u/l

1.42

590

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

155

1526

1.02

0.05

1.2

1.3

20.93

32.35

u/l

1.17

135

1330

Benign neoplasm: Skin of lower limb, including hip

141

0.92

0.05

1.2

261.94

20.67

u/l

—

123

Melanocytic naevi of lower limb, including hip

202

0.94

0.05

1.2

26.21

28.11

u/l

0.05

174

Disorders of eyelid in diseases classified elsewhere

161

0.93

0.05

1.1

1.2

18.92

29.76

u/l

0.60

144

Left ventricular outflow tract obstruction, narrow definition

228

1.05

0.05

1.1

1.2

17.97

46.30

u/l

1.29

197

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

426

1.03

0.05

1.6

1.2

18.72

35.36

u/l

1.83

365

Endometriosis diagnosis and infertility diagnosis occurring together

343

0.96

0.04

1.3

1.2

18.21

20.13

u/l

0.09

296

Endometriosis ASRM stages 3,4

962

1.02

0.04

1.3

1.2

29.37

25.01

u/l

0.20

837

Inguinal hernia, bilateral

716

0.98

0.04

1.2

1.3

97.07

37.38

u/l

0.55

628

Malignant neoplasm of head and neck

494

0.97

0.04

1.7

1.2

24.05

40.58

u/l

1.48

431

Chalazion

615

1.02

0.04

1.3

1.2

30.92

43.38

u/l

0.59

531

Infections of breast associated with childbirth

1.10

0.04

1.4

1.2

15.21

17.46

u/l

—

Degenerative macular diseases

715

1.02

0.04

1.3

1.2

49.64

41.95

u/l

0.23

625

Benign neoplasm: Cerebral meninges

447

1.03

0.04

1.1

1.2

29.54

23.92

u/l

0.24

386

Reimbursement for rheumatic diseases

365

3668

0.99

0.04

1.2

1.3

54.58

33.50

u/l

1.01

326

3179

LSIL lesion of the cervix uteri

352

0.97

0.04

1.4

1.2

51.40

19.42

u/l

0.41

309

Benign neoplasm: Larynx

170

1.06

0.04

1.1

1.2

109.77

19.43

u/l

0.82

147

Lichen planus, including avohilmo

100

1016

0.98

0.04

1.2

23.56

38.97

u/l

2.21

885

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

119

0.92

0.04

1.1

1.2

22.07

15.80

u/l

0.26

105

Intracerebral haemorrhage

754

0.98

0.03

1.2

1.3

35.11

46.00

u/l

0.37

642

Mixed conductive and sensorineural hearing loss

724

0.98

0.03

1.7

1.2

64.48

39.92

u/l

0.60

629

Psoriatic and enteropathic arthropathies

597

1.02

0.03

1.2

1.3

41.17

36.63

u/l

0.10

520

Impacted maxillary molar

131

1.07

0.03

1.4

1.5

210.03

31.22

u/l

0.43

115

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

240

1.04

0.03

1.4

1.2

13.93

38.75

u/l

1.86

204

Benign neoplasm of meninges

522

0.98

0.03

1.1

1.2

34.32

36.44

u/l

0.07

441

Retinal detachment with retinal break

793

0.98

0.03

1.2

1.3

41.70

41.52

u/l

0.00

694

Obstructed labour due to maternal pelvic abnormality

622

0.98

0.03

1.3

1.2

23.21

24.33

u/l

0.06

547

Sulfasalazine

162

1636

0.99

0.03

1.3

1.2

53.31

30.13

u/l

0.51

144

1410

Graves ophthalmopathy, strict

1.09

0.03

1.1

1.2

14.09

22.90

u/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

847

1.02

0.03

1.2

1.3

34.06

38.19

u/l

0.16

738

Other enthesopathy of foot (+metatarsalgia)

459

1.02

0.03

1.1

1.2

28.37

39.14

u/l

0.35

395

Benign neoplasm of breast

491

0.98

0.03

1.1

1.2

26.70

25.19

u/l

0.06

423

Other disorders of breast

489

1.02

0.03

1.4

1.2

32.56

24.30

u/l

0.23

418

Use of disulfiram, acamprosate or naltrexone

521

0.98

0.03

1.2

28.11

42.57

u/l

0.55

449

Short Achilles tendon (acquired)

122

1.07

0.02

1.3

1.2

61.69

23.74

u/l

0.40

105

Fall on and from ladder

500

1.02

0.02

1.9

1.3

35.58

44.21

u/l

0.26

437

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

158

0.95

0.02

2.4

1.2

16.61

22.98

u/l

0.36

139

Other menopausal disorders

125

728

0.99

0.02

1.3

1.2

22.35

30.91

u/l

0.65

112

635

Alcohol abuse, main dg, excluding more controls

851

0.99

0.02

1.4

1.3

25.81

39.58

u/l

0.65

757

Other degenerative diseases of the nervous system

165

1241

1.01

0.02

1.2

1.3

42.89

45.46

u/l

0.09

142

1054

Malignant neoplasm of corpus uteri

381

1.02

0.02

1.2

105.14

29.55

u/l

0.43

328

Childhood allergy (age < 16)

287

0.98

0.02

2.3

1.2

106.40

39.10

u/l

0.32

258

Malignant melanoma

899

0.99

0.01

1.2

1.3

106.46

35.98

u/l

1.16

774

Benign neoplasm: Larynx

173

1.04

0.01

1.1

1.2

109.77

43.38

u/l

0.54

148

Obstructed labour due to malposition and malpresentation of fetus

639

0.99

0.01

1.3

1.2

18.78

24.64

u/l

0.41

564

Colorectal cancer, excluding all cancers (controls excluding all cancers)

167

1624

0.99

0.01

1.2

69.25

26.44

u/l

1.20

144

1387

UC patients in KELA-register (code 208), prior to 1994

253

1.03

0.01

1.1

1.2

19.10

43.46

u/l

1.59

217

Maternal care for known or suspected abnormality of pelvic organs

578

0.99

0.01

1.3

1.2

20.57

31.88

u/l

0.81

512

Abrasion of teeth

146

1067

1.01

0.01

1.2

1.3

61.89

28.74

u/l

0.64

127

953

Malignant melanoma of skin

663

1.01

0.01

1.2

92.23

37.06

u/l

0.73

573

Pregnancy with abortive outcome

329

1725

1.00

0.01

1.2

35.18

33.51

u/l

0.06

280

1509

Contusion of toe(s) without damage to nail

1.06

0.01

1.1

1.2

19.70

22.47

u/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

116

0.95

0.00

1.1

1.2

13.68

19.13

u/l

0.47

Loose body in joint

126

0.95

0.00

1.2

1.4

28.56

34.98

u/l

0.12

103

Lichen planus

716

0.99

0.00

1.2

23.37

40.59

u/l

1.82

619

Lichen ruber planus, wide definition including periferal and oral lichen planus

119

1196

0.99

0.00

1.2

1.3

24.07

37.04

u/l

2.00

1046

Retained placenta and membranes, without haemorrhage

452

1.00

0.00

1.2

22.85

19.21

u/l

0.23

394

Other benign neoplasms of connective and other soft tissue

488

1.00

0.00

1.3

1.2

15.91

29.50

u/l

1.54

419

Memory loss

562

1.00

0.00

1.2

24.43

48.21

u/l

1.60

490

Superficial injury of shoulder and upper arm

588

1.00

0.00

1.3

1.2

39.22

37.52

u/l

0.04

508

Metatarsalgia

435

0.99

0.00

1.1

1.2

30.60

38.46

u/l

0.21

372

Somnolence, stupor and coma

224

0.98

0.00

1.4

1.2

55.14

35.67

u/l

0.18

198

Other noninflammatory disorders of cervix uteri

224

0.98

0.00

1.2

42.54

25.09

u/l

0.40

194

Nummular dermatitis

466

1.01

0.00

1.2

20.14

41.47

u/l

2.17

404

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

449

1.00

0.00

1.2

90.04

26.97

u/l

0.42

387

Melanocytic naevi of lower limb, including hip

191

0.99

0.00

1.2

26.21

20.08

u/l

0.19

162

Benign neoplasm: Cerebral meninges

459

1.00

0.00

1.1

1.2

29.54

37.30

u/l

0.31

388

Oral lichen ruber planus wide, hypothyreosis or thyroxin

258

1.01

0.00

1.3

1.2

19.29

25.41

u/l

0.38

222

Graves ophthalmopathy

109

1.01

0.00

1.1

1.2

13.68

20.71

u/l

0.62

Burn and corrosion of wrist and hand

175

1.03

0.00

1.5

1.3

12.45

41.16

u/l

1.55

150

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

0.94

0.00

1.0

1.3

45.44

16.20

u/l

—

Haemorrhagic disorder due to circulating anticoagulants

0.91

0.00

1.0

1.2

28.36

55.10

u/l

—

Fibrosis and sclerosis of liver

0.00

0.0

1.2

—

18.10

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.0

1.0

—

6.75

—

Benign neoplasm: Trachea

0.00

0.0

1.3

—

13.38

—

Use of cabergoline

0.93

0.00

1.2

1.1

19.45

13.90

u/l

—

Dysplastic lesion of the vulva of unknown severity

0.00

0.0

1.0

—

34.48

—

Other sudden death, cause unknown

0.00

0.0

1.4

—

32.45

—

Retained (old) foreign body following penetrating wound of orbit

0.00

0.0

1.2

—

6.13

—

Guillain-Barre syndrome

0.90

0.00

1.5

1.2

10.51

34.51

u/l

—

Hypersensitivity pneumonitis due to organic dust

0.95

0.00

3.7

1.2

216.11

41.23

u/l

—

Benign neoplasm: Appendix

1.02

0.00

1.2

76.82

16.74

u/l

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

0.0

1.0

—

12.56

—

Deep bite that required surgery

0.94

0.00

1.0

1.2

10.84

11.04

u/l

—

Ovarian dysfunction: estrogen excess

0.00

0.0

1.0

—

6.28

—

Mixed disorder of acid-base balance

0.00

0.0

1.0

—

17.62

—

Environmental-pollution-related condition

0.00

0.0

1.1

—

12.08

—

Endometriosis in cutaneous scar

0.00

0.0

1.1

—

24.39

—

Injury of muscle and tendon at neck level

0.00

0.0

1.3

—

12.07

—

Pemphigus foliaceus

0.00

0.0

1.3

—

8.53

—

Syndactyly

0.00

0.0

1.4

—

10.45

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.0

1.3

—

9.61

—

Acrodermatitis chronica atrophicans

0.00

0.0

1.1

—

16.50

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.0

1.3

—

32.13

—

Causalgia

0.88

0.00

1.1

1.2

9.57

30.30

u/l

—

Disorders of multiple cranial nerves

0.00

0.0

1.0

—

17.36

—

Benign neoplasm: Oesophagus

0.88

0.00

1.2

1.1

123.92

37.55

u/l

—

Dengue fever [classical dengue]

0.00

0.0

1.3

—

11.88

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.0

1.2

—

15.92

—

Tympanosclerosis

0.00

0.0

1.2

—

14.95

—

Q fever

0.00

0.0

1.8

—

12.30

—

Benign neoplasm: Skin of lip

0.99

0.00

1.0

1.2

13.41

18.56

u/l

—

Congenital malformations of uterus and cervix

1.00

0.00

1.0

1.1

8.02

25.40

u/l

—

Hereditary retinal dystrophy

0.97

0.00

1.0

1.3

48.55

27.77

u/l

—

Drug-induced tics and other tics of organic origin

0.00

0.0

1.0

—

16.34

—

Somnolence

1.00

0.00

1.4

1.1

9.75

12.28

u/l

—

Drowning to ice

0.00

0.0

1.0

—

11.20

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.0

1.1

—

9.48

—

Asphyxiation

0.00

0.0

1.2

—

13.25

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

0.0

1.0

—

16.82

—

Malignant neoplasm of rectosigmoid junction

0.88

0.00

1.1

1.2

52.00

49.07

u/l

—

Other disorders of binocular movement

0.89

0.00

1.1

1.2

20.44

12.80

u/l

—

Cellulitis of external ear

1.02

0.00

1.7

1.1

21.73

14.65

u/l

—

Myopathy due to other toxic agents

0.00

0.0

1.4

—

11.66

—

Calcium deposit in bursa

0.00

0.0

1.1

—

18.04

—

Primary ovarian failure

0.88

0.00

1.2

7.52

15.16

u/l

—

Disorders of olfactory nerve

0.00

0.0

1.2

—

13.12

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

0.94

0.00

1.5

1.1

8.13

44.15

u/l

—

Adhesive middle ear disease

0.97

0.00

1.3

1.2

12.41

25.71

u/l

—

Benign neoplasm: Parathyroid gland

1.02

0.00

1.2

1.1

58.88

16.86

u/l

—

Certolizumab pegol

0.89

0.00

1.2

19.94

11.79

u/l

—

Disorders of hypoglossal nerve

0.00

0.0

1.0

—

25.10

—

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

1.00

0.00

1.2

28.22

13.45

u/l

—

Cleft lip

0.00

0.0

1.4

—

9.63

—

Cardiovascular devices associated with adverse incidents

0.00

0.0

1.2

—

12.82

—

Congenital malformations of great veins

0.00

0.0

1.0

—

25.12

—

Bacterial sepsis of newborn

0.00

0.0

1.1

—

9.90

—

Ascorbic acid deficiency

0.00

0.0

1.2

—

35.48

—

Benign neoplasm: Skin of lip

1.01

0.00

1.0

1.2

13.41

15.81

u/l

—

Traumatic subcutaneous emphysema

0.00

0.0

1.2

—

13.22

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

1.0

—

11.06

—

Intentional self-harm by other and unspecified firearm discharge

0.00

0.0

1.4

—

18.67

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

0.0

1.0

—

7.54

—

Porphyria cutanea tarda

0.00

0.0

1.0

—

15.73

—

Other hypertrichosis

0.00

0.0

1.0

—

13.07

—

Bacterial meningoencephalitis and meningomyelitis

0.00

0.0

1.5

—

11.18

—

Disorders of vagus nerve

0.00

0.0

1.1

—

12.47

—

Lumbosacral root disorders, not elsewhere classified

0.99

0.00

1.0

1.2

21.27

19.18

u/l

—

Liveborn infants according to place of birth

0.00

0.0

1.5

—

10.73

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.2

—

19.64

—

Toxic liver disease

0.91

0.00

1.0

1.2

15.99

13.55

u/l

—

CR(E)ST syndrome

1.00

0.00

1.0

1.2

50.40

16.95

u/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Erythropoietin (EPO) [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS